
<html lang="en"     class="pb-page"  data-request-id="9f41b6bd-c0e9-4a94-a8a0-1dd4455edd69"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-24;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01447;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity" /></meta><meta name="dc.Creator" content="Tino  Heimburg" /></meta><meta name="dc.Creator" content="Fiona R.  Kolbinger" /></meta><meta name="dc.Creator" content="Patrik  Zeyen" /></meta><meta name="dc.Creator" content="Ehab  Ghazy" /></meta><meta name="dc.Creator" content="Daniel  Herp" /></meta><meta name="dc.Creator" content="Karin  Schmidtkunz" /></meta><meta name="dc.Creator" content="Jelena  Melesina" /></meta><meta name="dc.Creator" content="Tajith Baba  Shaik" /></meta><meta name="dc.Creator" content="Frank  Erdmann" /></meta><meta name="dc.Creator" content="Matthias  Schmidt" /></meta><meta name="dc.Creator" content="Christophe  Romier" /></meta><meta name="dc.Creator" content="Dina  Robaa" /></meta><meta name="dc.Creator" content="Olaf  Witt" /></meta><meta name="dc.Creator" content="Ina  Oehme" /></meta><meta name="dc.Creator" content="Manfred  Jung" /></meta><meta name="dc.Creator" content="Wolfgang  Sippl" /></meta><meta name="dc.Description" content="Histone deacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent se..." /></meta><meta name="Description" content="Histone deacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent se..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 15, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01447" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01447" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01447" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01447" /></link>
        
    
    

<title>Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01447" /></meta><meta property="og:title" content="Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0016.jpeg" /></meta><meta property="og:description" content="Histone deacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent selective inhibitors have been obtained, for other subtypes much less is known on selective inhibitors and the consequences of their inhibition. The present report describes the development of substituted benzhydroxamic acids as potent and selective HDAC8 inhibitors. Docking studies using available crystal structures have been used for structure-based optimization of this series of compounds. Within this study, we have investigated the role of HDAC8 in the proliferation of cancer cells and optimized hits for potency and selectivity, both in vitro and in cell culture. The combination of structure-based design, synthesis, and in vitro screening to cellular testing resulted in potent and selective HDAC8 inhibitors that showed anti-neuroblastoma activity in cellular testing." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01447"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01447">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01447&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01447&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01447&amp;href=/doi/10.1021/acs.jmedchem.7b01447" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10188-10204</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01454" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01520" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tino++Heimburg">Tino Heimburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fiona+R.++Kolbinger">Fiona R. Kolbinger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>2.1</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrik++Zeyen">Patrik Zeyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ehab++Ghazy">Ehab Ghazy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Herp">Daniel Herp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Schmidtkunz">Karin Schmidtkunz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jelena++Melesina">Jelena Melesina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tajith+Baba++Shaik">Tajith Baba Shaik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Erdmann">Frank Erdmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Schmidt">Matthias Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Romier">Christophe Romier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dina++Robaa">Dina Robaa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olaf++Witt">Olaf Witt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>2.1</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ina++Oehme">Ina Oehme</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>2.1</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manfred++Jung">Manfred Jung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6361-7716" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Sippl">Wolfgang Sippl</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5985-9261" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany</span></div><div class="aff-info" id="aff2.1"><span class="aff-symbol">2.1</span> <span class="aff-text">German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Preclinical Program, Hopp Children’s Cancer Center at NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institute of Pharmaceutical Sciences, University of Freiburg, 79104 Freiburg, Germany</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Département de Biologie Structurale Intégrative, Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UDS), CNRS, INSERM, 67404 Illkirch Cedex, France</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +493455525040. E-mail: <a href="/cdn-cgi/l/email-protection#04736b686263656a632a776d74746844746c657669657e6d612a716a6d296c656868612a6061"><span class="__cf_email__" data-cfemail="6c1b03000a0b0d020b421f051c1c002c1c040d1e010d1605094219020541040d000009420809">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01447&amp;href=/doi/10.1021%2Facs.jmedchem.7b01447" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10188–10204</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 30, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2017</li><li><span class="item_label"><b>Published</b> online</span>15 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01447" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01447</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10188%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTino%2BHeimburg%252C%2BFiona%2BR.%2BKolbinger%252C%2BPatrik%2BZeyen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D24%26contentID%3Dacs.jmedchem.7b01447%26title%3DStructure-Based%2BDesign%2Band%2BBiological%2BCharacterization%2Bof%2BSelective%2BHistone%2BDeacetylase%2B8%2B%2528HDAC8%2529%2BInhibitors%2Bwith%2BAnti-Neuroblastoma%2BActivity%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10204%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01447"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3474</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01447" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tino&quot;,&quot;last_name&quot;:&quot;Heimburg&quot;},{&quot;first_name&quot;:&quot;Fiona&quot;,&quot;last_name&quot;:&quot;R. Kolbinger&quot;},{&quot;first_name&quot;:&quot;Patrik&quot;,&quot;last_name&quot;:&quot;Zeyen&quot;},{&quot;first_name&quot;:&quot;Ehab&quot;,&quot;last_name&quot;:&quot;Ghazy&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Herp&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Schmidtkunz&quot;},{&quot;first_name&quot;:&quot;Jelena&quot;,&quot;last_name&quot;:&quot;Melesina&quot;},{&quot;first_name&quot;:&quot;Tajith&quot;,&quot;last_name&quot;:&quot;Baba Shaik&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Erdmann&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Schmidt&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Romier&quot;},{&quot;first_name&quot;:&quot;Dina&quot;,&quot;last_name&quot;:&quot;Robaa&quot;},{&quot;first_name&quot;:&quot;Olaf&quot;,&quot;last_name&quot;:&quot;Witt&quot;},{&quot;first_name&quot;:&quot;Ina&quot;,&quot;last_name&quot;:&quot;Oehme&quot;},{&quot;first_name&quot;:&quot;Manfred&quot;,&quot;last_name&quot;:&quot;Jung&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Sippl&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;10188-10204&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01447&quot;},&quot;abstract&quot;:&quot;Histone deacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent selective inhibitors have been obtained, for other subtypes much less is known on selective inhibitors and the consequences of their inhibition. The present report describes the development of substituted benzhydroxamic acids as potent and selective HDAC8 inhibitors. Docking studies using available crystal structures have been used for structure-based optimization of this series of compounds. Within this study, we have investigated the role of HDAC8 in the proliferation of cancer cells and optimized hits for potency and selectivity, both in vitro and in cell culture. The combination of structure-based design, synthesis, and in vitro screening to cellular testing resulted in potent and selective HDAC8 inhibitors that showed anti-neuroblastoma activity in cellular testing.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01447&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01447" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01447&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01447" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01447&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01447" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01447&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01447&amp;href=/doi/10.1021/acs.jmedchem.7b01447" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01447" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01447" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01447%26sid%3Dliteratum%253Aachs%26pmid%3D29190092%26genre%3Darticle%26aulast%3DHeimburg%26date%3D2017%26atitle%3DStructure-Based%2BDesign%2Band%2BBiological%2BCharacterization%2Bof%2BSelective%2BHistone%2BDeacetylase%2B8%2B%2528HDAC8%2529%2BInhibitors%2Bwith%2BAnti-Neuroblastoma%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D24%26spage%3D10188%26epage%3D10204%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/jmcmar.2017.60.issue-24/20171228/jmcmar.2017.60.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0016.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Histone deacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent selective inhibitors have been obtained, for other subtypes much less is known on selective inhibitors and the consequences of their inhibition. The present report describes the development of substituted benzhydroxamic acids as potent and selective HDAC8 inhibitors. Docking studies using available crystal structures have been used for structure-based optimization of this series of compounds. Within this study, we have investigated the role of HDAC8 in the proliferation of cancer cells and optimized hits for potency and selectivity, both in vitro and in cell culture. The combination of structure-based design, synthesis, and in vitro screening to cellular testing resulted in potent and selective HDAC8 inhibitors that showed anti-neuroblastoma activity in cellular testing.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuroblastoma, the most common extracranial solid tumor occurring in childhood, arises from abnormal growth of the neuronal crest progenitor cells of the devolving sympathetic nervous system. A distinguishing mark of neuroblastoma is its highly heterogeneous clinical behavior, which ranges from spontaneous tumor regression to highly aggressive, treatment-resistant and fatal tumor progression. Despite numerous advances and the implementation of intensive multimodal therapies, the prognosis for patients with high risk disease, which represents almost half of all neuroblastoma patients, still remains poor with less than 50% long-term survival rates.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Further, high risk patients suffer from severe treatment-related immediate and long-term adverse effects, and a significant number will still relapse.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> This emphasizes the urgent need for novel, more effective, and less toxic therapeutic approaches to improve the survival and the life-quality of neuroblastoma patients. Diverse genomic abnormalities have been described in neuroblastoma, yet no common genomic aberration has been uniformly identified in all high risk patients. One of the most important genetic marks of neuroblastoma is the amplification of the proto-oncogene MYCN<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> which is usually associated with tumor aggressiveness, resistance to therapy, and poor survival.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3, 7)</a> Besides MYCN, <i>ALK</i> has also been implicated as another causative gene in neuroblastoma; activation mutations of ALK occur in all cases of familial neuroblastoma and in ∼14% of sporadic cases.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Other recurrent genetic alterations include deletions on chromosomes 1p and 11q or gains on 17q, which are all used as prognostic markers.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">HDAC inhibitors are an emerging class of drugs that have shown promise in the treatment of a wide variety of malignancies.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> We have previously demonstrated that specifically the isozyme HDAC8 is involved in the pathogenesis of neuroblastoma and that its expression significantly correlates with advanced tumor stage and markers for poor prognosis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">HDAC8 is a 42 kDa protein composed of 377 amino acids, which is ubiquitously expressed and located in the nucleus and in the cytoplasm, where it supports smooth muscle cell differentiation and contractility by interaction with α-actin and modulators of cytoskeleton dynamics.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Histones are not considered to be bona fide HDAC8 substrates, and acetylation patterns observed in vitro and in cells regularly differ.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> While SMC3, a cohesin complex protein exerting its role during the separation of sister chromatids, is directly deacetylated by HDAC8, the enzyme can also interact with other proteins as a scaffold.</div><div class="NLM_p">HDAC8 plays a significant role in regulating spindle assembly during mouse oocyte meiosis.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In oral squamous cell carcinoma cells, HDAC8 knockdown induced apoptotic cell death through caspases activation and prosurvival autophagy, consequently, the additional treatment with autophagy inhibitors enhanced cell death.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">HDAC8 has also been shown to be one of the causative genes in Cornelia de Lange syndrome (CdLS), a rare genetic disease causing congenital malformations, and has been identified as SMC3 deacetylase.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Chromatin-released acetylated SMC3 is deacetylated by the HDAC8 enzyme in early mitosis facilitating cohesin recycling for subsequent cell cycles. There have been several loss-of-function mutations reported for HDAC8 that result in a strong loss of activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, specific HDAC8 activators, such as <i>N</i>-(phenylcarbamothioyl)benzamide, have been reported as useful leads in the search for new therapeutic strategies in managing CdLS.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">In INSS stage 4 neuroblastoma patient samples, HDAC8 is the only HDAC isoform showing significant transcriptional upregulation as compared to stages 1, 2, 3, and 4S. High HDAC8 levels were found to be correlated with predictors of poor prognosis in neuroblastoma such as unfavorable Shimada histopathologic classification and loss of chromosomes 1p and 11q.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Zhao et al. revealed that targeted inhibition of HDAC8 by subtype-selective HDAC8 inhibitors such as PCI-34051<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<b>1</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) can suppress the growth of neuroblastoma cells and increase doxorubicin sensitivity via upregulation of miR-137 and suppression of MDR1.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The pivotal role of this class I HDAC in differentiation and tumor progression has been confirmed in malignant peripheral nerve sheath tumors<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and neuroblastoma, where selective HDAC8 inhibition induces a differentiated phenotype, enhances retinoic acid mediated effects, and reduces tumor growth in cell culture and in vivo with decreased adverse effects as compared to unspecific HDAC inhibition.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This endorses selective HDAC8 inhibition as a very promising therapeutic option for neuroblastoma therapy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The FDA-approved broad-spectrum HDAC inhibitor vorinostat (SAHA), which is used to treat refractory cutaneous T-cell lymphoma, is a weaker inhibitor of HDAC8 (micromolar range) than of HDACs 1–3 (nanomolar range). Selective HDAC8 inhibitors were identified by either structure-based design, for example, linkerless hydroxamic acids (IC<sub>50</sub> = 0.3 μM, >100-fold selectivity over HDAC1 and HDAC6)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> or from high-throughput screens like the cyclic thiourea SB379278A (IC<sub>50</sub> = 0.5 μM)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is probably the most widely used HDAC8-specific inhibitor in research. On the basis of an indole linker, this hydroxamic acid showed good HDAC8 selectivity and cellular activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> NCC149 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and further analogs were identified using a rapid screen of a 151-triazole compound library generated using click chemistry.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> In vitro tests revealed an IC<sub>50</sub> of 70 nM against HDAC8 with a very high selectivity over major HDACs (HDAC1 IC<sub>50</sub> = 38 μM; HDAC2 IC<sub>50</sub> > 100 μM; HDAC4 IC<sub>50</sub> = 44 μM; HDAC6 IC<sub>50</sub> = 2.4 μM). Huang et al. reported <i>o</i>-aryl-<i>N</i>-hydroxycinnamides as further selective HDAC8 inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The biphenyl substituted <i>o</i>-aryl-<i>N</i>-hydroxycinnamide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) showed an IC<sub>50</sub> value of 27 nM for HDAC8, good selectivity over other HDACs, and moderate growth inhibition of lung cancer cell lines. Tang et al. reported on the synthesis of a small library of benzhydroxamic acids containing a hydrazide linker.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The most promising compound A8B4 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) showed an IC<sub>50</sub> of 23 nM and good selectivity over HDAC2 and HDAC3. However, no cellular data were reported. Very recently, Ingham et al. developed a highly potent HDAC8 inhibitor with good selectivity over HDAC1 and HDAC6. The triazole hydroxamic acid OJI-1 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) showed an IC<sub>50</sub> of 0.8 nM.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> However, no cellular data have been provided so far.</div><div class="NLM_p">Besides hydroxamic acids, inhibitors containing an amino acid group<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and an azetidinone group<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were reported as selective HDAC8 inhibitors (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Another potent, nonhydroxamic acid HDAC8 inhibitor that has been reported is β-phenyltropolone.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The β-isopropyltropolone derivative showed a <i>K</i><sub>i</sub> of 8 nM and about 1400-fold selectivity toward HDAC8 than HDAC4. Synthetic as well as structure-based approaches to develop benzhydroxamic acids as HDAC8 inhibitors have been recently reported and reviewed.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a></div><div class="NLM_p">On the basis of our previous study<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> to develop inhibitors of <i>Schistosoma mansoni</i> HDAC8, we identified the benzhydroxamic acids <b>2</b>, <b>3</b>, and <b>4</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>; IC<sub>50</sub> values are listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) as promising starting points for the development of inhibitors of the homologous human HDAC8. Our previous results showed that the lead benzamidohydroxamic acid <b>2</b> displays good inhibition of hHDAC8, high selectivity over HDAC1, and a moderate selectivity over HDAC6. Modifying the capping group to quinoline and introducing a methyl substituent in the para-position of the benzhydroxamic acid moiety (<b>3</b>) resulted in a significant improvement in HDAC8 inhibition but were coupled with a loss of selectivity toward HDAC6. Meanwhile, switching from an amide- to an amine-linker (<b>4</b>) resulted in a considerable enhancement of HDAC8 inhibition, but simultaneously a decreased selectivity against HDAC1 was observed as compared to <b>2</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously identified benzhydroxamic acid based HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro IC<sub>50</sub> Values of Reference Compounds<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Values of <b>2</b>, <b>3</b>, and <b>4</b> were taken from Heimburg et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (±standard error, SI = selectivity index).</p></div></div><div></div></div><div class="NLM_p">On the basis of our initial data, we wanted to get insights into the structure–activity relationships (SARs) of HDAC8 inhibitors with a meta-substituted benzhydroxamic acid structure. Here we report that changes of the linker attached to the benzhydroxamic acid have a huge impact on HDAC8 potency and selectivity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). In addition, anti-neuroblastoma activity of the most promising inhibitors was verified by viability and colony formation assays as well as detection of neurite-like outgrowths and upregulation of differentiation markers, such as p21/CDKN1, TrkA/NTRK1, and tyrosine hydroxylase (TH).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Series of the herein described benzhydroxamic acids as HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to obtain the described 3-aminobenzhydroxamic acids (<b>8a</b>–<b>s</b>), both nonsubstituted and 4-substituted-3-aminobenzoic acids (<b>5a</b>–<b>s</b>) were used as starting points. Alkyl and aryl residues were introduced on the aromatic NH<sub>2</sub> group via reductive amination, which was performed by the reaction of the 3-aminobenzoic acids <b>5a</b>–<b>s</b> with the respective aldehyde using sodium triacetoxyborohydride as a reducing agent.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> To avoid byproducts in the following synthetic steps, the secondary amine <b>6</b> was protected by <i>tert</i>-butyloxycarbonyl (Boc) group initially (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). However, we recognized in further trials that this step could be skipped because the byproducts were only obtained in small amounts and could be neglected. The <i>N</i>-phenethyl substituted derivatives <b>6l</b> and <b>6s</b> were alternatively attained through N-alkylation since the products of the reductive amination using phenylacetaldehyde and sodium triacetoxyborohydride showed poor purity. The desired hydroxamic acids <b>8a</b>–<b>s</b> were finally obtained using PyBOP as an activating agent and <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine followed by cleavage of the protecting group (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Generally, using tetrahydropyran (THP)-protected hydroxylamine increased the yields of the desired benzhydroxamic acids compared to other methods using hydroxylamine hydrochloride and KOH or potassium methanolate.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) aldehyde, toluene; (ii) Na(AcO)<sub>3</sub>BH, AcOH; (b) Boc<sub>2</sub>O, MeOH, <i>t</i>-BuOH; (c) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF; (<b>7a</b>,<b>b</b>) (iii) TFA, CHCl<sub>3</sub>.</p></p></figure><div class="NLM_p">The desired phenylcarbamoylbenzhydroxamic acids <b>12a</b>–<b>d</b> could be obtained starting from the methoxycarbonylbenzoic acid derivatives <b>9a</b>–<b>d</b>, which were first activated using thionyl chloride or oxalyl chloride and subsequently coupled with the respective aniline to yield the corresponding amides <b>10a</b>–<b>d</b>. Alkaline hydrolysis of the methyl ester to the respective 3-substituted carbamoylbenzoic acid <b>11a</b>–<b>d</b> was followed by the conversion to the hydroxamic acids <b>12a</b>–<b>d</b> using the aforementioned protocol. While the 3-phenyl-4-carbamoylbenzoic acid <b>11a</b> could be directly prepared from the commercially available 3-methoxycarbonylbenzoic acid <b>9a</b> using thionyl chloride and coupling with aniline, the starting materials 5-methoxycarbonyl-2-substituted-benzoic acids <b>9b</b>–<b>d</b> had to first be prepared as described in literature (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf" class="ext-link">Scheme S1 in Supporting Information</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Activation of the three acids <b>9b</b>–<b>d</b> was achieved using oxalyl chloride as a mild and efficient activating agent. The activated acid chlorides were then coupled with 4-chloroaniline using DIPEA as a base to form the respective amides <b>10b</b>–<b>d</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, aniline; (b) (COCl)<sub>2</sub>, 4-chloroaniline, cat. DMF, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>; (c) aq NaOH, MeOH; (d) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF.</p></p></figure><div class="NLM_p">The 3-benzyloxy-4-methoxybenzhydroxamic acid <b>20a</b> was directly synthesized from the commercially available carboxylic acid <b>25</b> using the aforementioned procedure (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). To obtain <b>20b</b>–<b>g</b>, the acid derivatives <b>21</b> were first converted to the methyl esters <b>22</b> to avoid byproducts in the following steps. O-benzylation to the ether derivatives <b>24b</b>–<b>g</b> was performed through Williamson ether synthesis using K<sub>2</sub>CO<sub>3</sub> and the respective substituted benzyl bromides <b>23</b>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The corresponding 3-benzyloxybenzhydroxamic acids <b>20b</b>–<b>g</b> were synthesized by cleavage of the methyl ester followed by the conversion of the carboxylic acid as previously described (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, MeOH; (b) K<sub>2</sub>CO<sub>3</sub>, DMF; (c) aq NaOH, MeOH; (d) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Structure–Activity Relationships</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial optimization studies focused on the linker between the benzhydroxamic acid and the terminal aromatic ring used as capping group. Our previously reported lead benzamidohydroxamic acid <b>2</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> showed a moderate HDAC8 inhibitory activity as compared to the selective HDAC8 inhibitor <b>1</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and exhibited a good selectivity profile against HDAC1 and to a lesser extent HDAC6. As previously described, switching from an amide- to an amine-linker (compound <b>4,</b><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) resulted in a slight improvement in the HDAC8 inhibitory potency, a considerable loss in the selectivity over HDAC1, and a slight increase in the selectivity over HDAC6.</div><div class="NLM_p">In order to guide further optimization efforts, docking studies were performed using the lead structures in available crystal structures of HDAC8 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5X">2V5X</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>), HDAC1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BKX">4BKX</a><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a>), and HDAC6 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EDU">5EDU</a><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I">5G0I</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a>) in an attempt to detect the structural aspects determinant for achieving high HDAC8 inhibitory potency as well as selectivity over HDAC1 and -6. As could be expected, the benzhydroxamic acid group of all lead compounds showed a similar interaction pattern in the catalytic pocket of HDAC8: The hydroxamic acid group is able to chelate the zinc ion in a bidentate fashion and undergo three H-bond interactions with the side chains of His142, His143, and Tyr306. Meanwhile the benzene ring is sandwiched between Phe152 and His180, where it exhibits π–π stacking interactions. The capping group of the different leads showed, however, more diverse interactions, which might give a primary explanation for the differences in the HDAC8 inhibitory activity. The benzyl moiety of <b>1</b> exhibits π–π stacking interactions with Tyr306 and Phe152, which are lost in the case of the less potent benzamide derivative <b>2</b>. The corresponding highly active quinoline derivative <b>3</b> seems to benefit from additional hydrophobic interactions with Tyr306 and Pro273, while the 3-aminobenzhydroxamic acid <b>4</b> shows, like <b>1</b>, π–π stacking interactions with Tyr306 and Phe152. (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>)</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding modes in HDAC8: (a) reference inhibitor <b>1</b>, (b) benzamidohydroxamic acid <b>2</b>, (c) corresponding quinoline derivative <b>3</b>, and (d) 3-aminobenzhydroxamic acid derivative <b>4</b>. Side chains of active site residues are shown as white sticks and the ligands as yellow sticks. The zinc ion is depicted as cyan ball, while cocrystallized water molecules are shown as red spheres. Hydrogen bonds are shown as yellow dashed lines, and coordination of the zinc ion is shown as pale-cyan dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The selectivity of the compounds over HDAC1 could be easily explained by the docking results (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>) which clearly show that the compounds are not able to properly chelate the catalytic zinc ion. HDAC1 is characterized by its narrow pocket as compared to HDAC8 and -6, and hence, meta-substituted benzhydroxamic acids generally show a HDAC6/8 over HDAC1 selectivity as has been frequently demonstrated in previous studies.<a onclick="showRef(event, 'ref31 ref40 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref31 ref40 ref47 ref48 ref49">(31, 40, 47-49)</a></div><div class="NLM_p">Meanwhile, the docking results cannot completely rationalize the selectivity of the compounds for HDAC8 over HDAC6. Crystal structures of HDAC6 and HDAC8 clearly demonstrate that the substrate binding grooves in both isoforms show a significantly different shape, with one of the main differences in HDAC6 being the presence of an additional loop (L1 loop: Asp460-Pro464, DrHDAC6 numbering). While in HDAC8 the benzyl capping group of <b>1</b> is placed perpendicular to Tyr306 and Phe152 allowing for a perfect π–π stacking interaction, the additional loop in HDAC6 hinders the ligand from binding to this hydrophobic subpocket. In the case of <b>1</b>, only a hydrophobic interaction with Leu712 of HDAC6 can be observed. The benzamidohydroxamic acids <b>2</b> and <b>3</b> seem to benefit from additional water-mediated H-bond interactions with the conserved water molecule at the rim of the catalytic tunnel. Interestingly, the quinoline group of <b>3</b> is able to undergo additional hydrophobic interactions that extend to Pro464 of the L1 loop, which might explain the observed increase in HDAC6 inhibitory potency. Meanwhile, due to the flexibility of the aminomethyl linker of compound <b>4</b>, the capping benzyl group can undergo π–π stacking interactions with Phe583 (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>).</div><div class="NLM_p">In order to obtain more potent and selective HDAC8 inhibitors, we started with the derivatization of the 3-aminobenzhydroxamic acid <b>4</b> by introducing different substituents at the 4-position of the benzhydroxamic acid core and modifying the capping groups to maximize the interactions in the previously described hydrophobic side pocket of HDAC8.</div><div class="NLM_p">Regarding the 3-aminobenzhydroxamic acid series (<b>8a</b>–<b>s</b>), the introduction of a hydrophobic substituent in the para-position of the benzhydroxamic acid moiety generally resulted in a decreased inhibitory activity against HDAC1 as compared to the unsubstituted derivative <b>4</b>, however, had little impact on the HDAC6 activities (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Only compounds with a methoxy (<b>8b</b>) and a fluoro substituent (<b>8o)</b> showed increased HDAC8 inhibitory activity and consequently higher selectivity over HDAC1 and -6, as compared to the respective 4-methyl and the unsubstituted derivative (<b>8a</b> and <b>4</b>). Docking of <b>8b</b> to HDAC8 shows that it adopts a highly similar binding conformation as that predicted for the unsubstituted 3-aminobenzhydroxamic acid <b>4</b>, where the hydroxamic acid group chelates the zinc ion and forms three H-bond interactions with the conserved His and Tyr residues, the core benzene moiety is sandwiched between Phe152 and His180, and the capping benzyl group exhibits π–π stacking interactions with Tyr306 and Phe152. Additionally, the 4-methoxy group can undergo hydrophobic interactions with Phe208 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). Meanwhile, the 4-fluoro derivative <b>8o</b> and the 4-chloro derivative <b>8m</b> also showed a similar binding mode to <b>4</b> (not shown). Whereas the fluoro substitution (<b>8o)</b> resulted in a similar inhibitory activity, the chloro substitution (<b>8m</b>) was found to be less favorable. However, the obtained docking results offer no explanation for the differences in HDAC8 inhibition. Similarly, increasing the length of the linker to ethylene and propylene moieties (<b>8k</b>, <b>8l</b>, <b>8r</b>, and <b>8s</b>) did not result in an increase in the inhibitory activity against HDAC8 or an enhancement of the compounds’ selectivity. With respect to the capping groups, most of the probed moieties were well tolerated by HDAC8, even bulkier groups like biphenyl (<b>8p</b>) and naphthyl (<b>8q</b>). A significant enhancement in the inhibitory activity against HDAC8, together with an improvement in the selectivity over HDAC1 and HDAC6, was only observed for the 2,4-dichloro derivative <b>8f</b>. This might be explained by the dichlorophenyl capping group undergoing additional vdW interaction with the hydrophobic side pocket of HDAC8 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b). Among this series, the 4-methoxybenzyl derivative <b>8b</b> and the 4-methyl-2,4-dichloro derivative <b>8f</b> displayed the highest potency against HDAC8 (IC<sub>50</sub> of 69 nM and 35 nM, respectively) and simultaneously showed the best selectivity over HDAC1 (210- and 534-fold HDAC8/HDAC1, respectively) and HDAC6 (74- and 411-fold HDAC8/HDAC6, respectively).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding mode of the most potent HDAC8 inhibitors: (a) 4-methoxy-3-benzylaminobenzhydroxamic acid <b>8b</b>, (b) 2,4-dichlorobenzylaminobenzhydroxamic acid derivative <b>8f</b>, (c) inverted amide derivative <b>12b</b>, and (d) 3-benzyloxybenzhydroxamic acid derivative <b>20a</b> in human HDAC8. Ligands are colored in yellow, side chains of active site residues are shown as white sticks, the zinc ion is depicted as cyan ball, while the cocrystallized water molecule is shown as red balls. Hydrogen bonds are shown as yellow dashed lines, and coordination of the zinc ion is shown as pale-cyan dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro IC<sub>50</sub> Values of 3-Aminobenzhydroxamic Acid Derivatives<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0012.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">hHDAC8 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">hHDAC1 % inhibition</th><th class="colsep0 rowsep0" align="center">hHDAC1 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hHDAC6 % inhibition</th><th class="colsep0 rowsep0" align="center">hHDAC6 IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">260 ± 36</td><td class="colsep0 rowsep0" align="left">39% @ 25 μM, 16% @ 5 μM</td><td class="colsep0 rowsep0" align="left">21.8 ± 2.1 (SI 84)</td><td class="colsep0 rowsep0" align="left">69% @ 25 μM, 35% @ 5 μM</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.3 (SI 20)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">69 ± 17</td><td class="colsep0 rowsep0" align="left">97% @ 100 μM, 49% @ 10 μM</td><td class="colsep0 rowsep0" align="left">14.5 ± 1.4 (SI 210)</td><td class="colsep0 rowsep0" align="left">70% @ 10 μM, 12% @ 1 μM</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.8 (SI 74)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2-chlorobenzyl</td><td class="colsep0 rowsep0" align="left">286 ± 41</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">4-chlorobenzyl</td><td class="colsep0 rowsep0" align="left">161 ± 21</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2,6-dichlorobenzyl</td><td class="colsep0 rowsep0" align="left">335 ± 55</td><td class="colsep0 rowsep0" align="left">32% @ 10 μM, 3% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">61% @ 10 μM, 11% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8f</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2,4-dichlorobenzyl</td><td class="colsep0 rowsep0" align="left">35 ± 4</td><td class="colsep0 rowsep0" align="left">66% @ 50 μM, 16% @ 1 μM</td><td class="colsep0 rowsep0" align="left">18.7 ± 2.5 (SI 534)</td><td class="colsep0 rowsep0" align="left">75% @ 50 μM, 1.6% @ 1 μM</td><td class="colsep0 rowsep0" align="left">14.4 ± 2.4 (SI 411)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">3-methoxybenzyl</td><td class="colsep0 rowsep0" align="left">167 ± 59</td><td class="colsep0 rowsep0" align="left">31% @ 10 μM, 3.5% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">38% @ 10 μM, ni % @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">3-phenoxybenzyl</td><td class="colsep0 rowsep0" align="left">202 ± 22</td><td class="colsep0 rowsep0" align="left">32% @ 10 μM, 10% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">63% @ 10 μM, 11% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">2-quinolinylmethyl</td><td class="colsep0 rowsep0" align="left">481 ± 93</td><td class="colsep0 rowsep0" align="left">45% @ 10 μM, 8% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">73% @ 10 μM, 19% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">4-chlorobenzyl</td><td class="colsep0 rowsep0" align="left">147 ± 18</td><td class="colsep0 rowsep0" align="left">51% @ 10 μM, 14% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">59% @ 10 μM, 11% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">1-(4-chlorophenyl)ethyl</td><td class="colsep0 rowsep0" align="left">240 ± 22</td><td class="colsep0 rowsep0" align="left">31% @ 10 μM, 5% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">46% @ 10 μM, 5% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8l</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2-phenylethyl</td><td class="colsep0 rowsep0" align="left">130 ± 20</td><td class="colsep0 rowsep0" align="left">34% @ 10 μM, 9% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">63% @ 10 μM, 20% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8m</b></td><td class="colsep0 rowsep0" align="left">chloro</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">254 ± 41</td><td class="colsep0 rowsep0" align="left">48% @ 10 μM, 3% @ 1 μM</td><td class="colsep0 rowsep0" align="left">10.4 ± 1.2 (SI 41)</td><td class="colsep0 rowsep0" align="left">74% @ 10 μM, 22% @ 1 μM</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.2 (SI 16)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8n</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">136 ± 17</td><td class="colsep0 rowsep0" align="left">33% @ 10 μM, 8% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">62% @ 10 μM, ni. @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8o</b></td><td class="colsep0 rowsep0" align="left">fluoro</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">72 ± 12</td><td class="colsep0 rowsep0" align="left">40% @ 10 μM, ni @ 1 μM</td><td class="colsep0 rowsep0" align="left">25.0 ± 6.5 (SI 347)</td><td class="colsep0 rowsep0" align="left">67% @ 10 μM, 20% @ 1 μM</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.7 (SI 69)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8p</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">4-phenylbenzyl</td><td class="colsep0 rowsep0" align="left">227 ± 54</td><td class="colsep0 rowsep0" align="left">43% @ 10 μM, 5% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">58% @ 10 μM, 11% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2-naphtylmethyl</td><td class="colsep0 rowsep0" align="left">119 ± 34</td><td class="colsep0 rowsep0" align="left">37% @ 10 μM, 8% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">52% @ 10 μM, 11% @ 1 μM</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8r</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="left">2-phenylethyl</td><td class="colsep0 rowsep0" align="left">151 ± 33</td><td class="colsep0 rowsep0" align="left">41% @ 10 μM, 0% @ 1 μM</td><td class="colsep0 rowsep0" align="left">19.1 ± 3.0 (SI 126)</td><td class="colsep0 rowsep0" align="left">63% @ 10 μM, 20% @ 1 μM</td><td class="colsep0 rowsep0" align="left">7.5 ± 2.8 (SI 50)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8s</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">248 ± 52</td><td class="colsep0 rowsep0" align="left">29% @ 10 μM, 3% @ 1 μM</td><td class="colsep0 rowsep0" align="left">25.6 ± 5.5 (SI 103)</td><td class="colsep0 rowsep0" align="left">55% @ 10 μM, 42% @ 1 μM</td><td class="colsep0 rowsep0" align="left">8.9 ± 1.7 (SI 36)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">± standard error, SI = selectivity index.</p></div></div></div><div class="NLM_p">Another series of inhibitors that we prepared was obtained by inverting the amide linker of <b>2</b>. The inverted amide <b>12a</b> (which has already been reported)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> showed about 4 times increased HDAC8 inhibitory activity compared to <b>2</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Adding a methoxy group at the para-position of the benzhydroxamic acid and modifying the terminal phenyl ring with a para-chloro substituent resulted in a highly potent HDAC8 inhibitor (<b>12b</b>, IC<sub>50</sub> = 38 nM) but was coupled with an increase in the inhibition of HDAC1 and -6. Docking studies revealed that the inverted amide is able to benefit from an additional water-mediated H-bond interaction which is missing in the analogous benzamidohydroxamic acid <b>2</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>c). Further modifications did not result in an improvement in the potency against HDAC8. Due to the strong HDAC6 inhibition, we did not further study the most active compound in this series (<b>12b</b>; HDAC6, 59% inhibition at 1 μM), in the cellular testing.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro IC<sub>50</sub> Values of 3-(Phenylcarbamoyl)benzhydroxamic Acid Derivatives<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">± standard error, SI = selectivity index. *IC<sub>50</sub> value of compound <b>12a</b> was previously reported by Olson et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Difference in the herein determined IC<sub>50</sub> value to the reported one might be due to the use of different substrates.</p></div></div><div></div></div><div class="NLM_p">The third linker that we tested was a methylenoxy group (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). As described for the 3-aminobenzhydroxamic acids, the para-position of the benzhydroxamic acid scaffold was modified and hydrophobic substituents at the terminal benzyl group were used in an attempt to increase the potency of the compounds. The 4-methoxy substituted inhibitor <b>20a</b> showed the strongest HDAC8 inhibition among all tested compounds with good selectivity indices (448-fold against HDAC1, 107-fold against HDAC6). Our docking studies revealed that the ether linker in <b>20a</b> is able to undergo water-mediated H-bond interaction with the water molecule at the rim of the catalytic tunnel of HDAC8, while the capping benzyl group shows π–π stacking with Phe152 and Tyr306 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>d). Derivatives bearing a 4-chloro substituent (<b>20e</b>–<b>g</b>) showed a decreased HDAC8 inhibition as compared to their 4-methoxy counterparts. Meanwhile, introducing chloro substituents at the capping benzyl group generally resulted in a significant loss in the HDAC8 inhibitory activity. Interestingly, a 2,4-dichloro substitution of <b>20d</b> and <b>20g</b> resulted in a pronounced decrease in HDAC8 inhibitory potency, which is in contrast to our previous observation where a similar substitution of the 3-benzylaminobenzhydroxamic acid scaffold (<b>8f</b>) led to an increase in HDAC8 inhibitory activity and improved selectivity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro IC<sub>50</sub> Values of 4-Benzyloxy-3-substituted-benzhydroxamic Acid Derivatives<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">± standard error, SI = selectivity index.</p></div></div><div></div></div><div class="NLM_p last">Among all herein described compounds, the 3-benzylaminobenzhydroxamic acids <b>8b</b> and <b>8f</b> and the 3-benzyloxybenzhydroxamic acid <b>20a</b> were the most potent and selective compounds in comparison with <b>1</b> as reference and were, hence, selected for further biological/cellular testing in comparison with reference inhibitors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Cytotoxicity Assay</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cytotoxicity of the compounds was tested against a human embryonic kidney cell line (HEK293). The cells were incubated with the compounds at a concentration of 50 μM for 45 h, and the cell viability was determined using the Alamar Blue assay. All tested compounds showed only a relatively weak cytotoxicity at the used concentration (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cytotoxicity Studies in HEK293 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">viability<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">viability<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">viability<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">72.0 ± 2.9</td><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">84.8 ± 4.9</td><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">86.0 ± 3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">66.2 ± 0.7</td><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">82.2 ± 1.3</td><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">73.2 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">78.3 ± 2.6</td><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">83.8 ± 5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">90.4 ± 1.7</td><td class="colsep0 rowsep0" align="left"><b>8l</b></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">79.7 ± 7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">68.1 ± 1.2</td><td class="colsep0 rowsep0" align="left"><b>8m</b></td><td class="colsep0 rowsep0" align="left">87.4 ± 3.4</td><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">69.1 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">95.3 ± 2.7</td><td class="colsep0 rowsep0" align="left"><b>8n</b></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left">62.8 ± 8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">82.9 ± 3.4</td><td class="colsep0 rowsep0" align="left"><b>8o</b></td><td class="colsep0 rowsep0" align="left">86.9 ± 6.3</td><td class="colsep0 rowsep0" align="left"><b>20c</b></td><td class="colsep0 rowsep0" align="left">77.6 ± 14.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="left">65.7 ± 3.6</td><td class="colsep0 rowsep0" align="left"><b>8p</b></td><td class="colsep0 rowsep0" align="left">77.0 ± 3.9</td><td class="colsep0 rowsep0" align="left"><b>20d</b></td><td class="colsep0 rowsep0" align="left">70.1 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8f</b></td><td class="colsep0 rowsep0" align="left">78.9 ± 3.89</td><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">89.9 ± 3.0</td><td class="colsep0 rowsep0" align="left"><b>20e</b></td><td class="colsep0 rowsep0" align="left">63.6 ± 14.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">77.3 ± 0.3</td><td class="colsep0 rowsep0" align="left"><b>8r</b></td><td class="colsep0 rowsep0" align="left">92.0 ± 4.1</td><td class="colsep0 rowsep0" align="left"><b>20f</b></td><td class="colsep0 rowsep0" align="left">74.7 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">55.0 ± 2.4</td><td class="colsep0 rowsep0" align="left"><b>8s</b></td><td class="colsep0 rowsep0" align="left">80.9 ± 2.7</td><td class="colsep0 rowsep0" align="left"><b>20g</b></td><td class="colsep0 rowsep0" align="left">65.4 ± 2.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Viability of cells in presence of 50 μM compound in comparison to an untreated sample. As positive control, daunorubicin was used, and an IC<sub>50</sub> value of 12.55 ± 0.07 μM was determined. nd: not determined.</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Cellular Activity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To show cellular target engagement and selectivity, Western blotting experiments were performed with a selection of compounds in neuroblastoma BE(2)-C cells. The tumor cells were incubated for 6 h with 10 μM <b>3</b>, <b>8a</b>, <b>8b</b>, <b>8f</b>, or <b>20a</b>. Cell lysates were blotted against Ac-SMC3 (HDAC8 substrate), Ac-α-tubulin (HDAC6 substrate), and Ac-histone H3 (HDAC1 substrate). As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A, all compounds induced increase of both SMC3 and tubulin acetylation compared to solvent (DMSO) control; thus they inhibit both HDAC6 and HDAC8 in BE(2)-C cells. In contrast, no significant effect on the acetylation level of histone H3 was observed. This indicates that the observed in vitro selectivity is also detected in a cellular setting. A summary and quantification of all Western blot repetitions are displayed in the corresponding bar diagrams (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular target engagement and selectivity. (A) Acetylation of SMC3, α-tubulin, and histone H3 is shown in Western blots of whole-cell lysates 6 h after treatment of BE(2)-C cells with 10 μM <b>3</b>, <b>8a</b>, <b>8b</b>, <b>8f</b>, or <b>20a</b>. HSC70, tubulin, histone H3, β-actin, and Ponceau staining were used as a loading control. (B) The normalized ratios from three independent experiments are shown in the bar graphs on the right.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Anti-Neuroblastoma Phenotype</h3><div class="NLM_p">In order to measure the functional consequence of HDAC8 inhibition, the BE(2)-C neuroblastoma cell model was applied, which responds with growth arrest and signs of neuronal differentiation upon knockdown or selective inhibition of HDAC8.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Growth arrest was determined by colony formation and viability assays. The induction of a more differentiated phenotype was detected by analysis of marker gene expression (<i>CDKN1A</i>, <i>TH</i>, and <i>NTRK1</i>).</div><div class="NLM_p">Tyrosine hydroxylase (TH) and neurotrophin receptor kinase A (<i>NTRK1/TrkA</i>) are neuronal marker genes. Tyrosine hydroxylase is encoded by the <i>TH</i> gene and is present in the central nervous system (CNS), peripheral sympathetic neurons, and the adrenal medulla. The enzyme catalyzes the rate limiting step in this synthesis of catecholamines. Differentiation of neuroblastoma cells is accompanied by an increase in tyrosine hydroxylase (TH) mRNA.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Activation of the neurotrophin receptor TrkA signaling pathway leads to neuronal differentiation, and high expression of NTRK1/TrkA is present in neuroblastomas with favorable biological features and is highly correlated with patient survival.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Differentiation is typically associated with a cell cycle arrest, and CDK inhibitor p21<sup>WAF1/CIP1</sup> (<i>CDKN1A</i>) is known to mediate cell cycle arrest in response to pharmacological HDAC inhibition.</div><div class="NLM_p">For colony formation assays, BE(2)-C cells were treated with 10 μM of each of the selected compound (<b>3</b>, <b>8a</b>, <b>8b</b>, <b>8f</b>, <b>20a</b>) for 96 h, followed by culturing for another 6 days without treatment. This assesses whether the treatment impairs the clonogenic growth capacity of tumor cells, indicating effectiveness of compounds on the survival and proliferation of tumor cells. All compounds significantly decreased the ability to form colonies (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). The WST-8 metabolic activity assay was applied to determine metabolic IC<sub>50</sub> values in BE(2)-C cells, employing six different inhibitor concentrations per compound and six replicates per inhibitor concentration.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The developed HDAC inhibitors decrease clonogenic growth capacity as well as metabolic activity and induce signs of neuronal differentiation in BE(2)-C neuroblastoma cells. (A) Colonies were stained (pictures) and quantified (bar diagram). Where treatment is indicated, cells were treated with 10 μM compound for 96 h and colonies were stained after another 6 d of growth time. Solvent (DMSO) treatment is marked with a minus sign. (B) Displayed are the IC<sub>50</sub> curves and the calculated metabolic IC<sub>50</sub> values. After 24 h of culture, BE(2)-C cells were treated with the compounds for 72 h. After incubation with WST-8, fluorescence intensity was measured to determine the metabolic activity of the treated cells. (C) Real-time PCR was used to analyze the expression of differentiation markers (<i>CDKN1A</i>, <i>TH</i>, <i>NTRK1</i>). After 24 h of culture, BE(2)-C cells were treated with compounds (6 μM <b>1</b>; 10 μM <b>8b</b>; 10 μM <b>20a</b>) for 72 h. Expression was normalized to solvent (DMSO; marked with a minus sign) treated cells. (D) Immunofluorescent pictures show neurofilament (red) and DAPI (blue) staining of BE(2)-C cells 6 days after treatment with 6 μM <b>1</b>, 10 μM <b>8b</b>, 10 μM <b>20a</b> (scale bar = 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The assay is based on the extracellular reduction of WST-8 by NADH produced in the mitochondria resulting in a water-soluble formazan which dissolves directly into the culture medium. It allows the colorimetric analysis of the number of viable cells. A reduction in cell viability or slowed-down proliferation results in lower metabolic activity. Thus, the metabolic IC<sub>50</sub> value serves to determine growth arrest/cytotoxicity upon treatment with selected compounds compared to solvent treated control cells.</div><div class="NLM_p last">Two representative compounds, the 3-amino-4-methoxybenzhydroxamic acid <b>8b</b> and the 3-benzyloxy-4-methoxybenzhydroxamic acid <b>20a</b>, were chosen for this assay and compared with <b>1</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). In addition the upregulation of differentiation marker genes, such as <i>p21/CDKN1</i>, <i>TrkA/NTRK1</i>, and <i>TH</i>, was studied (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). The developed inhibitors <b>8b</b> and <b>20a</b> showed a stronger upregulation compared to the reference inhibitor <b>1</b> and the outgrowth of neurofilament positive neurite-like structures (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D), indicating a strong HDAC8 inhibition phenotype.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure guided optimization of benzhydroxamic acids led to highly potent and selective HDAC8 inhibitors. Detailed structure–activity relationships were derived for the three series of synthesized inhibitors. The most selective inhibitor in vitro, the 3-benzylaminobenzhydroxamic acid <b>8f</b>, showed a 534- and 411-fold selectivity against HDAC1 and HDAC6, respectively. In the cellular testing, the 3-benzylaminobenzhydroxamic acid derivatives <b>8a</b>, <b>8b</b>, <b>8f</b> and the 3-benzyloxybenzhydroxamic acid derivative <b>20a</b> showed cellular target engagement and did not increase histone acetylation. Phenotypic markers, which are characteristic for HDAC8 inhibition, are similarly detected upon treatment with the inhibitors, such as <b>8b</b> and <b>20a</b>. The phenotypic markers (e.g., p21/<i>CDKN1</i> upregulation, NEF staining, and impaired colony formation ability) are the result of growth arrest and differentiation into a neuronal phenotype. The anti-neuroblastoma effects of the developed HDAC8 inhibitors <b>8b</b> and <b>20a</b> are at least as effective as those observed with <b>1</b>. These results suggest improved potential of selective HDAC inhibitors to target neuroblastoma without undesired side effects in vivo.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis and Analytics</h3><div class="NLM_p">Characterization data of the hydroxamic acids are listed in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">All materials and reagents were purchased from Sigma-Aldrich Co. Ltd. and Carbolution Chemicals. All solvents were analytically pure and dried before use. Thin layer chromatography was carried out on aluminum sheets coated with silica gel 60 F254 (Merck, Darmstadt, Germany). For column chromatography under normal pressure silica gel 60 (0.036–0.200 mm) was used.</div><div class="NLM_p">Final compounds were confirmed to be of >95% purity based on HPLC. Purity was measured by UV absorbance at 254 nm. The HPLC consists of an XTerra RP18 column (3.5 μm, 3.9 mm × 100 mm) from the manufacturer Waters (Milford, MA, USA) and two LC-10AD pumps, a SPD-M10A VP PDA detector, and a SIL-HT autosampler, all from the manufacturer Shimadzu (Kyoto, Japan). For preparative tasks a XTerra RP18 column (7 μm, 19 mm × 150 mm) from the manufacturer Waters (Milford, MA, USA) and two LC-20AD pumps were used. The mobile phase was in all cases a gradient of methanol/water (starting at 95% water going to 5% water).</div><div class="NLM_p">Mass spectrometry analyses were performed with a Finnigan MAT 710C (Thermo Separation Products, San Jose, CA, USA) for the ESI-MS spectra and with a LTQ (linear ion trap) Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) for the HRMS-ESI (high resolution mass spectrometry) spectra. For the HRMS analyses the signal for the isotopes with the highest prevalence was given and calculated (<sup>35</sup>Cl, <sup>79</sup>Br).</div><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were taken on a Varian Gemini 2000 and a Varian Inova 500 using deuterated chloroform and deuterated DMSO as solvent. Chemical shifts are referenced to the residual solvent signals.</div></div><div id="sec7_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Procedure A. Synthesis of the 3-(<i>N</i>-Arylamino)benzhydroxamic Acid Derivatives (<b>8a</b>–<b>s</b>). Synthesis of <i>N</i>-Substituted-3-aminobenzoic Acid Derivatives (<b>6a</b>–<b>k</b>, <b>6m</b>–<b>q</b>)</h3><div class="NLM_p last">The appropriate 4-substituted-3-aminobenzoic acid derivative (<b>5</b>; 2 mmol) was dissolved in toluene (100 mL), the respective aldehyde (4 mmol) was added, and the reaction mixture was heated for 2 h under reflux using a water trap. Subsequently, the solvent was evaporated under reduced pressure. The crude product was dissolved in tetrahydrofuran and cooled to 0 °C. Then sodium triacetoxyborohydride (16 mmol) was added and the reaction mixture was stirred for 15 min, after which acetic acid was given to the reaction and stirring was continued overnight at room temperature.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The reaction was quenched by adding water, and the pH was adjusted to 5 with aq potassium hydrogen carbonate solution. The mixture was extracted with ethyl acetate (3 × 25 mL), and the organic layers were combined and evaporated under vacuum. For compound <b>6k</b>, 4-chloroacetophenone was used instead of the aldehyde derivative.</div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of 4-Methyl-3-[<i>N</i>-(2-phenylethyl)amino]benzoic Acid (<b>6l</b>)</h3><div class="NLM_p last">Methyl 3-amino-4-methylbenzoic acid (1 mmol) was dissolved in 10 mL of MeCN, and then phenethyl bromide (3 mmol) was added. The reaction was irradiated at 110 °C for 10 min with 5 min warming time to 110 °C in a microwave. After that, the solvent was removed and the mixture was purified by column chromatography (chloroform/methanol, 98:2). In the next step, the ester was hydrolyzed using 1 M sodium hydroxide solution (10 mL) in methanol (40 mL). The reaction was refluxed for 1 h. After that methanol was removed under reduced pressure and the mixture was extracted with ethyl acetate (100 mL) and 1 M hydrochloric acid solution (100 mL), and the organic layers were combined and evaporated under vacuum to obtain the pure product.</div></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of 4-Methoxy-3-[<i>N</i>-(2-phenylethyl)amino]benzoic Acid (<b>6r</b>) and 4-Methyl-3-[<i>N</i>-(3-phenylpropyl)amino]benzoic Acid (<b>6s</b>)</h3><div class="NLM_p last">The procedure described above for <b>6l</b> was used with modified parameters for the microwave irradiation and for the purification of the final step. For <b>6r</b> and <b>6s</b>, the microwave was set to 150 °C for 30 min with 5 min warming time. In addition, the final product was purified via preparative HPLC.</div></div><div id="sec7_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Boc-Protection of 3-(<i>N-</i>Benzylamino)-4-methoxy- (<b>6a</b>) and 3-(<i>N-</i>Benzylamino)-4-methylbenzoic Acid (<b>6b</b>)</h3><div class="NLM_p last">For compounds <b>7a</b> and <b>7b</b>, the obtained crude amine (<b>6a</b> and <b>6b</b>, respectively) was dissolved in methanol (50 mL) and <i>tert</i>-butanol (50 mL), and then Boc<sub>2</sub>O was added and the reaction was stirred at room temperature overnight. The product was purified by column chromatography (chloroform/methanol, 98:2).</div></div><div id="sec7_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of the 3-(<i>N</i>-Arylamino)benzhydroxamic Acid Derivatives (<b>8a</b>–<b>s</b>)</h3><div class="NLM_p">The substituted benzoic acid derivative (1 equiv) was dissolved in dry tetrahydrofuran (50 mL), followed by the addition of PyBOP (1.2 equiv), and the mixture was stirred at room temperature for 15 min. To the activated acid a mixture of H<sub>2</sub>NOTHP (1.5 equiv) and DIPEA (2.5 equiv) in dry tetrahydrofuran (5 mL) was added, and the reaction mixture was stirred at room temperature overnight.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> For the 3-amino derivatives <b>8a</b>–<b>s</b>, the order of addition and also the amount of the reagents were changed to prevent side products. At first, the 3-aminobenzoic acid derivatives <b>7a</b>–<b>s</b> were dissolved in tetrahydrofuran followed by the addition of DIPEA and H<sub>2</sub>NOTHP, and then PyBOP was added.</div><div class="NLM_p">The reaction was monitored by TLC, and the solvent was finally evaporated under vacuum, and the residue was dissolved in ethyl acetate (50 mL) and washed with aq potassium hydrogen carbonate solution and brine. The organic layer was evaporated under vacuum and the product was purified by column chromatography (chloroform/methanol/TEA, 99.5:0.45:0.05).</div><div class="NLM_p">The obtained product was dissolved in tetrahydrofuran, a catalytic amount of diluted hydrochloric acid was added, and the reaction mixture was stirred at room temperature. The reaction was controlled by TLC. Finally, the solvent was evaporated under vacuum, and the obtained hydroxamic acid derivative was purified by column chromatography (chloroform/methanol/formic acid, 95:4.95:0.05).</div><div class="NLM_p last">In the cases of <b>8a</b> and <b>8b</b>, the Boc-protected hydroxamic acid derivatives were dissolved in a mixture of CHCl<sub>3</sub> (80 mL) and TFA (20 mL), and stirring was continued for 1 h at room temperature.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> After that the mixture was cooled to 0 °C and an aq potassium carbonate solution was added to adjust the pH to 6–7. The reaction mixture was extracted with CHCl<sub>3</sub> (3 × 25 mL), and the organic layers were combined and evaporated under vacuum. The product was purified by column chromatography (chloroform/methanol/formic acid, 95:4.95:0.05).</div></div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Procedure B. Synthesis of the 3-Phenylcarbamoylbenzhydroxamic Acid Derivatives (<b>12a</b>–<b>d</b>). Synthesis of 2-Methoxy-5-methoxycarbonylbenzoic Acid (<b>9b</b>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></h3><div class="NLM_p last">To a solution of methyl 3-formyl-4-methoxybenzoic acid (<b>15</b>; 2.4 mmol), sodium dihydrogen phosphate (2.4 mmol), 2-methyl-2-butene (10.6 mmol) in <i>tert</i>-butanol, and water was added sodium chlorite (8.17 mmol), and the mixture was stirred for 1 h at room temperature. The reaction mixture was adjusted to pH 4 by addition of 1 M hydrochloric acid. The aqueous layer was extracted with dichloromethane. The organic layers were combined, washed with brine, dried over anhydrous sodium sulfate, and concentrated under vacuum to give a white powder. Yield 60%. MS <i>m</i>/<i>z</i>: 209.23 [M – H]<sup>−</sup>.</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of 2-Chloro-5-methoxycarbonylbenzoic Acid (<b>9c</b>)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h3><div class="NLM_p last">Methyl 4-chloro-3-formylbenzoic acid (<b>17</b>; 1 mmol) was dissolved in a mixture of acetone and water (1:1), followed by the addition of potassium permanganate (4 mmol). The solution was then stirred at room temperature for 4 h. 1 M sodium carbonate solution was added, and the mixture was stirred for another 15 min. The mixture was then filtered, and the pH of the filtrate was adjusted to 2–3 with 1 M hydrochloric acid. The formed precipitate was filtered, washed with water, and dried to afford a white solid. Yield 57%. MS <i>m</i>/<i>z</i>: 213.31 [M – H]<sup>−</sup>.</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 5-Methoxycarbonyl-2-methylbenzoic Acid (<b>9d</b>)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></h3><div class="NLM_p last">Methyl 3-iodo-4-methylbenzoic acid (<b>18</b>; 40 mmol) was dissolved in dry tetrahydrofuran, and the mixture was stirred at −20 °C under argon. Isopropylmagnesium chloride (2 M in tetrahydrofuran; 44 mmol) was slowly added, and the suspension was stirred for a further 1 h at −20 °C. Dry ice (8 g) was then quickly added, and the resulting solution was stirred for another 1 h at room temperature. The solvent was removed under reduced pressure, and 1 M hydrochloric acid solution was added. The precipitated product was filtered, washed with water, and air-dried to afford a white solid. Yield 96%. MS <i>m</i>/<i>z</i>: 193.36 [M – H]<sup>−</sup>.</div></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of 3-Phenylcarbamoylbenzoic Acid (<b>11a</b>)</h3><div class="NLM_p last">2-Methoxycarbonylbenzoic acid (<b>9a</b>; 2 mmol) was dissolved in an excess of aniline cooled to 0 °C using an ice bath. Then thionyl chloride (12 mmol) was added and the reaction was heated under reflux for 1 h. After that, aniline and the remaining thionyl chloride were removed under reduced pressure. The mixture was dissolved in ethyl acetate (50 mL) and washed with aq potassium hydrogen carbonate solution and brine. The organic layer was evaporated under vacuum, and the obtained product was purified by column chromatography (chloroform/methanol, 99:5). In the next step, the ester <b>10a</b> was hydrolyzed using 1 M sodium hydroxide solution (10 mL) in methanol (40 mL). The reaction was refluxed for 1 h, methanol was subsequently removed under reduced pressure, and the mixture was extracted with ethyl acetate (100 mL) and 1 M hydrochloric acid solution (100 mL). The organic layers were combined and evaporated under vacuum to obtain the pure product. Yield 9%</div></div><div id="sec7_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of 3-[(4-Chlorophenyl)carbamoyl]-4-substituted-benzoic Acids (<b>11b</b>–<b>d</b>)</h3><div class="NLM_p">The appropriate 5-methoxycarbonyl-2-substituted-benzoic acids (<b>9b</b>–<b>d</b>; 3 mmol), DMF (one drop), and oxalyl chloride (4 mmol) were stirred in CH<sub>2</sub>Cl<sub>2</sub> at room temperature for 3 h. The mixture was then added dropwise to a solution of 4-chloroaniline (3 mmol) and DIPEA (8 mmol) in CH<sub>2</sub>Cl<sub>2</sub>, and stirring was continued for another 2 h at room temperature.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The reaction mixture was washed with a saturated aqueous solution of ammonium chloride and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated under vacuum. The obtained product was purified by column chromatography (chloroform/methanol, 99:1). Yield 80–86%.</div><div class="NLM_p last">In the next step, the esters <b>10b</b>–<b>d</b> were hydrolyzed using 1 M sodium hydroxide solution (10 mL) in methanol (40 mL). The reaction was refluxed for 1 h. Then methanol was removed under reduced pressure and the mixture was extracted with ethyl acetate and 1 M hydrochloric acid solution. The organic layers were combined and evaporated under reduced pressure to obtain the pure product. Yield 50–70%.</div></div><div id="sec7_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of the 3-Phenylcarbamoylbenzhydroxamic Acid Derivatives (<b>12a</b>–<b>d</b>)</h3><div class="NLM_p last">The benzoic acid derivatives <b>11a</b>–<b>d</b> were converted to the corresponding benzhydroxamic acids following the same procedure as described for <b>8a</b>–<b>s</b>.</div></div><div id="sec7_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of Methyl-3-formyl-4-hydroxybenzoic Acid (<b>14</b>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></h3><div class="NLM_p last">To a solution of methyl 4-hydroxybenzoic acid (<b>13</b>; 20 mmol) and triethylamine (118 mmol) in 1,2-dichloroethane was added anhydrous magnesium chloride (100 mmol), and the mixture was stirred for 1 h at 40 °C. Paraformaldehyde (197 mmol) was then added, and the reaction was stirred for further 3 h at 70 °C. The reaction was cooled, quenched with 1 M hydrochloric acid solution, and filtered. The organic layer was separated, washed with 1 M hydrochloric acid and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The product was purified by column chromatography (petroleum ether/ethyl acetate 94:6 to 92:8). Yield 30%. MS <i>m</i>/<i>z</i>: 181.00 [M + H]<sup>+</sup>.</div></div><div id="sec7_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of Methyl-3-formyl-4-methoxybenzoic Acid (<b>15</b>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></h3><div class="NLM_p last">To a suspension of methyl 3-formyl-4-hydroxybenzoic acid (<b>14</b>; 50 mmol) and potassium carbonate (60 mmol) in acetone was added dimethyl sulfate (62 mmol). The mixture was stirred for 2 h under reflux. After cooling, the mixture was filtered and the residue was washed with acetone. The solvent was removed under reduced pressure. The residue was extracted with ethyl acetate and a saturated aqueous solution of sodium hydrogen carbonate. The organic layer was separated, washed with brine, dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The product was pure enough for the next step. Yield 85%, MS <i>m</i>/<i>z</i>: 195.00 [M + H]<sup>+</sup>.</div></div><div id="sec7_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of Methyl-4-chloro-3-formylbenzoic Acid (<b>17</b>)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h3><div class="NLM_p last">Methyl 4-chloro-3-methylbenzoic acid (<b>16</b>; 10 mmol) was dissolved in a mixture of glacial acetic acid (17 mL), acetic anhydride (16.5 mL), and sulfuric acid (2.5 mL) at 0 °C. Chromium trioxide (30 mmol) was then added in small portions. The mixture was stirred in ice bath for further 3 h, then poured into ice–water and stirred vigorously for 30 min. The resulting precipitate was filtered and washed with water to afford a gray solid which was dissolved in a mixture of methanol (16 mL), water (16 mL), and sulfuric acid (0.4 mL) and refluxed for 1 h. The residue was added into water, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with water and brine and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to yield the product, which was purified by column chromatography (petroleum ether/ethyl acetate 93:7 to 90:10). Yield 57%. MS <i>m</i>/<i>z</i>: 213.36 [M – H]<sup>−</sup>.</div></div><div id="sec7_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Procedure C. Synthesis of the 3-Benzyloxybenzhydroxamic Acid Derivatives (<b>20a</b>–<b>g</b>)</h3><div class="NLM_p last">The benzoic acid derivatives (<b>11a</b>–<b>d</b>) were converted to the corresponding benzhydroxamic acids following the same procedure as described for <b>8a</b>–<b>s</b>.</div></div><div id="sec7_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of Methyl-3-hydroxy-4-substituted-benzoic Acid (<b>22</b>)</h3><div class="NLM_p last">The appropriate 3-hydroxy-4-substituted-benzoic acid (<b>21</b>; 0.87 mmol) was dissolved in 50 mL of methanol and cooled to 0 °C. Then thionyl chloride (2.64 mmol) was added dropwise and the reaction mixture was heated for 5 h under reflux. Subsequently, the solvent was evaporated under reduced pressure. The crude product was dissolved in ethyl acetate and washed with aq sodium hydroxide solution. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The product was purified by column chromatography (chloroform methanol, 99:1). Yield 91–99%.</div></div><div id="sec7_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 3-(Chloro-substituted-benzyloxy)-4-substituted-benzoates (<b>24b</b>–<b>g</b>)</h3><div class="NLM_p last">The appropriate methyl 3-hydroxy-4-substituted-benzoic acid (<b>22</b>; 1 mmol) was dissolved in 20 mL of DMF and cooled to 0 °C. Then potassium carbonate (3 mmol) and the appropriate chloro-substituted benzyl bromide (<b>23</b>; 1.6 mmol) were added. The reaction mixture was stirred for 3 h at 80 °C. It was then diluted with brine and extracted with ethyl acetate. The organic layer was concentrated under reduced pressure, and the product was purified by column chromatography (chloroform, 100). In the next step, the obtained esters (<b>24b</b>–<b>g</b>) were hydrolyzed using 1 M sodium hydroxide solution (10 mL) in methanol (40 mL) to get the carboxylic acid for the following synthesis of the corresponding hydroxamic acids <b>20b</b>–<b>g</b>. The reaction was refluxed for 3 h. Then methanol was removed under reduced pressure and the mixture was extracted with ethyl acetate and 1 M hydrochloric acid solution. The organic layer was evaporated under reduced pressure and the crude product was purified by column chromatography (chloroform/methanol, 97:3). Yields 69–81%.</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Molecular Docking</h3><div id="sec7_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ligand Preparation</h4><div class="NLM_p last">MOE<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (version 2014.09, Chemical Computing Group, Montreal, Canada) was used to generate the molecular structures of all compounds. The ligands were subsequently prepared for docking using the LigPrep tool<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> as implemented in Schrödinger’s software, where all possible tautomeric forms as well as stereoisomers were generated and energy minimized using the OPLS force field. Conformers of the prepared ligands were calculated with ConfGen using the default settings (Fast) and allowing minimization of the output conformations.</div></div><div id="sec7_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Protein Preparation</h4><div class="NLM_p">HDAC8: The crystal structure of HDAC8 in complex with a hydroxamic acid-based inhibitor (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5X">2V5X</a>) was retrieved from the Protein Data Bank (PDB; <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> All water molecules were deleted except the two water molecules occupying the catalytic pockets HOH2061 and 2152, which were kept in the docking step. The protein structure was subsequently prepared with Schrödinger’s Protein Preparation Wizard.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Hydrogen atoms were added, and the H-bond network was subsequently optimized. The protonation states at pH 7.0 were predicted using the PROPKA tool in Schrödinger. The structures were finally subjected to a restrained energy minimization step using the OPLS2005 force field (rmsd of the atom displacement for terminating the minimization was 0.3 Å).</div><div class="NLM_p">HDAC6: Docking studies in HDAC6 were performed in both the crystal structure of human HDAC6 in complex with trichostatin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EDU">5EDU</a>) and zebrafish HDAC6 in complex with nexturastat A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I">5G0I</a>). Two reasons prompted us to dock in both orthologues. Indeed, the binding pockets in catalytic domain 2 (CD2) of both orthologues show a 100% sequence identity; nevertheless, water molecules in the catalytic pocket are absent in the only available crystal structure of hHDAC6 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EDU">5EDU</a>). Our docking studies have generally demonstrated the necessity of keeping the water molecule located at the rim of the catalytic tunnel (in the vicinity of His614; DrHDAC8) to improve the accuracy of the predicted binding mode. This water molecule is conserved in all reported crystal structures of DrHDAC6 as well as in crystal structures of homologous HDACs. Further, in the crystal structure of hHDAC6 trichostatin A chelates the zinc ion in a bidentate fashion. Meanwhile, nexturastat A which, similar to the herein described compounds, possesses a benzhydroxamic acid head group shows only a monodentate chelation of the catalytic zinc ion of HDAC6 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I">5G0I</a>).</div><div class="NLM_p">For docking, only CD2 of chain A of both PDB structures was kept. The proteins were subsequently prepared as described for HDAC8. The previously mentioned water molecule (HOH2249 in PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I">5G0I</a>) was considered during the subsequent docking step.</div><div class="NLM_p last">HDAC1: The crystal structure of HDAC1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BKX">4BKX</a>) was retrieved and prepared as previously described for HDAC8.</div></div><div id="sec7_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Docking</h4><div class="NLM_p last">The receptor grid preparation for the docking procedure was carried out by assigning the cocrystallized ligand as the centroid of the grid box. In the case of HDAC1, only residues Ala15-Arg17 of the peptide were considered as ligand for assigning the grid box. The generated 3D conformers were docked into the receptor model using Glide<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (Schrödinger Inc., New York, USA) in the Standard Precision mode. A total of 20 poses per ligand conformer were included in the postdocking minimization step, and a maximum of two docking poses were output for each ligand conformer.</div></div></div><div id="sec7_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> PAINS Filter</h3><div class="NLM_p last">All the herein described benzhydroxamic acids were filtered for pan-assay interference compounds<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> (PAINS). For this purpose, PAINS1, PAINS2, and PAINS3 filters, as implemented in Schrödinger’s Canvas program,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> were employed. None of the compounds was flagged as PAINS.</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> In Vitro Testing</h3><div class="NLM_p">Recombinant human HDAC1 and -6 were purchased from BPS Biosciences. Enzyme inhibition was determined by using a homogeneous fluorescence assay which was described before.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The enzymes were incubated for 90 min at 37 °C, with the fluorogenic substrate ZMAL (Z-(Ac)Lys-AMC) in a concentration of 10.5 μM and increasing concentrations of inhibitors. Fluorescence intensity was measured at an excitation wavelength of 390 nm and an emission wavelength of 460 nm in a microtiter plate reader (BMG Polarstar).</div><div class="NLM_p last">Recombinant hHDAC8 was produced as described before.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The HDAC8 activity assay was performed using a commercial HDAC8 fluorimetric drug discovery kit [Fluor de Lys(R)-HDAC8, BML-KI178] according to the manufacturer’s instructions as described earlier.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The enzyme was incubated for 90 min at 37 °C, with a substrate concentration of 50 μM and increasing concentrations of inhibitors. Measurement was performed as described for HDAC1/6.</div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cytotoxicity Studies</h3><div class="NLM_p last">HEK293 cells (DSMZ Braunschweig, ACC305) were incubated at 37 °C in a humidified incubator with 5% CO<sub>2</sub> in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% FCS and 5 mM glutamine. Cells were seeded out at 1.5 × 10<sup>3</sup> cells per well in a 96-well cell culture plate (TPP, Switzerland). The compounds were added immediately to the medium at 50 μM or increasing concentrations to determine IC<sub>50</sub> values. After 24 h, Alamar Blue reagent (Invitrogen, CA) was added according to the manufacturer’s instructions and incubated again for 21 h before samples were analyzed. Detection of viable cells which convert the resazurine compound of reagent into the high fluorescent resorufin was performed by using a FLUOstar OPTIMA microplate reader (BMG Labtec) with the following filter set: Ex 560 nm/Em 590 nm. All measurements were performed in triplicate, and data are the mean with SD ≤ 12%. As a positive control daunorubicin was used, and an IC<sub>50</sub> value of 12.55 ± 0.07 μM was determined.</div></div><div id="sec7_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Cellular Testing. Cell Culture</h3><div class="NLM_p last">Neuroblastoma BE(2)-C (ECACC, Salisbury, U.K.) cells were grown under standard conditions in DMEM with <span class="smallcaps smallerCapital">l</span>-glutamine, 4.5 g/L glucose (Lonza, Basel, Switzerland), and 1% nonessential amino acids (NEAA) (Invitrogen, Darmstadt, Germany), supplemented with 10% fetal bovine serum (FBS) (Sigma, Munich, Germany). BE(2)-C cells were genotyped in April 2012 (DSMZ) and were routinely (once per month) tested for mycoplasma contamination.</div></div><div id="sec7_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Western Blot</h3><div class="NLM_p last">Western blot analysis was performed as described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The following antibodies were used for detection: anti-acetyl-SMC3 (provided by Prof. K Shirahige, University of Tokyo, Tokyo, Japan), anti-acetyl tubulin (clone 6-11B-1; Sigma), anti-acetyl-histone H3 (polyclonal; Millipore, Schwalbach am Taunus, Germany), anti-HSC70/HSP70 (polyclonal; Santa Cruz), anti-tubulin (polyclonal; Cell Signaling Technology, Leiden, Netherlands), anti-histone H3 (polyclonal; Cell Signaling Technology), and anti-β-actin (clone AC-15; Sigma).</div></div><div id="sec7_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Colony Assay</h3><div class="NLM_p last">In six-well plates, 500 cells were seeded and treated 18–24 h after seeding as indicated. After 96 h of treatment, the medium was changed to fresh medium containing no compounds. After a minimum of another 7 days, viable colonies were stained with crystal violet (1% in 70% ethanol). For quantification, the plates were scanned in and colonies were counted in 16-bit binary pictures with the ITCN plugin for ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA; <a href="http://imagej.nih.gov/ij/" class="extLink">http://imagej.nih.gov/ij/</a>).</div></div><div id="sec7_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cell Viability</h3><div class="NLM_p last">Metabolic activity was colorimetrically determined using the WST-8 assay (GERBU Biotechnik GmbH, Heidelberg, Germany) according to the manufacturer’s instructions. Absorbance was quantified using the “FLUOstar OPTIMA” multiwell plate reader, and IC<sub>50</sub> values were calculated with GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA, <a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>).</div></div><div id="sec7_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Real-Time PCR</h3><div class="NLM_p last">Real-time reverse transcription PCR was performed as described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Data were normalized against neuroblastoma housekeeping genes <i>SDHA</i> and <i>HPRT</i><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and set in relation to negative control. The following specific primer pairs were used: <i>CDKN1</i> (forward, 5′-TGG AGA CTC TCA GGG TCG AAA-3′; reverse, 5′-GGC GTT TGG AGT GGT AGA AAT C-3′); <i>HPRT</i> (forward, 5′-TGA CAC TGG CAA AAC AAT GCA-3′; reverse, 5′-GGT CCT TTT CAC CAG CAA GCT-3′); <i>NTRK1</i> (forward, 5′-CAG CCG GCA CCG TCT CT-3′; reverse, 5′-TCC AGG AAC TCA GTG AAG ATG AAG-3′); <i>SDHA</i> (forward, 5′-TGG GAA CAA GAG GGC ATC TG-3′; reverse, 5′-CCA CCA CTG CAT CAA ATT CAT G-3′). The <i>TH</i> prime pair was from Qiagen (QT00067221).</div></div><div id="sec7_8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Immunofluorescence Staining</h3><div class="NLM_p last">BE(2)-C cells (3 × 10<sup>4</sup>) were grown on eight-well chambers (ibidi). Six days after treatment with compounds, cells were fixed for 15 min in 2% (w/v) paraformaldehyde and permeabilized for 15 min with 0.1% (v/v) Triton X-100 in PBS. After washing thrice with PBS, cells were blocked [PBS-Triton with 10% goat serum and 0.25% (w/v) BSA] for 1 h at room temperature, incubated overnight with anti-NEF-M antibody (polyclonal rabbit, Millipore; 1:500) at 4 °C, washed with PBS, and incubated with Cy3-labeled goat anti-rabbit antibody (Dianova; 1:200) for 3 h at room temperature. Nuclei were co-stained with 250 ng/mL DAPI solution and analyzed with the Olympus CKX41 microscope and ColorView I FW camera.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01447">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This material is available free of charge. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01447" class="ext-link">10.1021/acs.jmedchem.7b01447</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Spectral data for the compounds and docking figures (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf">jm7b01447_si_001.pdf (791.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_002.csv">jm7b01447_si_002.csv (2.3 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01447" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Sippl</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5985-9261" title="Orcid link">http://orcid.org/0000-0002-5985-9261</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1d6a72717b7a7c737a336e746d6d715d6d757c6f707c6774783368737430757c717178337978"><span class="__cf_email__" data-cfemail="dbacb4b7bdbcbab5bcf5a8b2ababb79babb3baa9b6baa1b2bef5aeb5b2f6b3bab7b7bef5bfbe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tino Heimburg</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fiona R. Kolbinger</span> - <span class="hlFld-Affiliation affiliation">Clinical
Cooperation Unit Pediatric Oncology, German
Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">German
Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Preclinical
Program, Hopp Children’s Cancer Center at NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrik Zeyen</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ehab Ghazy</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Herp</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Sciences, University of
Freiburg, 79104 Freiburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Schmidtkunz</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Sciences, University of
Freiburg, 79104 Freiburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jelena Melesina</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tajith Baba Shaik</span> - <span class="hlFld-Affiliation affiliation">Département
de Biologie Structurale Intégrative, Institut de Génétique
et Biologie Moléculaire et Cellulaire (IGBMC), Université
de Strasbourg (UDS), CNRS, INSERM, 67404 Illkirch Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Erdmann</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Schmidt</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Romier</span> - <span class="hlFld-Affiliation affiliation">Département
de Biologie Structurale Intégrative, Institut de Génétique
et Biologie Moléculaire et Cellulaire (IGBMC), Université
de Strasbourg (UDS), CNRS, INSERM, 67404 Illkirch Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dina Robaa</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy, Martin-Luther University of
Halle-Wittenberg, 06120 Halle/Saale, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olaf Witt</span> - <span class="hlFld-Affiliation affiliation">Clinical
Cooperation Unit Pediatric Oncology, German
Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">German
Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Preclinical
Program, Hopp Children’s Cancer Center at NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatric Oncology, Hematology and Immunology, University of Heidelberg Medical Center, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ina Oehme</span> - <span class="hlFld-Affiliation affiliation">Clinical
Cooperation Unit Pediatric Oncology, German
Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">German
Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Preclinical
Program, Hopp Children’s Cancer Center at NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manfred Jung</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Sciences, University of
Freiburg, 79104 Freiburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6361-7716" title="Orcid link">http://orcid.org/0000-0002-6361-7716</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by the Deutsche Forschungsgemeinschaft (DFG Grants Ju 295/13-1, Si 846/13-1, Oe 542/2-1, Wi 1461-/4-1). F.R.K. was supported by the Deutsche Krebshilfe (DKH) with a Mildred Scheel doctoral scholarship (Grant 112065).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">Ac<sub>2</sub>O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidin-2-phenylindole</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">(d)DMSO</td><td class="NLM_def"><p class="first last">(deuterated) dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">ethylene dichloride</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term"><i>i</i>-PrMgCl</td><td class="NLM_def"><p class="first last">isopropylmagnesium chloride</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">Na(AcO)<sub>3</sub>BH</td><td class="NLM_def"><p class="first last">sodium triacetoxyborohydride</p></td></tr><tr><td class="NLM_term">na</td><td class="NLM_def"><p class="first last">not active</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NEF</td><td class="NLM_def"><p class="first last">negative factor</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>NOTHP</td><td class="NLM_def"><p class="first last"><i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine</p></td></tr><tr><td class="NLM_term">PCR</td><td class="NLM_def"><p class="first last">polymerase chain reaction</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">sol</td><td class="NLM_def"><p class="first last">solution</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOH</td><td class="NLM_def"><p class="first last"><i>tert</i>-butanol</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoracetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">vdW</td><td class="NLM_def"><p class="first last">van der Waals</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 65 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Matthay, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiermacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackall, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">Neuroblastoma</span> <span class="citation_source-journal">Nat. Rev. Dis. Primers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">16078</span><span class="refDoi"> DOI: 10.1038/nrdp.2016.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnrdp.2016.78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27830764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC2snkslKjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=16078&author=K.+K.+Matthayauthor=J.+M.+Marisauthor=G.+Schleiermacherauthor=A.+Nakagawaraauthor=C.+L.+Mackallauthor=L.+Dillerauthor=W.+A.+Weiss&title=Neuroblastoma&doi=10.1038%2Fnrdp.2016.78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroblastoma</span></div><div class="casAuthors">Matthay Katherine K; Weiss William A; Matthay Katherine K; Weiss William A; Maris John M; Maris John M; Schleiermacher Gudrun; Nakagawara Akira; Mackall Crystal L; Diller Lisa; Diller Lisa; Weiss William A</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16078</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuroblastoma is the most common extracranial solid tumour occurring in childhood and has a diverse clinical presentation and course depending on the tumour biology.  Unique features of these neuroendocrine tumours are the early age of onset, the high frequency of metastatic disease at diagnosis and the tendency for spontaneous regression of tumours in infancy.  The most malignant tumours have amplification of the MYCN oncogene (encoding a transcription factor), which is usually associated with poor survival, even in localized disease.  Although transgenic mouse models have shown that MYCN overexpression can be a tumour-initiating factor, many other cooperating genes and tumour suppressor genes are still under investigation and might also have a role in tumour development.  Segmental chromosome alterations are frequent in neuroblastoma and are associated with worse outcome.  The rare familial neuroblastomas are usually associated with germline mutations in ALK, which is mutated in 10-15% of primary tumours, and provides a potential therapeutic target.  Risk-stratified therapy has facilitated the reduction of therapy for children with low-risk and intermediate-risk disease.  Advances in therapy for patients with high-risk disease include intensive induction chemotherapy and myeloablative chemotherapy, followed by the treatment of minimal residual disease using differentiation therapy and immunotherapy; these have improved 5-year overall survival to 50%.  Currently, new approaches targeting the noradrenaline transporter, genetic pathways and the tumour microenvironment hold promise for further improvements in survival and long-term quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQdT7LUUfcj9K0qsdY6Nc1fW6udTcc2eYOb11XxFBaQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snkslKjug%253D%253D&md5=532f7d7b32c15182fa6b366c5470f3b5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2016.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2016.78%26sid%3Dliteratum%253Aachs%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DSchleiermacher%26aufirst%3DG.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DMackall%26aufirst%3DC.%2BL.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DNeuroblastoma%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2016%26volume%3D2%26spage%3D16078%26doi%3D10.1038%2Fnrdp.2016.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Applebaum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volchenboum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, S. L.</span><span> </span><span class="NLM_article-title">Second malignancies in patients with neuroblastoma: the effects of risk-based therapy</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1002/pbc.25249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fpbc.25249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ktVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=128-133&author=M.+A.+Applebaumauthor=T.+O.+Hendersonauthor=S.+M.+Leeauthor=N.+Pintoauthor=S.+L.+Volchenboumauthor=S.+L.+Cohn&title=Second+malignancies+in+patients+with+neuroblastoma%3A+the+effects+of+risk-based+therapy&doi=10.1002%2Fpbc.25249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Second malignancies in patients with neuroblastoma: the effects of risk-based therapy</span></div><div class="casAuthors">Applebaum Mark A; Henderson Tara O; Lee Sang Mee; Pinto Navin; Volchenboum Samuel L; Cohn Susan L</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  To investigate the incidence of second malignant neoplasms (SMN) for patients with neuroblastoma, we analyzed patients from the SEER database according to three treatment eras (Era 1: 1973-1989, Era 2: 1990-1996, and Era 3: 1997-2006) corresponding to the introduction of multi-agent chemotherapy, risk-based treatment, and stem cell transplant.  PROCEDURES:  The SEER database was mined for all patients with neuroblastoma or ganglioneuroblastoma.  Cumulative incidence of SMN was calculated with death as a competing risk.  A poisson regression model was used to estimate incidence rate ratios and 95% confidence intervals to compare the rates of SMN between patients in different Eras.  RESULTS:  The analytic cohort included 2,801 patients.  Thirty-four patients developed a SMN, accounting for 1.2% of all patients.  Of the patients who developed a SMN, 47.1% received radiation for their primary neuroblastoma.  Fourteen of the SMN were carcinomas, and 10 were hematologic malignancies, with six cases of acute myelogenous leukemia.  There was no difference in the incidence of SMN in Era 1 compared to Era 3 (P = 0.48).  The cumulative incidence of SMN at 30 years for high-risk patients was 10.44% (95% CI 3.98-20.52%) compared to 3.57% (95% CI 1.87-6.12%) for non-high-risk patients (P < 0.001).  CONCLUSIONS:  This study showed no increase in the incidence of SMNs for children treated in the most recent treatment era as compared to earlier Eras.  However, as the risk for developing SMN does not plateau, the number of SMNs will likely continue to rise in the cohort of patients treated after 1996.  Comprehensive follow-up care for these survivors will be important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDA1hbcBHxjv3jf77P2BG3fW6udTcc2eYPJjnbEUIQ_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ktVyrug%253D%253D&md5=b4417f0399494267ca6aaff83bf7aa55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fpbc.25249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.25249%26sid%3Dliteratum%253Aachs%26aulast%3DApplebaum%26aufirst%3DM.%2BA.%26aulast%3DHenderson%26aufirst%3DT.%2BO.%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DPinto%26aufirst%3DN.%26aulast%3DVolchenboum%26aufirst%3DS.%2BL.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26atitle%3DSecond%2520malignancies%2520in%2520patients%2520with%2520neuroblastoma%253A%2520the%2520effects%2520of%2520risk-based%2520therapy%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2015%26volume%3D62%26spage%3D128%26epage%3D133%26doi%3D10.1002%2Fpbc.25249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croucher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolla, V.</span><span> </span><span class="NLM_article-title">Therapeutic targets for neuroblastomas</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1517/14728222.2014.867946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1517%2F14728222.2014.867946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=24387342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=277-292&author=G.+M.+Brodeurauthor=R.+Iyerauthor=J.+L.+Croucherauthor=T.+G.+Zhuangauthor=M.+Higashiauthor=V.+Kolla&title=Therapeutic+targets+for+neuroblastomas&doi=10.1517%2F14728222.2014.867946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for neuroblastomas</span></div><div class="casAuthors">Brodeur, Garrett M.; Iyer, Radhika; Croucher, Jamie L.; Zhuang, Tiangang; Higashi, Mayumi; Kolla, Venkatadri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Neuroblastoma (NB) is the most common and deadly solid tumor in children.  Despite recent improvements, the long-term outlook for high-risk NB is still < 50%.  Further, there is considerable short- and long-term toxicity.  More effective, less toxic therapy is needed, and the development of targeted therapies offers great promise.  Areas covered: Relevant literature was reviewed to identify current and future therapeutic targets that are crit. to malignant transformation and progression of NB.  The potential or actual NB therapeutic targets are classified into four categories: i) genes activated by amplification, mutation, translocation or autocrine overexpression; ii) genes inactivated by deletion, mutation or epigenetic silencing; iii) membrane-assocd. genes expressed on most NBs but few other tissues; or iv) common target genes relevant to NB as well as other tumors.  Expert opinion: Therapeutic approaches have been developed to some of these targets, but many remain untargeted at the present time.  It is unlikely that single targeted agents will be sufficient for long-term cure, at least for high-risk NBs.  The challenge will be how to integrate targeted agents with each other and with conventional therapy to enhance their efficacy, while simultaneously reducing systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ArJGyg75X7Vg90H21EOLACvtfcHk0lhFfYIoibhWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLk%253D&md5=2b4a761c3dfa0eb78f6ff14429a06672</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.867946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.867946%26sid%3Dliteratum%253Aachs%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DCroucher%26aufirst%3DJ.%2BL.%26aulast%3DZhuang%26aufirst%3DT.%2BG.%26aulast%3DHigashi%26aufirst%3DM.%26aulast%3DKolla%26aufirst%3DV.%26atitle%3DTherapeutic%2520targets%2520for%2520neuroblastomas%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D277%26epage%3D292%26doi%3D10.1517%2F14728222.2014.867946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klempnauer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span> </span><span class="NLM_article-title">Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1038/305245a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F305245a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1983&pages=245-248&author=M.+Schwabauthor=K.+Alitaloauthor=K.+H.+Klempnauerauthor=H.+E.+Varmusauthor=J.+M.+Bishopauthor=F.+Gilbertauthor=G.+Brodeurauthor=M.+Goldsteinauthor=J.+Trent&title=Amplified+DNA+with+limited+homology+to+myc+cellular+oncogene+is+shared+by+human+neuroblastoma+cell+lines+and+a+neuroblastoma+tumour&doi=10.1038%2F305245a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F305245a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F305245a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DKlempnauer%26aufirst%3DK.%2BH.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26aulast%3DGilbert%26aufirst%3DF.%26aulast%3DBrodeur%26aufirst%3DG.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DTrent%26aufirst%3DJ.%26atitle%3DAmplified%2520DNA%2520with%2520limited%2520homology%2520to%2520myc%2520cellular%2520oncogene%2520is%2520shared%2520by%2520human%2520neuroblastoma%2520cell%2520lines%2520and%2520a%2520neuroblastoma%2520tumour%26jtitle%3DNature%26date%3D1983%26volume%3D305%26spage%3D245%26epage%3D248%26doi%3D10.1038%2F305245a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span> </span><span class="NLM_article-title">Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1038/316160a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F316160a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1985&pages=160-162&author=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishop&title=Human+N-myc+gene+contributes+to+neoplastic+transformation+of+mammalian+cells+in+culture&doi=10.1038%2F316160a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F316160a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F316160a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26atitle%3DHuman%2520N-myc%2520gene%2520contributes%2520to%2520neoplastic%2520transformation%2520of%2520mammalian%2520cells%2520in%2520culture%26jtitle%3DNature%26date%3D1985%26volume%3D316%26spage%3D160%26epage%3D162%26doi%3D10.1038%2F316160a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzeschik, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span> </span><span class="NLM_article-title">Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1038/308288a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F308288a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1984&pages=288-291&author=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishopauthor=K.+H.+Grzeschikauthor=S.+L.+Naylorauthor=A.+Y.+Sakaguchiauthor=G.+Brodeurauthor=J.+Trent&title=Chromosome+localization+in+normal+human+cells+and+neuroblastomas+of+a+gene+related+to+c-myc&doi=10.1038%2F308288a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F308288a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F308288a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26aulast%3DGrzeschik%26aufirst%3DK.%2BH.%26aulast%3DNaylor%26aufirst%3DS.%2BL.%26aulast%3DSakaguchi%26aufirst%3DA.%2BY.%26aulast%3DBrodeur%26aufirst%3DG.%26aulast%3DTrent%26aufirst%3DJ.%26atitle%3DChromosome%2520localization%2520in%2520normal%2520human%2520cells%2520and%2520neuroblastomas%2520of%2520a%2520gene%2520related%2520to%2520c-myc%26jtitle%3DNature%26date%3D1984%26volume%3D308%26spage%3D288%26epage%3D291%26doi%3D10.1038%2F308288a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span> </span><span class="NLM_article-title">Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span><span class="refDoi"> DOI: 10.1126/science.6719137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1126%2Fscience.6719137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=6719137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADyaL2c7ps1Chtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=1984&pages=1121-1124&author=G.+M.+Brodeurauthor=R.+C.+Seegerauthor=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishop&title=Amplification+of+N-myc+in+untreated+human+neuroblastomas+correlates+with+advanced+disease+stage&doi=10.1126%2Fscience.6719137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage</span></div><div class="casAuthors">Brodeur G M; Seeger R C; Schwab M; Varmus H E; Bishop J M</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">4653</span>),
    <span class="NLM_cas:pages">1121-4</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A domain of DNA designated N-myc is amplified 20- to 140-fold in human neuroblastoma cell lines but not in cell lines from other tumor types.  N-myc has now been found to be amplified in neuroblastoma tissue from 24 of 63 untreated patients (38 percent).  The extent of amplification appears to be bimodal, with amplification of 100- to 300-fold in 12 cases and 3- to 10-fold in 10 others.  Amplification was found in 0 of 15 patients with stage 1 or 2 disease, whereas 24 of 48 cases (50 percent) with stage 3 or 4 had evidence of N-myc amplification.  These data indicate that N-myc amplification is a common event in untreated human neuroblastomas.  Furthermore, N-myc amplification is highly correlated with advanced stages of disease (P less than 0.001) and with the ability to grow in vitro as an established cell line, both of which are associated with a poor prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ87Kw6s8IBfftos8R3JUhXfW6udTcc2eZ1qrvvcYb0f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7ps1Chtw%253D%253D&md5=8920f3fcf76f0f8ae977a839a36c04b0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.6719137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6719137%26sid%3Dliteratum%253Aachs%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DSeeger%26aufirst%3DR.%2BC.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26atitle%3DAmplification%2520of%2520N-myc%2520in%2520untreated%2520human%2520neuroblastomas%2520correlates%2520with%2520advanced%2520disease%2520stage%26jtitle%3DScience%26date%3D1984%26volume%3D224%26spage%3D1121%26epage%3D1124%26doi%3D10.1126%2Fscience.6719137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1038/nature07261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnature07261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=18724359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene&doi=10.1038%2Fnature07261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ALK as a major familial neuroblastoma predisposition gene</span></div><div class="casAuthors">Mosse, Yael P.; Laudenslager, Marci; Longo, Luca; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Perri, Patrizia; Laureys, Genevieve; Speleman, Frank; Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon; Torkamani, Ali; Schork, Nicholas J.; Brodeur, Garrett M.; Tonini, Gian P.; Rappaport, Eric; Devoto, Marcella; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">930-935</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma is a childhood cancer that can be inherited, but the genetic etiol. is largely unknown.  Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired.  We first identified a significant linkage signal at chromosome bands 2p23-24 using a whole-genome scan in neuroblastoma pedigrees.  Re-sequencing of regional candidate genes identified three sep. germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight sep. families.  Re-sequencing in 194 high-risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples.  Nine of the ten mutations map to crit. regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers.  Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK mRNA resulted in profound inhibition of growth in all cell lines harboring mutant or amplified ALK, as well as in two out of six wild-type cell lines for ALK.  Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell-surface kinase is a tractable therapeutic target for this lethal pediatric malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNOcIFf5xjbVg90H21EOLACvtfcHk0lgV-YFIFZtRsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP&md5=bb998ef8f6bfbd85f928263e13954ce4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature07261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07261%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935%26doi%3D10.1038%2Fnature07261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1016/j.canlet.2010.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.canlet.2010.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=20934803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=81-94&author=E.+Ardiniauthor=P.+Magnaghiauthor=P.+Orsiniauthor=A.+Galvaniauthor=M.+Menichincheri&title=Anaplastic+Lymphoma+Kinase%3A+role+in+specific+tumours%2C+and+development+of+small+molecule+inhibitors+for+cancer+therapy&doi=10.1016%2Fj.canlet.2010.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic Lymphoma Kinase: Role in specific tumours, and development of small molecule inhibitors for cancer therapy</span></div><div class="casAuthors">Ardini, E.; Magnaghi, P.; Orsini, P.; Galvani, A.; Menichincheri, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase first identified as the product of a gene rearrangement in Anaplastic Large Cell Lymphoma.  ALK has subsequently been found to be rearranged, mutated, or amplified in a further series of tumors including neuroblastoma, and Non-Small Cell Lung Cancer.  There is strong preclin. evidence that ALK is a driving force for oncogenesis in these cases, and that inhibition of ALK kinase activity results in anti-tumoral efficacy.  These observations have sparked the development of small mol. kinase inhibitors, the most advanced of which is currently in clin. testing and which has shown promising preliminary activity in the subset of lung cancer patients whose tumors harbor activated ALK.  In this review, we describe the various oncogenic forms of ALK, relevant clin. settings, and give a detailed overview of current drug discovery efforts in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw80IgX8jf7rVg90H21EOLACvtfcHk0lgV-YFIFZtRsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7vF&md5=9b72a030b1c4e3c90c0e570ce0c48f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DMenichincheri%26aufirst%3DM.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520role%2520in%2520specific%2520tumours%252C%2520and%2520development%2520of%2520small%2520molecule%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2010%26volume%3D299%26spage%3D81%26epage%3D94%26doi%3D10.1016%2Fj.canlet.2010.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogarty, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, S. L.</span><span> </span><span class="NLM_article-title">Neuroblastoma</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">2106</span><span class="NLM_x">–</span> <span class="NLM_lpage">2120</span><span class="refDoi"> DOI: 10.1016/S0140-6736(07)60983-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS0140-6736%2807%2960983-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=17586306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVKqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=2106-2120&author=J.+M.+Marisauthor=M.+D.+Hogartyauthor=R.+Bagatellauthor=S.+L.+Cohn&title=Neuroblastoma&doi=10.1016%2FS0140-6736%2807%2960983-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroblastoma</span></div><div class="casAuthors">Maris, John M.; Hogarty, Michael D.; Bagatell, Rochelle; Cohn, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">9579</span>),
    <span class="NLM_cas:pages">2106-2120</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. hallmark of neuroblastoma is heterogeneity, with the likelihood of cure varying widely according to age at diagnosis, extent of disease, and tumor biol.  A subset of tumors will undergo spontaneous regression while others show relentless progression.  Around half of all cases are currently classified as high-risk for disease relapse, with overall survival rates less than 40% despite intensive multimodal therapy.  This Seminar focuses on recent advances in our understanding of the biol. of this complex pediatric solid tumor.  We outline plans for the development of a uniform International Neuroblastoma Risk Group (INRG) classification system, and summarize strategies for risk-based therapies.  We also update readers on new discoveries related to the underlying mol. pathogenesis of this tumor, with special emphasis on advances that are translatable to the clinic.  Finally, we discuss new approaches to treatment, including recently discovered mol. targets that might provide more effective treatment strategies with the potential for less toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5PXEdfjVYN7Vg90H21EOLACvtfcHk0lhBOxtWQm-TNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVKqtb0%253D&md5=bb569d774aae58d605b4eee46ef2229a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2960983-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252960983-0%26sid%3Dliteratum%253Aachs%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DHogarty%26aufirst%3DM.%2BD.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26atitle%3DNeuroblastoma%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D2106%26epage%3D2120%26doi%3D10.1016%2FS0140-6736%2807%2960983-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">The clinical development of histone deacetylase inhibitors as targeted anticancer drugs</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span><span class="refDoi"> DOI: 10.1517/13543784.2010.510514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1517%2F13543784.2010.510514" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1049-1066&author=P.+A.+Marks&title=The+clinical+development+of+histone+deacetylase+inhibitors+as+targeted+anticancer+drugs&doi=10.1517%2F13543784.2010.510514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543784.2010.510514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2010.510514%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DThe%2520clinical%2520development%2520of%2520histone%2520deacetylase%2520inhibitors%2520as%2520targeted%2520anticancer%2520drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D1049%26epage%3D1066%26doi%3D10.1517%2F13543784.2010.510514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span><span class="refDoi"> DOI: 10.1038/nrd2133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnrd2133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=16955068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors&doi=10.1038%2Fnrd2133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of histone deacetylase inhibitors</span></div><div class="casAuthors">Bolden, Jessica E.; Peart, Melissa J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">769-784</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and have a key role in the epigenetic regulation of gene expression.  In addn., the activity of non-histone proteins can be regulated through HDAC-mediated hypo-acetylation.  In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes assocd. with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclin. studies.  However, such studies have also indicated that the effects of HDAC inhibitors could be considerably broader and more complicated than originally understood.  Here we summarize recent advances in the understanding of the mol. events that underlie the anticancer effects of HDAC inhibitors, and discuss how such information could be used in optimizing the development and application of these agents in the clinic, either as monotherapies or in combination with other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhfqS1awkOHbVg90H21EOLACvtfcHk0lhBOxtWQm-TNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D&md5=91e55ee942fda3e4e2055ddf299fc866</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2133%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D769%26epage%3D784%26doi%3D10.1038%2Fnrd2133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wagner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackanson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1007/s13148-010-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1007%2Fs13148-010-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21258646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeqsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=117-136&author=J.+M.+Wagnerauthor=B.+Hackansonauthor=M.+Lubbertauthor=M.+Jung&title=Histone+deacetylase+%28HDAC%29+inhibitors+in+recent+clinical+trials+for+cancer+therapy&doi=10.1007%2Fs13148-010-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy</span></div><div class="casAuthors">Wagner, Julia M.; Hackanson, Bjoern; Luebbert, Michael; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">117-136</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7075</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Heritable changes in gene expression that are not based upon alterations in the DNA sequence are defined as epigenetics.  The most common mechanisms of epigenetic regulation are the methylation of CpG islands within the DNA and the modification of amino acids in the N-terminal histone tails.  In the last years, it became evident that the onset of cancer and its progression may not occur only due to genetic mutations but also because of changes in the patterns of epigenetic modifications.  In contrast to genetic mutations, which are almost impossible to reverse, epigenetic changes are potentially reversible.  This implies that they are amenable to pharmacol. interventions.  Therefore, a lot of work in recent years has focussed on the development of small mol. enzyme inhibitors like DNA-methyltransferase inhibitors or inhibitors of histone-modifying enzymes.  These may reverse misregulated epigenetic states and be implemented in the treatment of cancer or other diseases, e.g., neurol. disorders.  Today, several epigenetic drugs are already approved by the FDA and the EMEA for cancer treatment and around ten histone deacetylase (HDAC) inhibitors are in clin. development.  This review will give an update on recent clin. trials of the HDAC inhibitors used systemically that were reported in 2009 and 2010 and will present an overview of different biomarkers to monitor the biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62EyFQbmSEbVg90H21EOLACvtfcHk0lhBOxtWQm-TNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeqsrrF&md5=c2b02cc37f94c85c4496822b9bf13af9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs13148-010-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13148-010-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BM.%26aulast%3DHackanson%26aufirst%3DB.%26aulast%3DLubbert%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520in%2520recent%2520clinical%2520trials%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Epigenet.%26date%3D2010%26volume%3D1%26spage%3D117%26epage%3D136%26doi%3D10.1007%2Fs13148-010-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deubzer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hero, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp-Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span> </span><span class="NLM_article-title">Histone deacetylase 8 in neuroblastoma tumorigenesis</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1158%2F1078-0432.CCR-08-0684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=19118036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=91-99&author=I.+Oehmeauthor=H.+E.+Deubzerauthor=D.+Wegenerauthor=D.+Pickertauthor=J.+P.+Linkeauthor=B.+Heroauthor=A.+Kopp-Schneiderauthor=F.+Westermannauthor=S.+M.+Ulrichauthor=A.+von+Deimlingauthor=M.+Fischerauthor=O.+Witt&title=Histone+deacetylase+8+in+neuroblastoma+tumorigenesis&doi=10.1158%2F1078-0432.CCR-08-0684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase 8 in Neuroblastoma Tumorigenesis</span></div><div class="casAuthors">Oehme, Ina; Deubzer, Hedwig E.; Wegener, Dennis; Pickert, Diana; Linke, Jan-Peter; Hero, Barbara; Kopp-Schneider, Annette; Westermann, Frank; Ulrich, Scott M.; von Deimling, Andreas; Fischer, Matthias; Witt, Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The effects of pan-histone deacetylase (HDAC) inhibitors on cancer cells have shown that HDACs are involved in fundamental tumor biol. processes such as cell cycle control, differentiation, and apoptosis.  However, because of the unselective nature of these compds., little is known about the contribution of individual HDAC family members to tumorigenesis and progression.  The purpose of this study was to evaluate the role of individual HDACs in neuroblastoma tumorigenesis.  Exptl. Design: We have investigated the mRNA expression of all HDAC1-11 family members in a large cohort of primary neuroblastoma samples covering the full spectrum of the disease.  HDACs assocd. with disease stage and survival were subsequently functionally evaluated in cell culture models.  RESULTS: Only HDAC8 expression was significantly correlated with advanced disease and metastasis and down-regulated in stage 4S neuroblastoma assocd. with spontaneous regression.  High HDAC8 expression was assocd. with poor prognostic markers and poor overall and event-free survival.  The knockdown of HDAC8 resulted in the inhibition of proliferation, reduced clonogenic growth, cell cycle arrest, and differentiation in cultured neuroblastoma cells.  The treatment of neuroblastoma cell lines as well as short-term-culture neuroblastoma cells with an HDAC8-selective small-mol. inhibitor inhibited cell proliferation and clone formation, induced differentiation, and thus reproduced the HDAC8 knockdown phenotype.  Global histone 4 acetylation was not affected by HDAC8 knockdown or by selective inhibitor treatment.  CONCLUSIONS: Our data point toward an important role of HDAC8 in neuroblastoma pathogenesis and identify this HDAC family member as a specific drug target for the differentiation therapy of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsN9HmNgpdA7Vg90H21EOLACvtfcHk0ljoMz6FWV0W5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Cjuw%253D%253D&md5=8c8e0b989c0036b233332a74a355dece</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0684%26sid%3Dliteratum%253Aachs%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DPickert%26aufirst%3DD.%26aulast%3DLinke%26aufirst%3DJ.%2BP.%26aulast%3DHero%26aufirst%3DB.%26aulast%3DKopp-Schneider%26aufirst%3DA.%26aulast%3DWestermann%26aufirst%3DF.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DWitt%26aufirst%3DO.%26atitle%3DHistone%2520deacetylase%25208%2520in%2520neuroblastoma%2520tumorigenesis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D91%26epage%3D99%26doi%3D10.1158%2F1078-0432.CCR-08-0684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Waltregny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leval, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenisson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly Tran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellahcene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castronovo, V.</span><span> </span><span class="NLM_article-title">Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)63320-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS0002-9440%2810%2963320-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15277229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFWjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=553-564&author=D.+Waltregnyauthor=L.+De+Levalauthor=W.+Glenissonauthor=S.+Ly+Tranauthor=B.+J.+Northauthor=A.+Bellahceneauthor=U.+Weidleauthor=E.+Verdinauthor=V.+Castronovo&title=Expression+of+histone+deacetylase+8%2C+a+class+I+histone+deacetylase%2C+is+restricted+to+cells+showing+smooth+muscle+differentiation+in+normal+human+tissues&doi=10.1016%2FS0002-9440%2810%2963320-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues</span></div><div class="casAuthors">Waltregny, David; de Leval, Laurence; Glenisson, Wendy; Tran, Siv Ly; North, Brian J.; Bellahcene, Akeila; Weidle, Ulrich; Verdin, Eric; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) were originally identified as nuclear enzymes involved in gene transcription regulation.  Until recently, it was thought that their activity was restricted within the nucleus, with histones as unique substrates.  The demonstration that specific HDACs deacetylate nonhistone proteins, such as p53 and α-tubulin, broadened the field of activity of these enzymes.  HDAC8, a class I HDAC, is considered to be ubiquitously expressed, as suggested by results of Northern blots performed on tissue RNA exts., and transfection expts. using various cell lines have indicated that this enzyme may display a prominent nuclear localization.  Using immunohistochem., we unexpectedly found that, in normal human tissues, HDAC8 is exclusively expressed by cells showing smooth muscle differentiation, including visceral and vascular smooth muscle cells, myoepithelial cells, and myofibroblasts, and is mainly detected in their cytosol.  These findings were confirmed in vitro by nucleo-cytoplasmic fractionation and immunoblot expts. performed on human primary smooth muscle cells and by the cytosolic detection of epitope-tagged HDAC8 overexpressed in fibroblasts.  Immunocytochem. strongly suggested a cytoskeleton-like distribution of the enzyme.  Further double-immunofluorescence staining expts. coupled with confocal microscopy anal. showed that epitope-tagged HDAC8 overexpressed in murine fibroblasts formed cytoplasmic stress fiber-like structures that co-localized with the smooth muscle cytoskeleton protein smooth muscle α-actin.  Our works represent the first demonstration of the restricted expression of a class I HDAC to a specific cell type and indicate that HDAC8, besides being a novel marker of smooth muscle differentiation, may play a role in the biol. of these contractile cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpOq75rK-D27Vg90H21EOLACvtfcHk0ljoMz6FWV0W5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFWjsrg%253D&md5=732e18585b7a3917e81a7b9f9560f94e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963320-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963320-2%26sid%3Dliteratum%253Aachs%26aulast%3DWaltregny%26aufirst%3DD.%26aulast%3DDe%2BLeval%26aufirst%3DL.%26aulast%3DGlenisson%26aufirst%3DW.%26aulast%3DLy%2BTran%26aufirst%3DS.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DWeidle%26aufirst%3DU.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DExpression%2520of%2520histone%2520deacetylase%25208%252C%2520a%2520class%2520I%2520histone%2520deacetylase%252C%2520is%2520restricted%2520to%2520cells%2520showing%2520smooth%2520muscle%2520differentiation%2520in%2520normal%2520human%2520tissues%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D553%26epage%3D564%26doi%3D10.1016%2FS0002-9440%2810%2963320-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Waltregny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenisson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colige, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castronovo, V.</span><span> </span><span class="NLM_article-title">Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1096/fj.04-2303fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1096%2Ffj.04-2303fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15772115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=966-968&author=D.+Waltregnyauthor=W.+Glenissonauthor=S.+L.+Tranauthor=B.+J.+Northauthor=E.+Verdinauthor=A.+Coligeauthor=V.+Castronovo&title=Histone+deacetylase+HDAC8+associates+with+smooth+muscle+alpha-actin+and+is+essential+for+smooth+muscle+cell+contractility&doi=10.1096%2Ffj.04-2303fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle cell contractility</span></div><div class="casAuthors">Waltregny, David; Glenisson, Wendy; Tran, Siv Ly; North, Brian J.; Verdin, Eric; Colige, Alain; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">966-968, 10.1096/fj.04-2303fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Although originally characterized as nuclear enzymes controlling the stability of nucleosomes, histone deacetylases (HDACs) may also exert their activity within the cytosol.  Recently, we have demonstrated that HDAC8, a class I HDAC, is a novel, prominently cytosolic marker of smooth muscle differentiation.  As HDAC8 displays a striking stress fiber-like pattern of distribution and is coexpressed in vivo with smooth muscle α-actin (α-SMA) and smooth muscle myosin heavy chain, we have explored the possible participation of this HDAC in smooth muscle cytoskeleton regulation.  Cell fractionation assays performed with primary human smooth muscle cells (HSMCs) showed that HDAC8, in contrast to HDAC1 and HDAC3, was enriched in cytoskeleton-bound protein fractions and insol. cell pellets, suggesting an assocn. of HDAC8 with the cytoskeleton.  Coimmunopptn. expts. using HSMCs, NIH-3T3 cells, and human prostate tissue lysates further demonstrated that HDAC8 assocs. with α-SMA but not with β-actin.  HDAC8 silencing through RNA interference strongly reduced the capacity of HSMCs to contract collagen lattices.  Mock transfections had no effect on HSMC contractility, and transfections with small interfering RNAs (siRNAs) specific for HDAC6, a cytosolic HDAC that functions as an α-tubulin deacetylase, resulted in a weak contraction inhibition.  Although mock- and HDAC6 siRNA-transfected HSMCs showed no noticeable morphol. changes, HDAC8 siRNA-transfected HSMCs displayed a size redn. with diminished cell spreading after replating.  Altogether, our findings indicate that HDAC8 assocs. with the smooth muscle actin cytoskeleton and may regulate the contractile capacity of smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgU-_XQBcSZLVg90H21EOLACvtfcHk0ljoMz6FWV0W5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVaguro%253D&md5=a279fcbb0866cf8b90d9a6d288719c45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-2303fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-2303fje%26sid%3Dliteratum%253Aachs%26aulast%3DWaltregny%26aufirst%3DD.%26aulast%3DGlenisson%26aufirst%3DW.%26aulast%3DTran%26aufirst%3DS.%2BL.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DColige%26aufirst%3DA.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DHistone%2520deacetylase%2520HDAC8%2520associates%2520with%2520smooth%2520muscle%2520alpha-actin%2520and%2520is%2520essential%2520for%2520smooth%2520muscle%2520cell%2520contractility%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D966%26epage%3D968%26doi%3D10.1096%2Ffj.04-2303fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">HDAC8: a multifaceted target for therapeutic interventions</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.tips.2015.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=26013035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=481-492&author=A.+Chakrabartiauthor=I.+Oehmeauthor=O.+Wittauthor=G.+Oliveiraauthor=W.+Sipplauthor=C.+Romierauthor=R.+J.+Pierceauthor=M.+Jung&title=HDAC8%3A+a+multifaceted+target+for+therapeutic+interventions&doi=10.1016%2Fj.tips.2015.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC8: a multifaceted target for therapeutic interventions</span></div><div class="casAuthors">Chakrabarti, Alokta; Oehme, Ina; Witt, Olaf; Oliveira, Guilherme; Sippl, Wolfgang; Romier, Christophe; Pierce, Raymond J.; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">481-492</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 8 (HDAC8) is a class I histone deacetylase implicated as a therapeutic target in various diseases, including cancer, X-linked intellectual disability, and parasitic infections.  It is a structurally well-characterized enzyme that also deacetylates nonhistone proteins.  In cancer, HDAC8 is a major 'epigenetic player' that is linked to deregulated expression or interaction with transcription factors crit. to tumorigenesis.  In the parasite Schistosoma mansoni and in viral infections, HDAC8 is a novel target to subdue infection.  The current challenge remains in the development of potent selective inhibitors that would specifically target HDAC8 with fewer adverse effects compared with pan-HDAC inhibitors.  Here, we review HDAC8 as a drug target and discuss inhibitors with respect to their structural features and therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPwG01nKtWHLVg90H21EOLACvtfcHk0lg6h90Iv7GdPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGqsL4%253D&md5=c99b5c390930dc17398d15f20127758b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DHDAC8%253A%2520a%2520multifaceted%2520target%2520for%2520therapeutic%2520interventions%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D481%26epage%3D492%26doi%3D10.1016%2Fj.tips.2015.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">HDAC8 functions in spindle assembly during mouse oocyte meiosis</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">20092</span><span class="NLM_x">–</span> <span class="NLM_lpage">20102</span><span class="refDoi"> DOI: 10.18632/oncotarget.15383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.18632%2Foncotarget.15383" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=20092-20102&author=K.+Zhangauthor=Y.+Luauthor=C.+Jiangauthor=W.+Liuauthor=J.+Shuauthor=X.+Chenauthor=Y.+Shiauthor=E.+Wangauthor=L.+Wangauthor=Q.+Huauthor=Y.+Daiauthor=B.+Xiong&title=HDAC8+functions+in+spindle+assembly+during+mouse+oocyte+meiosis&doi=10.18632%2Foncotarget.15383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15383%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DHDAC8%2520functions%2520in%2520spindle%2520assembly%2520during%2520mouse%2520oocyte%2520meiosis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D20092%26epage%3D20102%26doi%3D10.18632%2Foncotarget.15383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ahn, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span> </span><span class="NLM_article-title">Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.3892/or.2016.5280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.3892%2For.2016.5280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28004115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FnsVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=540-546&author=M.+Y.+Ahnauthor=J.+H.+Yoon&title=Histone+deacetylase+8+as+a+novel+therapeutic+target+in+oral+squamous+cell+carcinoma&doi=10.3892%2For.2016.5280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma</span></div><div class="casAuthors">Ahn Mee-Young; Yoon Jung-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">540-546</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The overexpression of histone deacetylases (HDACs) has been observed in many cancers and inhibition of specific HDAC has emerged as a new target for cancer therapy.  The present study examined the expression of HDAC8 and the inhibitory effect of HDAC8 in oral squamous cell carcinoma (OSCC).  The expression of HDAC8 was measured in human OSCC tissues and OSCC cell lines using immunohistochemistry and immunoblotting.  HDAC8 was knocked down in OSCC cells by transfection with HDAC8 siRNAs and cell proliferation was quantified.  Apoptosis and autophagy were measured using flow cytometry and immunoblotting.  HDAC8 were overexpressed in OSCC tissues and OSCC cells, mainly localized in the cytoplasm.  HDAC8 siRNAs effectively reduced the level of HDAC8 expression and HDAC8 silencing significantly inhibited the proliferation of OSCC cells.  HDAC8 knockdown induced apoptotic cell death through caspases activation and pro-survival autophagy in OSCC cells.  Combination with HDAC silencing and autophagy inhibition enhanced cell death by increasing apoptosis in OSCC cells.  This study suggests that inhibition of HDAC8 might become a novel therapeutic strategy for OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8yUczl3YjjK__Jf7-eMvJfW6udTcc2eZQU7vrUTrAYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FnsVWlsA%253D%253D&md5=a27ce3d78ba9e6f16b0ef97f6540f579</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3892%2For.2016.5280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2016.5280%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DM.%2BY.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26atitle%3DHistone%2520deacetylase%25208%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D540%26epage%3D546%26doi%3D10.3892%2For.2016.5280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minamino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Baere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decroos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Donato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francey, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyftodimou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hullings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaulin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi-Jaulin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seimiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillessen-Kaesbach, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krantz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span> </span><span class="NLM_article-title">HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nature11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnature11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=22885700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOgsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2012&pages=313-317&author=M.+A.+Deardorffauthor=M.+Bandoauthor=R.+Nakatoauthor=E.+Watrinauthor=T.+Itohauthor=M.+Minaminoauthor=K.+Saitohauthor=M.+Komataauthor=Y.+Katouauthor=D.+Clarkauthor=K.+E.+Coleauthor=E.+De+Baereauthor=C.+Decroosauthor=N.+Di+Donatoauthor=S.+Ernstauthor=L.+J.+Franceyauthor=Y.+Gyftodimouauthor=K.+Hirashimaauthor=M.+Hullingsauthor=Y.+Ishikawaauthor=C.+Jaulinauthor=M.+Kaurauthor=T.+Kiyonoauthor=P.+M.+Lombardiauthor=L.+Magnaghi-Jaulinauthor=G.+R.+Mortierauthor=N.+Nozakiauthor=M.+B.+Petersenauthor=H.+Seimiyaauthor=V.+M.+Siuauthor=Y.+Suzukiauthor=K.+Takagakiauthor=J.+J.+Wildeauthor=P.+J.+Willemsauthor=C.+Prigentauthor=G.+Gillessen-Kaesbachauthor=D.+W.+Christiansonauthor=F.+J.+Kaiserauthor=L.+G.+Jacksonauthor=T.+Hirotaauthor=I.+D.+Krantzauthor=K.+Shirahige&title=HDAC8+mutations+in+Cornelia+de+Lange+syndrome+affect+the+cohesin+acetylation+cycle&doi=10.1038%2Fnature11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle</span></div><div class="casAuthors">Deardorff, Matthew A.; Bando, Masashige; Nakato, Ryuichiro; Watrin, Erwan; Itoh, Takehiko; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Clark, Dinah; Cole, Kathryn E.; De Baere, Elfride; Decroos, Christophe; Di Donato, Nataliya; Ernst, Sarah; Francey, Lauren J.; Gyftodimou, Yolanda; Hirashima, Kyotaro; Hullings, Melanie; Ishikawa, Yuuichi; Jaulin, Christian; Kaur, Maninder; Kiyono, Tohru; Lombardi, Patrick M.; Magnaghi-Jaulin, Laura; Mortier, Geert R.; Nozaki, Naohito; Petersen, Michael B.; Seimiya, Hiroyuki; Siu, Victoria M.; Suzuki, Yutaka; Takagaki, Kentaro; Wilde, Jonathan J.; Willems, Patrick J.; Prigent, Claude; Gillessen-Kaesbach, Gabriele; Christianson, David W.; Kaiser, Frank J.; Jackson, Laird G.; Hirota, Toru; Krantz, Ian D.; Shirahige, Katsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">489</span>
        (<span class="NLM_cas:issue">7415</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL for nearly 60% of individuals with classical CdLS, and by mutations in the core cohesin components SMC1A (∼5%) and SMC3 (<1%) for a smaller fraction of probands.  In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein.  These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion and also has key roles in gene regulation.  SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin, and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase.  Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands.  Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissoln. of the used' cohesin complex released from chromatin in both prophase and anaphase.  SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunopptn. sequencing anal. demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfmQ9HBsaFrVg90H21EOLACvtfcHk0lgcQaITr4f7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOgsLnK&md5=27192552507822ccf105587884fb16f4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11316%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DNakato%26aufirst%3DR.%26aulast%3DWatrin%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMinamino%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DK.%26aulast%3DKomata%26aufirst%3DM.%26aulast%3DKatou%26aufirst%3DY.%26aulast%3DClark%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DK.%2BE.%26aulast%3DDe%2BBaere%26aufirst%3DE.%26aulast%3DDecroos%26aufirst%3DC.%26aulast%3DDi%2BDonato%26aufirst%3DN.%26aulast%3DErnst%26aufirst%3DS.%26aulast%3DFrancey%26aufirst%3DL.%2BJ.%26aulast%3DGyftodimou%26aufirst%3DY.%26aulast%3DHirashima%26aufirst%3DK.%26aulast%3DHullings%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DJaulin%26aufirst%3DC.%26aulast%3DKaur%26aufirst%3DM.%26aulast%3DKiyono%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DP.%2BM.%26aulast%3DMagnaghi-Jaulin%26aufirst%3DL.%26aulast%3DMortier%26aufirst%3DG.%2BR.%26aulast%3DNozaki%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DM.%2BB.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DV.%2BM.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DTakagaki%26aufirst%3DK.%26aulast%3DWilde%26aufirst%3DJ.%2BJ.%26aulast%3DWillems%26aufirst%3DP.%2BJ.%26aulast%3DPrigent%26aufirst%3DC.%26aulast%3DGillessen-Kaesbach%26aufirst%3DG.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26aulast%3DKaiser%26aufirst%3DF.%2BJ.%26aulast%3DJackson%26aufirst%3DL.%2BG.%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DKrantz%26aufirst%3DI.%2BD.%26aulast%3DShirahige%26aufirst%3DK.%26atitle%3DHDAC8%2520mutations%2520in%2520Cornelia%2520de%2520Lange%2520syndrome%2520affect%2520the%2520cohesin%2520acetylation%2520cycle%26jtitle%3DNature%26date%3D2012%26volume%3D489%26spage%3D313%26epage%3D317%26doi%3D10.1038%2Fnature11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Structural aspects of HDAC8 mechanism and dysfunction in Cornelia de Lange syndrome spectrum disorders</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1002/pro.3030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fpro.3030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaku73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=1965-1976&author=M.+A.+Deardorffauthor=N.+J.+Porterauthor=D.+W.+Christianson&title=Structural+aspects+of+HDAC8+mechanism+and+dysfunction+in+Cornelia+de+Lange+syndrome+spectrum+disorders&doi=10.1002%2Fpro.3030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Aspects of HDAC8 Mechanism and Dysfunction in Cornelia de Lange Syndrome Spectrum Disorders</span></div><div class="casAuthors">Deardorff, Matthew A.; Porter, Nicholas A.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cornelia de Lange Syndrome (CdLS) encompasses a broad spectrum of phenotypes characterized by distinctive craniofacial abnormalities, limb malformations, growth retardation, and intellectual disability.  CdLS spectrum disorders are referred to as cohesinopathies, with approx. 70% of patients having a mutation in a gene encoding a core cohesin protein (SMC1A, SMC3, or RAD21) or a cohesin regulatory proteins (NIPBL or HDAC8).  Notably, the regulatory function of HDAC8 in cohesin biol. has only recently been discovered.  This Zn2+-dependent hydrolase catalyzes the deacetylation of SMC3, a necessary step for cohesin recycling during the cell cycle.  To date, 23 different missense mutants in the gene encoding HDAC8 have been identified in children with developmental features that overlap those of CdLS.  Enzymol., biophys., and structural studies of CdLS HDAC8 protein mutants have yielded crit. insight on compromised catalysis in vitro.  Most CdLS HDAC8 mutations trigger structural changes that directly or indirectly impact substrate binding and catalysis.  Addnl., several mutations significantly compromise protein thermostability.  Intriguingly, catalytic activity in many HDAC8 mutants can be partially or fully restored by an N-acylthiourea activator, suggesting a plausible strategy for the chem. rescue of compromised HDAC8 catalysis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMxVdwmHSqrbVg90H21EOLACvtfcHk0lgcQaITr4f7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaku73E&md5=6449ec62657ab407b0206ea1e1c7f173</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpro.3030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3030%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DStructural%2520aspects%2520of%2520HDAC8%2520mechanism%2520and%2520dysfunction%2520in%2520Cornelia%2520de%2520Lange%2520syndrome%2520spectrum%2520disorders%26jtitle%3DProtein%2520Sci.%26date%3D2016%26volume%3D25%26spage%3D1965%26epage%3D1976%26doi%3D10.1002%2Fpro.3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Decroos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2157</span><span class="NLM_x">–</span> <span class="NLM_lpage">2164</span><span class="refDoi"> DOI: 10.1021/cb5003762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5003762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eksLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2157-2164&author=C.+Decroosauthor=C.+M.+Bowmanauthor=J.+A.+Moserauthor=K.+E.+Christiansonauthor=M.+A.+Deardorffauthor=D.+W.+Christianson&title=Compromised+structure+and+function+of+HDAC8+mutants+identified+in+Cornelia+de+Lange+Syndrome+spectrum+disorders&doi=10.1021%2Fcb5003762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Compromised Structure and Function of HDAC8 Mutants Identified in Cornelia de Lange Syndrome Spectrum Disorders</span></div><div class="casAuthors">Decroos, Christophe; Bowman, Christine M.; Moser, Joe-Ann S.; Christianson, Karen E.; Deardorff, Matthew A.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2157-2164</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cornelia de Lange Syndrome (CdLS) is a multiple congenital anomaly disorder resulting from mutations in genes that encode the core components of the cohesin complex, SMC1A, SMC3, and RAD21, or two of its regulatory proteins, NIPBL and HDAC8.  HDAC8 is the human SMC3 lysine deacetylase required for cohesin recycling in the cell cycle.  To date, 16 different missense mutations in HDAC8 have recently been identified in children diagnosed with CdLS.  To understand the mol. effects of these mutations in causing CdLS and overlapping phenotypes, we have fully characterized the structure and function of five HDAC8 mutants: C153F, A188T, I243N, T311M, and H334R.  X-ray crystal structures reveal that each mutation causes local structural changes that compromise catalysis and/or thermostability.  For example, the C153F mutation triggers conformational changes that block acetate product release channels, resulting in only 2% residual catalytic activity.  In contrast, the H334R mutation causes structural changes in a polypeptide loop distant from the active site and results in 91% residual activity, but the thermostability of this mutant is significantly compromised.  Strikingly, the catalytic activity of these mutants can be partially or fully rescued in vitro by the HDAC8 activator N-(phenylcarbamothioyl)benzamide.  These results suggest that HDAC8 activators might be useful leads in the search for new therapeutic strategies in managing CdLS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8dzIXLt_xjrVg90H21EOLACvtfcHk0lgcQaITr4f7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eksLjF&md5=5872ac8e7a5b59c484d879de209a93a9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb5003762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5003762%26sid%3Dliteratum%253Aachs%26aulast%3DDecroos%26aufirst%3DC.%26aulast%3DBowman%26aufirst%3DC.%2BM.%26aulast%3DMoser%26aufirst%3DJ.%2BA.%26aulast%3DChristianson%26aufirst%3DK.%2BE.%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DCompromised%2520structure%2520and%2520function%2520of%2520HDAC8%2520mutants%2520identified%2520in%2520Cornelia%2520de%2520Lange%2520Syndrome%2520spectrum%2520disorders%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2157%26epage%3D2164%26doi%3D10.1021%2Fcb5003762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span><span class="refDoi"> DOI: 10.1038/leu.2008.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fleu.2008.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=18256683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1026-1034&author=S.+Balasubramanianauthor=J.+Ramosauthor=W.+Luoauthor=M.+Sirisawadauthor=E.+Vernerauthor=J.+J.+Buggy&title=A+novel+histone+deacetylase+8+%28HDAC8%29-specific+inhibitor+PCI-34051+induces+apoptosis+in+T-cell+lymphomas&doi=10.1038%2Fleu.2008.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas</span></div><div class="casAuthors">Balasubramanian, S.; Ramos, J.; Luo, W.; Sirisawad, M.; Verner, E.; Buggy, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1026-1034</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We have developed a potent, histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 with >200-fold selectivity over the other HDAC isoforms.  PCI-34051 induces caspase-dependent apoptosis in cell lines derived from T-cell lymphomas or leukemias, but not in other hematopoietic or solid tumor lines.  Unlike broad-spectrum HDAC inhibitors, PCI-34051 does not cause detectable histone or tubulin acetylation.  Cells defective in T-cell receptor signaling were still sensitive to PCI-34051-induced apoptosis, whereas a phospholipase C-γ1 (PLCγ1)-defective line was resistant.  Jurkat cells showed a dose-dependent decrease in PCI-34051-induced apoptosis upon treatment with a PLC inhibitor U73122, but not with an inactive analog.  We found that rapid intracellular calcium mobilization from endoplasmic reticulum (ER) and later cytochrome c release from mitochondria are essential for the apoptotic mechanism.  The rapid Ca2+ flux was dependent on PCI-34051 concn., and was blocked by the PLC inhibitor U73122.  Further, apoptosis was blocked by Ca2+ chelators (BAPTA) and enhanced by Ca2+ effectors (thapsigargin), supporting this model.  These studies show that HDAC8-selective inhibitors have a unique mechanism of action involving PLCγ1 activation and calcium-induced apoptosis, and could offer benefits including a greater therapeutic index for treating T-cell malignancies.  Leukemia (2008) 22, 1026-1034; doi:10.1038/leu.2008.9; published online 7 Feb. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-VB4Wb3h1bVg90H21EOLACvtfcHk0li5QkvtcTrHtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtr0%253D&md5=03446a05b396ea9497e4f6f9254cae03</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fleu.2008.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2008.9%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520novel%2520histone%2520deacetylase%25208%2520%2528HDAC8%2529-specific%2520inhibitor%2520PCI-34051%2520induces%2520apoptosis%2520in%2520T-cell%2520lymphomas%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1026%26epage%3D1034%26doi%3D10.1038%2Fleu.2008.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">802</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2017.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejphar.2017.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28223126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=802&publication_year=2017&pages=20-26&author=G.+Zhaoauthor=G.+Wangauthor=H.+Baiauthor=T.+Liauthor=F.+Gongauthor=H.+Yangauthor=J.+Wenauthor=W.+Wang&title=Targeted+inhibition+of+HDAC8+increases+the+doxorubicin+sensitivity+of+neuroblastoma+cells+via+up+regulation+of+miR-137&doi=10.1016%2Fj.ejphar.2017.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137</span></div><div class="casAuthors">Zhao, Gang; Wang, Guoliang; Bai, Hongmin; Li, Tiandong; Gong, Fanghe; Yang, Huan; Wen, Jinchong; Wang, Weimin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">802</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) have been suggested to be potential therapeutic targets for cancer treatment.  Recent studies revealed that HDAC8 expression was assocd. with poor prognostic markers and poor overall survival rate of neuroblastoma (NB).  Our present study revealed that among the four members of class I HDACs, HDAC8 is significantly over expressed in NB cells as compared with the normal fibroblast 3T3 cells or primary normal human astrocytes (NHA) cells.  Targeted inhibition of HDAC8 by its specific siRNA (si-HDAC8) can inhibit the in vitro growth of NB cells.  Furthermore, si-HDAC8 significantly increases the sensitivity of NB cells to doxorubicin (Dox).  Silencing of HDAC8 can increase the expression of miR-137, which has been suggested to mediate the Dox sensitivity of NB cells.  Knockdown of miR-137 can attenuate si-HDAC8 enhanced Dox sensitivity.  Further, si-HDAC8 can also inhibit the expression of multi-drug resistance gene 1 (MDR1).  While knockdown of miR-137 can attenuate si-HDAC8 induced down regulation of MDR1.  Collectively, our data revealed that targeted inhibition of HDAC8 can suppress the growth of NB cells and increase Dox sensitivity via up regulation of miR-137 and suppression of MDR1.  Therefor, combination of HDAC8 inhibitor will be helpful to elevate the treatment outcome of NB patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgKOpVYIWCerVg90H21EOLACvtfcHk0li5QkvtcTrHtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGmu70%253D&md5=ef067dab9ddb0ae88505ea7be4969a7b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DTargeted%2520inhibition%2520of%2520HDAC8%2520increases%2520the%2520doxorubicin%2520sensitivity%2520of%2520neuroblastoma%2520cells%2520via%2520up%2520regulation%2520of%2520miR-137%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D802%26spage%3D20%26epage%3D26%26doi%3D10.1016%2Fj.ejphar.2017.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bid, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewdu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. E.</span><span> </span><span class="NLM_article-title">HDAC8, a potential therapeutic target for the treatment of malignant peripheral nerve sheath tumors (MPNST)</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0133302</span><span class="refDoi"> DOI: 10.1371/journal.pone.0133302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.pone.0133302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0133302&author=G.+Lopezauthor=K.+L.+Billauthor=H.+K.+Bidauthor=D.+Braggioauthor=D.+Constantinoauthor=B.+Prudnerauthor=A.+Zewduauthor=K.+Batteauthor=D.+Levauthor=R.+E.+Pollock&title=HDAC8%2C+a+potential+therapeutic+target+for+the+treatment+of+malignant+peripheral+nerve+sheath+tumors+%28MPNST%29&doi=10.1371%2Fjournal.pone.0133302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0133302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0133302%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DBill%26aufirst%3DK.%2BL.%26aulast%3DBid%26aufirst%3DH.%2BK.%26aulast%3DBraggio%26aufirst%3DD.%26aulast%3DConstantino%26aufirst%3DD.%26aulast%3DPrudner%26aufirst%3DB.%26aulast%3DZewdu%26aufirst%3DA.%26aulast%3DBatte%26aufirst%3DK.%26aulast%3DLev%26aufirst%3DD.%26aulast%3DPollock%26aufirst%3DR.%2BE.%26atitle%3DHDAC8%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520malignant%2520peripheral%2520nerve%2520sheath%2520tumors%2520%2528MPNST%2529%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0133302%26doi%3D10.1371%2Fjournal.pone.0133302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rettig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeneke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trippel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burhenne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp-Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernekorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deubzer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span> </span><span class="NLM_article-title">Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1657</span><span class="refDoi"> DOI: 10.1038/cddis.2015.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fcddis.2015.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25695609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1657&author=I.+Rettigauthor=E.+Koenekeauthor=F.+Trippelauthor=W.+C.+Muellerauthor=J.+Burhenneauthor=A.+Kopp-Schneiderauthor=J.+Fabianauthor=A.+Schoberauthor=U.+Fernekornauthor=A.+von+Deimlingauthor=H.+E.+Deubzerauthor=T.+Mildeauthor=O.+Wittauthor=I.+Oehme&title=Selective+inhibition+of+HDAC8+decreases+neuroblastoma+growth+in+vitro+and+in+vivo+and+enhances+retinoic+acid-mediated+differentiation&doi=10.1038%2Fcddis.2015.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation</span></div><div class="casAuthors">Rettig, I.; Koeneke, E.; Trippel, F.; Mueller, W. C.; Burhenne, J.; Kopp-Schneider, A.; Fabian, J.; Schober, A.; Fernekorn, U.; von Deimling, A.; Deubzer, H. E.; Milde, T.; Witt, O.; Oehme, I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1657</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For differentiation-defective malignancies, compds. that modulate transcription, such as retinoic acid and histone deacetylase (HDAC) inhibitors, are of particular interest.  HDAC inhibitors are currently under investigation for the treatment of a broad spectrum of cancer diseases.  However, one clin. drawback is class-specific toxicity of unselective inhibitors, limiting their full anticancer potential.  Selective targeting of individual HDAC isoenzymes in defined tumor entities may therefore be an attractive alternative treatment approach.  We have previously identified HDAC family member 8 (HDAC8) as a novel target in childhood neuroblastoma.  Using small-mol. inhibitors, we now demonstrate that selective inhibition of HDAC8 exhibits antineuroblastoma activity without toxicity in two xenograft mouse models of MYCN oncogene-amplified neuroblastoma.  In contrast, the unselective HDAC inhibitor vorinostat was more toxic in the same models.  HDAC8-selective inhibition induced cell cycle arrest and differentiation in vitro and in vivo.  Upon combination with retinoic acid, differentiation was significantly enhanced, as demonstrated by elongated neurofilament-pos. neurites and upregulation of NTRK1.  Addnl., MYCN oncogene expression was downregulated in vitro and tumor cell growth was markedly reduced in vivo.  Mechanistic studies suggest that cAMP-response element-binding protein (CREB) links HDAC8- and retinoic acid-mediated gene transcription.  In conclusion, HDAC-selective targeting can be effective in tumors exhibiting HDAC isoenzyme-dependent tumor growth in vivo and can be combined with differentiation-inducing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ55O9b9Q78LVg90H21EOLACvtfcHk0ljv-jQzuMd1bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSis7s%253D&md5=41a5cfe6aaa685304b3bef0eae03a8ff</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.24%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DI.%26aulast%3DKoeneke%26aufirst%3DE.%26aulast%3DTrippel%26aufirst%3DF.%26aulast%3DMueller%26aufirst%3DW.%2BC.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DKopp-Schneider%26aufirst%3DA.%26aulast%3DFabian%26aufirst%3DJ.%26aulast%3DSchober%26aufirst%3DA.%26aulast%3DFernekorn%26aufirst%3DU.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DMilde%26aufirst%3DT.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DOehme%26aufirst%3DI.%26atitle%3DSelective%2520inhibition%2520of%2520HDAC8%2520decreases%2520neuroblastoma%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%2520and%2520enhances%2520retinoic%2520acid-mediated%2520differentiation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1657%26doi%3D10.1038%2Fcddis.2015.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Krennhrubec, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedglin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span> </span><span class="NLM_article-title">Design and evaluation of “Linkerless” hydroxamic acids as selective HDAC8 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2878</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmcl.2007.02.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2874-2878&author=K.+Krennhrubecauthor=B.+L.+Marshallauthor=M.+Hedglinauthor=E.+Verdinauthor=S.+M.+Ulrich&title=Design+and+evaluation+of+%E2%80%9CLinkerless%E2%80%9D+hydroxamic+acids+as+selective+HDAC8+inhibitors&doi=10.1016%2Fj.bmcl.2007.02.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.064%26sid%3Dliteratum%253Aachs%26aulast%3DKrennhrubec%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DHedglin%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520%25E2%2580%259CLinkerless%25E2%2580%259D%2520hydroxamic%2520acids%2520as%2520selective%2520HDAC8%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2874%26epage%3D2878%26doi%3D10.1016%2Fj.bmcl.2007.02.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macarron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawiec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, M.</span><span> </span><span class="NLM_article-title">Identification of novel isoform-selective inhibitors within class I histone deacetylases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span><span class="refDoi"> DOI: 10.1124/jpet.103.055541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1124%2Fjpet.103.055541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=12975486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Shs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=720-728&author=E.+Huauthor=E.+Dulauthor=C.+M.+Sungauthor=Z.+Chenauthor=R.+Kirkpatrickauthor=G.+F.+Zhangauthor=K.+Johansonauthor=R.+Liuauthor=A.+Lagoauthor=G.+Hofmannauthor=R.+Macarronauthor=M.+de+los+Frailesauthor=P.+Perezauthor=J.+Krawiecauthor=J.+Winklerauthor=M.+Jaye&title=Identification+of+novel+isoform-selective+inhibitors+within+class+I+histone+deacetylases&doi=10.1124%2Fjpet.103.055541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel isoform-selective inhibitors within class I histone deacetylases</span></div><div class="casAuthors">Hu, Erding; Dul, Edward; Sung, Chiu-Mei; Chen, Zunxuan; Kirkpatrick, Robert; Zhang, Gui-Feng; Johanson, Kyung; Liu, Ronggang; Lago, Amparo; Hofmann, Glenn; MacArron, Ricardo; de los Frailes, Maite; Perez, Paloma; Krawiec, John; Winkler, James; Jaye, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">720-728</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) represent an expanding family of protein modifying-enzymes that play important roles in cell proliferation, chromosome remodeling, and gene transcription.  We have previously shown that recombinant human HDAC8 can be expressed in bacteria and retain its catalytic activity.  To further explore the catalytic activity of HDACs, we expressed two addnl. human class I HDACs, HDAC1 and HDAC3, in baculovirus.  Recombinant HDAC1 and HDAC3 fusion proteins remained sol. and catalytically active and were purified to near homogeneity.  Interestingly, trichostatin (TSA) was found to be a potent inhibitor for all three HDACs (IC50 value of ∼0.1 - 0.3 μM), whereas another HDAC inhibitor MS-27-275 (N-(2-aminophenyl)-4-[N-(pyridin-3-methyloxycarbonyl)-aminomethyl]benzamide) preferentially inhibited HDAC1 (IC50 value of ∼0.3 μM) vs. HDAC3 (IC50 value of ∼8 μM) and had no inhibitory activity toward HDAC8 (IC50 value >100 μM).  MS-27-275 as well as TSA increased histone H4 acetylation, induced apoptosis in the human colon cancer cell line SW620, and activated the simian virus 40 early promoter.  HDAC1 protein was more abundantly expressed in SW620 cells compared with that of HDAC3 and HDAC8.  Using purified recombinant HDAC proteins, we identified several novel HDAC inhibitors that preferentially inhibit HDAC1 or HDAC8.  These inhibitors displayed distinct properties in inducing histone acetylation and reporter gene expression.  These results suggest selective HDAC inhibitors could be identified using recombinantly expressed HDACs and that HDAC1 may be a promising therapeutic target for designing HDAC inhibitors for proliferative diseases such as cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNLO26_4qQdLVg90H21EOLACvtfcHk0ljv-jQzuMd1bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Shs7k%253D&md5=453e111a1f7f9cdf1249e26c254d93e9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055541%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKirkpatrick%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DJohanson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLago%26aufirst%3DA.%26aulast%3DHofmann%26aufirst%3DG.%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3Dde%2Blos%2BFrailes%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3DKrawiec%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DJaye%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520novel%2520isoform-selective%2520inhibitors%2520within%2520class%2520I%2520histone%2520deacetylases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D307%26spage%3D720%26epage%3D728%26doi%3D10.1124%2Fjpet.103.055541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbinger, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.4155%2Ffmc-2016-0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27572818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1609-1634&author=A.+Chakrabartiauthor=J.+Melesinaauthor=F.+R.+Kolbingerauthor=I.+Oehmeauthor=J.+Sengerauthor=O.+Wittauthor=W.+Sipplauthor=M.+Jung&title=Targeting+histone+deacetylase+8+as+a+therapeutic+approach+to+cancer+and+neurodegenerative+diseases&doi=10.4155%2Ffmc-2016-0117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases</span></div><div class="casAuthors">Chakrabarti, Alokta; Melesina, Jelena; Kolbinger, Fiona R.; Oehme, Ina; Senger, Johanna; Witt, Olaf; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1609-1634</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 8 (HDAC8), a unique class I zinc-dependent HDAC, is an emerging target in cancer and other diseases.  Its substrate repertoire extends beyond histones to many nonhistone proteins.  Besides being a deacetylase, HDAC8 also mediates signaling via scaffolding functions.  Aberrant expression or deregulated interactions with transcription factors are crit. in HDAC8-dependent cancers.  Many potent HDAC8-selective inhibitors with cellular activity and anticancer effects have been reported.  We present HDAC8 as a druggable target and discuss inhibitors of different chem. scaffolds with cellular effects.  Furthermore, we review HDAC8 activators that revert activity of mutant enzymes.  Isotype-selective HDAC8 targeting in patients with HDAC8-relevant cancers is challenging, however, is promising to avoid adverse side effects as obsd. with pan-HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgIFjNGH66LVg90H21EOLACvtfcHk0lgYnAF5oupmRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsrzF&md5=942984331e8f3c589b9257c17d2a9ec2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0117%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DKolbinger%26aufirst%3DF.%2BR.%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DTargeting%2520histone%2520deacetylase%25208%2520as%2520a%2520therapeutic%2520approach%2520to%2520cancer%2520and%2520neurodegenerative%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1609%26epage%3D1634%26doi%3D10.4155%2Ffmc-2016-0117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9562</span><span class="NLM_x">–</span> <span class="NLM_lpage">9575</span><span class="refDoi"> DOI: 10.1021/jm300837y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300837y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9562-9575&author=T.+Suzukiauthor=Y.+Otaauthor=M.+Riauthor=M.+Bandoauthor=A.+Gotohauthor=Y.+Itohauthor=H.+Tsumotoauthor=P.+R.+Tatumauthor=T.+Mizukamiauthor=H.+Nakagawaauthor=S.+Iidaauthor=R.+Uedaauthor=K.+Shirahigeauthor=N.+Miyata&title=Rapid+discovery+of+highly+potent+and+selective+inhibitors+of+histone+deacetylase+8+using+click+chemistry+to+generate+candidate+libraries&doi=10.1021%2Fjm300837y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Ri, Masaki; Bando, Masashige; Gotoh, Aogu; Itoh, Yukihiro; Tsumoto, Hiroki; Tatum, Prima R.; Mizukami, Tamio; Nakagawa, Hidehiko; Iida, Shinsuke; Ueda, Ryuzo; Shirahige, Katsuhiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9562-9575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each contg. a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site.  These compds. were synthesized by using click chem.  Screening identified HDAC8-selective inhibitors including (I) (IC50 = 0.070 μM), which was more potent than PCI-34058 (IC50 = 0.31 μM), a known HDAC8 inhibitor.  Mol. modeling suggested that the phenylthiomethyl group of I binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity.  The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI50 = 3-80 μM).  These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGB7i5Bnw337Vg90H21EOLACvtfcHk0lgYnAF5oupmRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI&md5=9b730c0469b62c3ebd93a5e58c520a12</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300837y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300837y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DGotoh%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRapid%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25208%2520using%2520click%2520chemistry%2520to%2520generate%2520candidate%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9562%26epage%3D9575%26doi%3D10.1021%2Fjm300837y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1002/cmdc.201300414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201300414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=657-664&author=T.+Suzukiauthor=N.+Mutoauthor=M.+Bandoauthor=Y.+Itohauthor=A.+Masakiauthor=M.+Riauthor=Y.+Otaauthor=H.+Nakagawaauthor=S.+Iidaauthor=K.+Shirahigeauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+NCC149+derivatives+as+histone+deacetylase+8-selective+inhibitors&doi=10.1002%2Fcmdc.201300414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300414%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMuto%26aufirst%3DN.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMasaki%26aufirst%3DA.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520NCC149%2520derivatives%2520as%2520histone%2520deacetylase%25208-selective%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D657%26epage%3D664%26doi%3D10.1002%2Fcmdc.201300414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Huang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. I.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of ortho-aryl <i>N</i>-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1824</span><span class="refDoi"> DOI: 10.1002/cmdc.201200300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201200300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=22907916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1WrtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1815-1824&author=W.+J.+Huangauthor=Y.+C.+Wangauthor=S.+W.+Chaoauthor=C.+Y.+Yangauthor=L.+C.+Chenauthor=M.+H.+Linauthor=W.+C.+Houauthor=M.+Y.+Chenauthor=T.+L.+Leeauthor=P.+Yangauthor=C.+I.+Chang&title=Synthesis+and+biological+evaluation+of+ortho-aryl+N-hydroxycinnamides+as+potent+histone+deacetylase+%28HDAC%29+8+isoform-selective+inhibitors&doi=10.1002%2Fcmdc.201200300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors</span></div><div class="casAuthors">Huang, Wei-Jan; Wang, Yi-Ching; Chao, Shi-Wei; Yang, Chen-Yui; Chen, Liang-Chieh; Lin, Mei-Hsiang; Hou, Wen-Chi; Chen, Mei-Yu; Lee, Tai-Lin; Yang, Ping; Chang, Chung-I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1815-1824, S1815/1-S1815/41</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biol. process and diseases.  In contrast to other isoenzymes, HDAC8 is uniquely incapable of histone acetylation.  To delineate its physiol. function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques.  Enzyme inhibitory anal. demonstrated that some of the resulting compds. exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50 nM.  Among them, compd. (I) showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells.  Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compd. I.  These results suggest the effectiveness of our design concept, which may lead to a tool compd. for studying the specific role of HDAC8 in cellular biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop4xm7qu7wc7Vg90H21EOLACvtfcHk0lgYnAF5oupmRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1WrtLzL&md5=05279fdc5e9bc353f12fa3b1b0f3e365</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200300%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DChao%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DL.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DHou%26aufirst%3DW.%2BC.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%2BI.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520ortho-aryl%2520N-hydroxycinnamides%2520as%2520potent%2520histone%2520deacetylase%2520%2528HDAC%2529%25208%2520isoform-selective%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1815%26epage%3D1824%26doi%3D10.1002%2Fcmdc.201200300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Discovery of histone deacetylase 8 selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2605</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmcl.2011.01.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21334896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2601-2605&author=W.+Tangauthor=T.+Luoauthor=E.+F.+Greenbergauthor=J.+E.+Bradnerauthor=S.+L.+Schreiber&title=Discovery+of+histone+deacetylase+8+selective+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of histone deacetylase 8 selective inhibitors</span></div><div class="casAuthors">Tang, Weiping; Luo, Tuoping; Greenberg, Edward F.; Bradner, James E.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2601-2605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An efficient method for synthesizing candidate histone deacetylase (HDAC) inhibitors in 96-well plates, which are used directly in high-throughput screening, is reported.  Building blocks having hydrazide, aldehyde and hydroxamic acid functionalities were used.  The hydrazides were coupled with different aldehydes in DMSO.  The resulting products have the previously identified cap/linker/biasing element structure known to favor inhibition of HDACs.  These compds. were assayed without further purifn.  HDAC8-selective inhibitors were discovered from this novel collection of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTgHmuzYhy_LVg90H21EOLACvtfcHk0lgLzKWwvfQrZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKisbw%253D&md5=5faa470ee503cbf4d3fb652295fc5075</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.134%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DGreenberg%26aufirst%3DE.%2BF.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520histone%2520deacetylase%25208%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2601%26epage%3D2605%26doi%3D10.1016%2Fj.bmcl.2011.01.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ingham, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yueh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porco, J. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeler, A. B.</span><span> </span><span class="NLM_article-title">Development of a potent and selective HDAC8 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeksbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=929-932&author=O.+J.+Inghamauthor=R.+M.+Paranalauthor=W.+B.+Smithauthor=R.+A.+Escobarauthor=H.+Yuehauthor=T.+Snyderauthor=J.+A.+Porcoauthor=J.+E.+Bradnerauthor=A.+B.+Beeler&title=Development+of+a+potent+and+selective+HDAC8+inhibitor&doi=10.1021%2Facsmedchemlett.6b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Potent and Selective HDAC8 Inhibitor</span></div><div class="casAuthors">Ingham, Oscar J.; Paranal, Ronald M.; Smith, William B.; Escobar, Randolph A.; Yueh, Han; Snyder, Tracy; Porco, John A.; Bradner, James E.; Beeler, Aaron B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel, isoform-selective inhibitor of histone deacetylase 8 (HDAC8) has been discovered by the repurposing of a diverse compd. collection.  Medicinal chem. optimization led to the identification of a highly potent (0.8 nM) and selective inhibitor I of HDAC8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKF0r_7S2dWLVg90H21EOLACvtfcHk0lgLzKWwvfQrZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeksbbP&md5=69ab76f942dfc6a6b7801b90f48aa619</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00239%26sid%3Dliteratum%253Aachs%26aulast%3DIngham%26aufirst%3DO.%2BJ.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DEscobar%26aufirst%3DR.%2BA.%26aulast%3DYueh%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DT.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBeeler%26aufirst%3DA.%2BB.%26atitle%3DDevelopment%2520of%2520a%2520potent%2520and%2520selective%2520HDAC8%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D929%26epage%3D932%26doi%3D10.1021%2Facsmedchemlett.6b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobler, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radetich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancost, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span> </span><span class="NLM_article-title">Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4626</span><span class="NLM_x">–</span> <span class="NLM_lpage">4634</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2011.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21723733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4626-4634&author=L.+Whiteheadauthor=M.+R.+Doblerauthor=B.+Radetichauthor=Y.+Zhuauthor=P.+W.+Atadjaauthor=T.+Claiborneauthor=J.+E.+Grobauthor=A.+McRinerauthor=M.+R.+Pancostauthor=A.+Patnaikauthor=W.+Shaoauthor=M.+Shultzauthor=R.+Tichkuleauthor=R.+A.+Tommasiauthor=B.+Vashauthor=P.+Wangauthor=T.+Stams&title=Human+HDAC+isoform+selectivity+achieved+via+exploitation+of+the+acetate+release+channel+with+structurally+unique+small+molecule+inhibitors&doi=10.1016%2Fj.bmc.2011.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors</span></div><div class="casAuthors">Whitehead, Lewis; Dobler, Markus R.; Radetich, Branko; Zhu, Yanyi; Atadja, Peter W.; Claiborne, Tavina; Grob, Jonathan E.; McRiner, Andrew; Pancost, Margaret R.; Patnaik, Anup; Shao, Wenlin; Shultz, Michael; Tichkule, Ritesh; Tommasi, Ruben A.; Vash, Brian; Wang, Ping; Stams, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4626-4634</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we report the discovery of a family of novel yet simple, amino-acid derived class I HDAC inhibitors that demonstrate isoform selectivity via access to the internal acetate release channel.  Isoform selectivity criteria is discussed on the basis of X-ray crystallog. and mol. modeling of these novel inhibitors bound to HDAC8, potentially revealing insights into the mechanism of enzymic function through novel structural features revealed at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgV7MIGevIxrVg90H21EOLACvtfcHk0lgLzKWwvfQrZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2ju7w%253D&md5=c252ec223e909e92ec165f60a1a33b16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DDobler%26aufirst%3DM.%2BR.%26aulast%3DRadetich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DAtadja%26aufirst%3DP.%2BW.%26aulast%3DClaiborne%26aufirst%3DT.%26aulast%3DGrob%26aufirst%3DJ.%2BE.%26aulast%3DMcRiner%26aufirst%3DA.%26aulast%3DPancost%26aufirst%3DM.%2BR.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DTichkule%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%2BA.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStams%26aufirst%3DT.%26atitle%3DHuman%2520HDAC%2520isoform%2520selectivity%2520achieved%2520via%2520exploitation%2520of%2520the%2520acetate%2520release%2520channel%2520with%2520structurally%2520unique%2520small%2520molecule%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4626%26epage%3D4634%26doi%3D10.1016%2Fj.bmc.2011.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Galletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintavalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, D.</span><span> </span><span class="NLM_article-title">Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span><span class="refDoi"> DOI: 10.1002/cmdc.200900309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.200900309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=19821480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWrs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1991-2001&author=P.+Gallettiauthor=A.+Quintavallaauthor=C.+Ventriciauthor=G.+Gianniniauthor=W.+Cabriauthor=S.+Pencoauthor=G.+Galloauthor=S.+Vincentiauthor=D.+Giacomini&title=Azetidinones+as+zinc-binding+groups+to+design+selective+HDAC8+inhibitors&doi=10.1002%2Fcmdc.200900309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors</span></div><div class="casAuthors">Galletti, Paola; Quintavalla, Arianna; Ventrici, Caterina; Giannini, Giuseppe; Cabri, Walter; Penco, Sergio; Gallo, Grazia; Vincenti, Silvia; Giacomini, Daria</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1991-2001</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Azetidinones, commonly known as β-lactams, are well-known heterocyclic compds.  Herein we described the synthesis and biol. evaluation of a series of novel β-lactams.  In vitro inhibition assays against HDAC isoforms showed an interesting isoform-selectivity of these compds. towards HDAC6 and HDAC8.  The isoform selectivity changed in response to modification of the azetidinone-ring nitrogen atom substituent.  The presence of an N-thiomethyl group is a prerequisite for the activity of these compds. in the micromolar range towards HDAC8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cOvRDsk9pLVg90H21EOLACvtfcHk0liC7kweiVnO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWrs7%252FE&md5=8d65eae30d5583a1273f52179a0d2602</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900309%26sid%3Dliteratum%253Aachs%26aulast%3DGalletti%26aufirst%3DP.%26aulast%3DQuintavalla%26aufirst%3DA.%26aulast%3DVentrici%26aufirst%3DC.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DVincenti%26aufirst%3DS.%26aulast%3DGiacomini%26aufirst%3DD.%26atitle%3DAzetidinones%2520as%2520zinc-binding%2520groups%2520to%2520design%2520selective%2520HDAC8%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1991%26epage%3D2001%26doi%3D10.1002%2Fcmdc.200900309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ononye, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanHeyst, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblak, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. L.</span><span> </span><span class="NLM_article-title">Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1021/ml400158k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400158k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=757-761&author=S.+N.+Ononyeauthor=M.+D.+VanHeystauthor=E.+Z.+Oblakauthor=W.+Zhouauthor=M.+Ammarauthor=A.+C.+Andersonauthor=D.+L.+Wright&title=Tropolones+as+lead-like+natural+products%3A+the+development+of+potent+and+selective+histone+deacetylase+inhibitors&doi=10.1021%2Fml400158k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors</span></div><div class="casAuthors">Ononye, Sophia N.; VanHeyst, Michael D.; Oblak, E. Zachary; Zhou, Wangda; Ammar, Mohamed; Anderson, Amy C.; Wright, Dennis L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">757-761</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products have long been recognized as a rich source of potent therapeutics, but further development is often limited by high structural complexity and high mol. wt.  In contrast, at the core of the thujaplicins is a lead-like tropolone scaffold characterized by relatively low mol. wt., ample sites for diversification, and metal-binding functionality poised for targeting a range of metalloenzyme drug targets.  Here, we describe the development of this underutilized scaffold for the discovery of tropolone derivs., e.g., I [R = Ph, 2-naphthyl, 4-MeOC6H4, 2,5-(MeOO)2C6H3, 2,3,4-(MeO)3C6H2], that function as isoenzyme-selective inhibitors of the validated anticancer drug target, histone deacetylase (HDAC).  Several monosubstituted tropolones display remarkable levels of selectivity for HDAC2 and potently inhibit the growth of T-cell lymphocyte cell lines.  The tropolones represent a new chemotype of isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWSNRk2L481rVg90H21EOLACvtfcHk0liC7kweiVnO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCjsLc%253D&md5=7268eddf4ca6e61601488f423d52aafb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml400158k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400158k%26sid%3Dliteratum%253Aachs%26aulast%3DOnonye%26aufirst%3DS.%2BN.%26aulast%3DVanHeyst%26aufirst%3DM.%2BD.%26aulast%3DOblak%26aufirst%3DE.%2BZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAmmar%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BL.%26atitle%3DTropolones%2520as%2520lead-like%2520natural%2520products%253A%2520the%2520development%2520of%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D757%26epage%3D761%26doi%3D10.1021%2Fml400158k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">De Vreese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’hooghe, M.</span><span> </span><span class="NLM_article-title">Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejmech.2017.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28453994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=174-195&author=R.+De+Vreeseauthor=M.+D%E2%80%99hooghe&title=Synthesis+and+applications+of+benzohydroxamic+acid-based+histone+deacetylase+inhibitors&doi=10.1016%2Fj.ejmech.2017.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors</span></div><div class="casAuthors">De Vreese, Rob; D'hooghe, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-195</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This paper provides an overview of the synthesis and biol. activity of the most representative benzohydroxamic acid-based histone deacetylase inhibitors published to date.  Benzohydroxamic acids comprise an important class of HDAC inhibitors, and recently several of these structures have been evaluated in clin. trials for the treatment of a variety of cancers.  In this overview, benzohydroxamic acids were divided in four different classes based on their reported selectivity towards zinc-dependent HDACs: a first and major class consists of HDAC6 selective inhibitors, a second class deals with pan-HDAC inhibitors, a third class comprises HDAC8 selective inhibitors and a fourth, minor class includes dual HDAC6/8 selective inhibitors.  Through this approach, structure-activity relationships were identified for each class, which could help future researchers in the design and development of novel benzohydroxamic acid-based HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyKAa1s9hoSbVg90H21EOLACvtfcHk0liC7kweiVnO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslOhur0%253D&md5=769c343bdbb3fe610eff001afa79e0bb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVreese%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599hooghe%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520benzohydroxamic%2520acid-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D174%26epage%3D195%26doi%3D10.1016%2Fj.ejmech.2017.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Di Micco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span> </span><span class="NLM_article-title">Structural basis for the design and synthesis of selective HDAC inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3807</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2013.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3795-3807&author=S.+Di+Miccoauthor=M.+G.+Chiniauthor=S.+Terraccianoauthor=I.+Brunoauthor=R.+Riccioauthor=G.+Bifulco&title=Structural+basis+for+the+design+and+synthesis+of+selective+HDAC+inhibitors&doi=10.1016%2Fj.bmc.2013.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DM.%2BG.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DBruno%26aufirst%3DI.%26aulast%3DRiccio%26aufirst%3DR.%26aulast%3DBifulco%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520the%2520design%2520and%2520synthesis%2520of%2520selective%2520HDAC%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3795%26epage%3D3807%26doi%3D10.1016%2Fj.bmc.2013.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Heimburg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robaa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of novel inhibitors targeting HDAC8 from Schistosoma mansoni for the treatment of schistosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2435</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Smtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2423-2435&author=T.+Heimburgauthor=A.+Chakrabartiauthor=J.+Lancelotauthor=M.+Marekauthor=J.+Melesinaauthor=A.+T.+Hauserauthor=T.+B.+Shaikauthor=S.+Duclaudauthor=D.+Robaaauthor=F.+Erdmannauthor=M.+Schmidtauthor=C.+Romierauthor=R.+J.+Pierceauthor=M.+Jungauthor=W.+Sippl&title=Structure-based+design+and+synthesis+of+novel+inhibitors+targeting+HDAC8+from+Schistosoma+mansoni+for+the+treatment+of+schistosomiasis&doi=10.1021%2Facs.jmedchem.5b01478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis</span></div><div class="casAuthors">Heimburg, Tino; Chakrabarti, Alokta; Lancelot, Julien; Marek, Martin; Melesina, Jelena; Hauser, Alexander-Thomas; Shaik, Tajith B.; Duclaud, Sylvie; Robaa, Dina; Erdmann, Frank; Schmidt, Matthias; Romier, Christophe; Pierce, Raymond J.; Jung, Manfred; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2423-2435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel.  In this study, a series of new benzohydroxamates were prepd. as potent inhibitors of Schistosoma mansoni histone deacetylase 8 (smHDAC8).  Crystallog. anal. provided insights into the inhibition mode of smHDAC8 activity by these 3-amidobenzohydroxamates.  The newly designed inhibitors were evaluated in screens for enzyme inhibitory activity against schistosome and human HDACs.  Twenty-seven compds. were found to be active in the nanomolar range, and some of them showed selectivity toward smHDAC8 over the major human HDACs (1 and 6).  The active benzohydroxamates were addnl. screened for lethality against the schistosome larval stage using a fluorescence-based assay.  Four of these showed significant dose-dependent killing of the schistosome larvae and markedly impaired egg laying of adult worm pairs maintained in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSRG-zzL4EB7Vg90H21EOLACvtfcHk0lj_dZc-86x9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Smtr8%253D&md5=ca2c4d9cb317d33484f22d350d41d55c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01478%26sid%3Dliteratum%253Aachs%26aulast%3DHeimburg%26aufirst%3DT.%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DA.%2BT.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26aulast%3DDuclaud%26aufirst%3DS.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520inhibitors%2520targeting%2520HDAC8%2520from%2520Schistosoma%2520mansoni%2520for%2520the%2520treatment%2520of%2520schistosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2423%26epage%3D2435%26doi%3D10.1021%2Facs.jmedchem.5b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyano, H.</span><span> </span><span class="NLM_article-title">Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.12.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2011.12.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1442-1460&author=K.+Hadaauthor=A.+Sudaauthor=K.+Asohauthor=T.+Tsukudaauthor=M.+Hasegawaauthor=Y.+Satoauthor=K.+Ogawaauthor=S.+Kuramotoauthor=Y.+Aokiauthor=N.+Shimmaauthor=T.+Ishikawaauthor=H.+Koyano&title=Angiogenesis+inhibitors+identified+by+cell-based+high-throughput+screening%3A+synthesis%2C+structure-activity+relationships+and+biological+evaluation+of+3-%5B%28E%29-styryl%5Dbenzamides+that+specifically+inhibit+endothelial+cell+proliferation&doi=10.1016%2Fj.bmc.2011.12.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.12.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.12.058%26sid%3Dliteratum%253Aachs%26aulast%3DHada%26aufirst%3DK.%26aulast%3DSuda%26aufirst%3DA.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKuramoto%26aufirst%3DS.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKoyano%26aufirst%3DH.%26atitle%3DAngiogenesis%2520inhibitors%2520identified%2520by%2520cell-based%2520high-throughput%2520screening%253A%2520synthesis%252C%2520structure-activity%2520relationships%2520and%2520biological%2520evaluation%2520of%25203-%255B%2528E%2529-styryl%255Dbenzamides%2520that%2520specifically%2520inhibit%2520endothelial%2520cell%2520proliferation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1442%26epage%3D1460%26doi%3D10.1016%2Fj.bmc.2011.12.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Tasler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegoraro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirrgiebel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlert, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubbutat, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachtele, C.</span><span> </span><span class="NLM_article-title">Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6728</span><span class="NLM_x">–</span> <span class="NLM_lpage">6737</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2009.07.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6728-6737&author=S.+Taslerauthor=O.+Mullerauthor=T.+Wieberauthor=T.+Herzauthor=S.+Pegoraroauthor=W.+Saebauthor=M.+Langauthor=R.+Kraussauthor=F.+Totzkeauthor=U.+Zirrgiebelauthor=J.+E.+Ehlertauthor=M.+H.+Kubbutatauthor=C.+Schachtele&title=Substituted+2-arylbenzothiazoles+as+kinase+inhibitors%3A+hit-to-lead+optimization&doi=10.1016%2Fj.bmc.2009.07.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DTasler%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DO.%26aulast%3DWieber%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DT.%26aulast%3DPegoraro%26aufirst%3DS.%26aulast%3DSaeb%26aufirst%3DW.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DR.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DZirrgiebel%26aufirst%3DU.%26aulast%3DEhlert%26aufirst%3DJ.%2BE.%26aulast%3DKubbutat%26aufirst%3DM.%2BH.%26aulast%3DSchachtele%26aufirst%3DC.%26atitle%3DSubstituted%25202-arylbenzothiazoles%2520as%2520kinase%2520inhibitors%253A%2520hit-to-lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6728%26epage%3D6737%26doi%3D10.1016%2Fj.bmc.2009.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Vannini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span> </span><span class="NLM_article-title">Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span><span class="refDoi"> DOI: 10.1038/sj.embor.7401047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fsj.embor.7401047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=17721440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFWks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=879-884&author=A.+Vanniniauthor=C.+Volpariauthor=P.+Gallinariauthor=P.+Jonesauthor=M.+Mattuauthor=A.+Carfiauthor=R.+De+Francescoauthor=C.+Steinkuhlerauthor=S.+Di+Marco&title=Substrate+binding+to+histone+deacetylases+as+shown+by+the+crystal+structure+of+the+HDAC8-substrate+complex&doi=10.1038%2Fsj.embor.7401047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex</span></div><div class="casAuthors">Vannini, Alessandro; Volpari, Cinzia; Gallinari, Paola; Jones, Philip; Mattu, Marco; Carfi, Andrea; De Francesco, Raffaele; Steinkuehler, Christian; Di Marco, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">879-884</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) - an enzyme family that deacetylates histones and non-histone proteins - are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clin. trials.  Here, we report the 2.0 Å resoln. crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate.  The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition.  Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation.  A similar interaction is obsd. in a new hydroxamate inhibitor-HDAC8 structure that we also solved.  The crucial role of Asp101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnS-LTrNkPbVg90H21EOLACvtfcHk0lj_dZc-86x9kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFWks7Y%253D&md5=1362cac7c0820d5b250b05597fafa7dc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7401047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7401047%26sid%3Dliteratum%253Aachs%26aulast%3DVannini%26aufirst%3DA.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DGallinari%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DMattu%26aufirst%3DM.%26aulast%3DCarfi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26atitle%3DSubstrate%2520binding%2520to%2520histone%2520deacetylases%2520as%2520shown%2520by%2520the%2520crystal%2520structure%2520of%2520the%2520HDAC8-substrate%2520complex%26jtitle%3DEMBO%2520Rep.%26date%3D2007%26volume%3D8%26spage%3D879%26epage%3D884%26doi%3D10.1038%2Fsj.embor.7401047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Millard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celardo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordiyenko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwabe, J. W.</span><span> </span><span class="NLM_article-title">Class I HDACs share a common mechanism of regulation by inositol phosphates</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.molcel.2013.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.molcel.2013.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=23791785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=57-67&author=C.+J.+Millardauthor=P.+J.+Watsonauthor=I.+Celardoauthor=Y.+Gordiyenkoauthor=S.+M.+Cowleyauthor=C.+V.+Robinsonauthor=L.+Fairallauthor=J.+W.+Schwabe&title=Class+I+HDACs+share+a+common+mechanism+of+regulation+by+inositol+phosphates&doi=10.1016%2Fj.molcel.2013.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates</span></div><div class="casAuthors">Millard, Christopher J.; Watson, Peter J.; Celardo, Ivana; Gordiyenko, Yuliya; Cowley, Shaun M.; Robinson, Carol V.; Fairall, Louise; Schwabe, John W. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Class I histone deacetylases (HDAC1, HDAC2, and HDAC3) are recruited by cognate corepressor proteins into specific transcriptional repression complexes that target HDAC activity to chromatin resulting in chromatin condensation and transcriptional silencing.  The authors previously reported the structure of HDAC3 in complex with the SMRT corepressor.  This structure revealed inositol-tetraphosphate [Ins(1,4,5,6)P4] at the interface of the two proteins.  It was previously unclear whether the role of Ins(1,4,5,6)P4 is to act as a structural cofactor or a regulator of HDAC3 activity.  Here the authors report the structure of HDAC1 in complex with MTA1 from the NuRD complex.  The ELM2-SANT domains from MTA1 wrap completely around HDAC1 occupying both sides of the active site such that the adjacent BAH domain is ideally positioned to recruit nucleosomes to the active site of the enzyme.  Functional assays of both the HDAC1 and HDAC3 complexes reveal that Ins(1,4,5,6)P4 is a bona fide conserved regulator of class I HDAC complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYPhL0103LkLVg90H21EOLACvtfcHk0lgs4O95yHZxnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVygu74%253D&md5=05a4267bf965b5a6217873217044ef2a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMillard%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DP.%2BJ.%26aulast%3DCelardo%26aufirst%3DI.%26aulast%3DGordiyenko%26aufirst%3DY.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DRobinson%26aufirst%3DC.%2BV.%26aulast%3DFairall%26aufirst%3DL.%26aulast%3DSchwabe%26aufirst%3DJ.%2BW.%26atitle%3DClass%2520I%2520HDACs%2520share%2520a%2520common%2520mechanism%2520of%2520regulation%2520by%2520inositol%2520phosphates%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fj.molcel.2013.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span><span class="refDoi"> DOI: 10.1038/nchembio.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnchembio.2134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27454933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=741-747&author=Y.+Haiauthor=D.+W.+Christianson&title=Histone+deacetylase+6+structure+and+molecular+basis+of+catalysis+and+inhibition&doi=10.1038%2Fnchembio.2134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span></div><div class="casAuthors">Hai, Yang; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">741-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a crit. target for drug design because of its role in oncogenic transformation and cancer metastasis, and is unique among all histone deacetylases in that it contains tandem catalytic domains designated CD1 and CD2.  We now report the crystal structures of CD2 from Homo sapiens HDAC6 and of CD1 and CD2 from Danio rerio HDAC6.  We correlated these structures with activity measurements using 13 different substrates.  The catalytic activity of CD2 from both species exhibited broad substrate specificity, whereas that of CD1 was highly specific for substrates bearing C-terminal acetyllysine residues.  Crystal structures of substrate complexes yielded unprecedented snapshots of the catalytic mechanism.  Addnl., crystal structures of complexes with eight different inhibitors, including belinostat and panobinostat (currently used in cancer chemotherapy), the macrocyclic tetrapeptide HC toxin, and the HDAC6-specific inhibitor N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide, revealed surprising new insight regarding changes in Zn2+ coordination and isoenzyme-specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCfziGBHBRLVg90H21EOLACvtfcHk0lgs4O95yHZxnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ&md5=e167bc6f66e00923da4f2bced2b306b9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2134%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DY.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520structure%2520and%2520molecular%2520basis%2520of%2520catalysis%2520and%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D741%26epage%3D747%26doi%3D10.1038%2Fnchembio.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Miyake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keusch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, P.</span><span> </span><span class="NLM_article-title">Structural insights into HDAC6 tubulin deacetylation and its selective inhibition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1038/nchembio.2140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnchembio.2140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27454931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=748-754&author=Y.+Miyakeauthor=J.+J.+Keuschauthor=L.+Wangauthor=M.+Saitoauthor=D.+Hessauthor=X.+Wangauthor=B.+J.+Melanconauthor=P.+Helquistauthor=H.+Gutauthor=P.+Matthias&title=Structural+insights+into+HDAC6+tubulin+deacetylation+and+its+selective+inhibition&doi=10.1038%2Fnchembio.2140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into HDAC6 tubulin deacetylation and its selective inhibition</span></div><div class="casAuthors">Miyake, Yasuyuki; Keusch, Jeremy J.; Wang, Longlong; Saito, Makoto; Hess, Daniel; Wang, Xiaoning; Melancon, Bruce J.; Helquist, Paul; Gut, Heinz; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report crystal structures of zebrafish histone deacetylase 6 (HDAC6) catalytic domains in tandem or as single domains in complex with the (R) and (S) enantiomers of trichostatin A (TSA) or with the HDAC6-specific inhibitor, nexturastat A.  The tandem domains formed, together with the inter-domain linker, an ellipsoid-shaped complex with pseudo-twofold symmetry.  The authors identified important active site differences between both catalytic domains and revealed the binding mode of HDAC6 selective inhibitors.  HDAC inhibition assays with (R)- and (S)-TSA showed that (R)-TSA was a broad-range inhibitor, whereas (S)-TSA had moderate selectivity for HDAC6.  The authors identified a uniquely positioned α-helix and a flexible Trp residue in the loop joining α-helixes H20 to H21 as crit. for deacetylation of the physiol. substrate, tubulin.  Using single-mol. measurements and biochem. assays, the authors demonstrated that HDAC6 catalytic domain 2 deacetylated α-tubulin Lys-40 in the lumen of microtubules, but that its preferred substrate was unpolymd. tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERJRurS1cC7Vg90H21EOLACvtfcHk0lgs4O95yHZxnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rM&md5=4abe529ab89615df33f54350a1a8c69a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2140%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DY.%26aulast%3DKeusch%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DGut%26aufirst%3DH.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DStructural%2520insights%2520into%2520HDAC6%2520tubulin%2520deacetylation%2520and%2520its%2520selective%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D748%26epage%3D754%26doi%3D10.1038%2Fnchembio.2140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rodrigues, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira-Silva, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sant’Anna, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ionta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of novel <i>N</i>-acylhydrazone derivatives as potent histone deacetylase 6/8 dual inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=655-670&author=D.+A.+Rodriguesauthor=G.+A.+Ferreira-Silvaauthor=A.+C.+Ferreiraauthor=R.+A.+Fernandesauthor=J.+K.+Kweeauthor=C.+M.+Sant%E2%80%99Annaauthor=M.+Iontaauthor=C.+A.+Fraga&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+novel+N-acylhydrazone+derivatives+as+potent+histone+deacetylase+6%2F8+dual+inhibitors&doi=10.1021%2Facs.jmedchem.5b01525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01525%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DFerreira-Silva%26aufirst%3DG.%2BA.%26aulast%3DFerreira%26aufirst%3DA.%2BC.%26aulast%3DFernandes%26aufirst%3DR.%2BA.%26aulast%3DKwee%26aufirst%3DJ.%2BK.%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DC.%2BM.%26aulast%3DIonta%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520N-acylhydrazone%2520derivatives%2520as%2520potent%2520histone%2520deacetylase%25206%252F8%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D655%26epage%3D670%26doi%3D10.1021%2Facs.jmedchem.5b01525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easmon, J.</span><span> </span><span class="NLM_article-title">2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic acids as novel selective histone deacetylase-6 inhibitors with antiproliferative activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0134556</span><span class="refDoi"> DOI: 10.1371/journal.pone.0134556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.pone.0134556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0134556&author=L.+Wangauthor=M.+Koflerauthor=G.+Broschauthor=J.+Melesinaauthor=W.+Sipplauthor=E.+D.+Martinezauthor=J.+Easmon&title=2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic+acids+as+novel+selective+histone+deacetylase-6+inhibitors+with+antiproliferative+activity&doi=10.1371%2Fjournal.pone.0134556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0134556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0134556%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKofler%26aufirst%3DM.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DEasmon%26aufirst%3DJ.%26atitle%3D2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic%2520acids%2520as%2520novel%2520selective%2520histone%2520deacetylase-6%2520inhibitors%2520with%2520antiproliferative%2520activity%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0134556%26doi%3D10.1371%2Fjournal.pone.0134556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Olson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidoud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davoine, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holson, E. B.</span><span> </span><span class="NLM_article-title">Discovery of the first histone deacetylase 6/8 dual inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4816</span><span class="NLM_x">–</span> <span class="NLM_lpage">4820</span><span class="refDoi"> DOI: 10.1021/jm400390r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400390r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4816-4820&author=D.+E.+Olsonauthor=F.+F.+Wagnerauthor=T.+Kayaauthor=J.+P.+Galeauthor=N.+Aidoudauthor=E.+L.+Davoineauthor=F.+Lazzaroauthor=M.+Weiwerauthor=Y.+L.+Zhangauthor=E.+B.+Holson&title=Discovery+of+the+first+histone+deacetylase+6%2F8+dual+inhibitors&doi=10.1021%2Fjm400390r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm400390r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400390r%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DKaya%26aufirst%3DT.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DAidoud%26aufirst%3DN.%26aulast%3DDavoine%26aufirst%3DE.%2BL.%26aulast%3DLazzaro%26aufirst%3DF.%26aulast%3DWeiwer%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DDiscovery%2520of%2520the%2520first%2520histone%2520deacetylase%25206%252F8%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4816%26epage%3D4820%26doi%3D10.1021%2Fjm400390r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Summerhill, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, M. C.</span><span> </span><span class="NLM_article-title">Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2F0169-328X%2887%2990002-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=2887236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADyaL2szgtVKltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1987&pages=99-103&author=E.+M.+Summerhillauthor=K.+Woodauthor=M.+C.+Fishman&title=Regulation+of+tyrosine+hydroxylase+gene+expression+during+differentiation+of+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells</span></div><div class="casAuthors">Summerhill E M; Wood K; Fishman M C</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-103</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Differentiation of N1E-115 neuroblastoma cells into neuron-like cells, with extension of neurites and acquisition of excitable membranes, can be induced by dimethyl sulfoxide (DMSO).  We have found this differentiation to be accompanied by an increase in tyrosine hydroxylase (TH) mRNA, an increase disproportionate to changes in mRNAs for other measured, non-neuron-specific genes.  The mRNA increases slowly over several days and falls gradually after removal of DMSO.  Nuclear run-on studies suggest that a change in the rate of transcription cannot explain the increase in steady-state mRNA levels.  TH mRNA half-life does, however, increase.  This suggests that regulation is exerted in this case not at the level of transcription but rather at that of mRNA stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvM5iSt7HV5otVjB3IRIyfW6udTcc2eawxzV9fXPE87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szgtVKltQ%253D%253D&md5=12c44bf5b4b352f2861c01a8222f5b90</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2887%2990002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252887%252990002-7%26sid%3Dliteratum%253Aachs%26aulast%3DSummerhill%26aufirst%3DE.%2BM.%26aulast%3DWood%26aufirst%3DK.%26aulast%3DFishman%26aufirst%3DM.%2BC.%26atitle%3DRegulation%2520of%2520tyrosine%2520hydroxylase%2520gene%2520expression%2520during%2520differentiation%2520of%2520neuroblastoma%2520cells%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D388%26spage%3D99%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Eggert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span> </span><span class="NLM_article-title">Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fsj.onc.1203518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10803465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtF2jsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2043-2051&author=A.+Eggertauthor=N.+Ikegakiauthor=X.+Liuauthor=T.+T.+Chouauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=G.+M.+Brodeur&title=Molecular+dissection+of+TrkA+signal+transduction+pathways+mediating+differentiation+in+human+neuroblastoma+cells&doi=10.1038%2Fsj.onc.1203518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells</span></div><div class="casAuthors">Eggert, Angelika; Ikegaki, Naohiko; Liu, Xing-Ge; Chou, Thomas T.; Lee, Virginia M.; Trojanowski, John Q.; Brodeur, Garrett M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2043-2051</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the neurotrophin receptor TrkA by its ligand nerve growth factor (NGF) initiates a cascade of signaling events leading to neuronal differentiation in vitro and might play an important role in the differentiation of favorable neuroblastomas (NB) in vivo.  To study TrkA signal transduction pathways and their effects on differentiation in NB, we stably expressed wild-type TrkA and five different TrkA mutants in the NGF unresponsive human NB cell line SH-SY5Y.  Resulting clones were characterized by TrkA mRNA and protein expression, and by autophosphorylation of the receptor.  Introduction of wild-type TrkA restored NGF responsiveness of SH-SY5Y cells, as demonstrated by morphol. differentiation, activation of mitogen-activated protein kinases (MAPK) and induction of immediate-early genes.  Expression of TrkA in the absence of NGF resulted in growth inhibition of transfectants compared to parental cells, whereas NGF-treatment increased their proliferation rate.  Anal. of downstream signal transduction pathways indicated that NGF-induced differentiation was dependent on TrkA kinase activity.  Our data suggest that several redundant pathways are present further downstream, but activation of the RAS/MAPK signaling pathway seems to be of major importance for NGF mediated differentiation of NB cells.  Our results also show that the signaling effector SH2-B is a substrate of NGF-mediated Trk signaling in NB, whereas it is not activated by NGF in rat pheochromocytoma PC12 cells.  This might explain the differences we obsd. in TrkA signaling between neuroblastoma and PC12 cells.  Further insight into TrkA signaling may suggest new options for the treatment of NB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMcffQwGzqfrVg90H21EOLACvtfcHk0lgTdwWMGpz2kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtF2jsbk%253D&md5=11c2bc9243954f97c9a8dab11d9103fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203518%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DA.%26aulast%3DIkegaki%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChou%26aufirst%3DT.%2BT.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26atitle%3DMolecular%2520dissection%2520of%2520TrkA%2520signal%2520transduction%2520pathways%2520mediating%2520differentiation%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2043%26epage%3D2051%26doi%3D10.1038%2Fsj.onc.1203518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrman, S. J.</span><span> </span><span class="NLM_article-title">A review on the use of sodium triacetoxyborohydride in the reductive amination of ketones and aldehydes</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1021/op0601013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0601013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=971-1031&issue=5&author=A.+F.+Abdel-Magidauthor=S.+J.+Mehrman&title=A+review+on+the+use+of+sodium+triacetoxyborohydride+in+the+reductive+amination+of+ketones+and+aldehydes&doi=10.1021%2Fop0601013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A Review on the Use of Sodium Triacetoxyborohydride in the Reductive Amination of Ketones and Aldehydes</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Mehrman, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-1031</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Sodium triacetoxyborohydride is a mild, very effective, and synthetically useful reducing agent for the reductive amination of aldehydes and ketones.  The examples presented illustrate the reagent's wide scope, the diverse and numerous applications, and the high tolerance for many functional groups.  It also shows fewer limitations than other reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo82o7gXZ4dc7Vg90H21EOLACvtfcHk0lh0QTW22CylJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVymurk%253D&md5=23826b51c561015e8aa887606804ec2a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fop0601013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0601013%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DMehrman%26aufirst%3DS.%2BJ.%26atitle%3DA%2520review%2520on%2520the%2520use%2520of%2520sodium%2520triacetoxyborohydride%2520in%2520the%2520reductive%2520amination%2520of%2520ketones%2520and%2520aldehydes%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26issue%3D5%26spage%3D971%26epage%3D1031%26doi%3D10.1021%2Fop0601013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kocienski, P. J.</span> <span class="citation_source-book">Protecting Groups</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Georg Thieme Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">206</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1055%2Fb-003-108603" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=206&author=P.+J.+Kocienski&title=Protecting+Groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fb-003-108603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1055%252Fb-003-108603%26sid%3Dliteratum%253Aachs%26aulast%3DKocienski%26aufirst%3DP.%2BJ.%26btitle%3DProtecting%2520Groups%26pub%3DGeorg%2520Thieme%2520Verlag%26date%3D2005%26spage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Jiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel 2-(1<i>H</i>-imidazol-2-yl) pyridine sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejmech.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25461318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=170-183&author=Y.+Jiaoauthor=B.+T.+Xinauthor=Y.+Zhangauthor=J.+Wuauthor=X.+Luauthor=Y.+Zhengauthor=W.+Tangauthor=X.+Zhou&title=Design%2C+synthesis+and+evaluation+of+novel+2-%281H-imidazol-2-yl%29+pyridine+sorafenib+derivatives+as+potential+BRAF+inhibitors+and+anti-tumor+agents&doi=10.1016%2Fj.ejmech.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents</span></div><div class="casAuthors">Jiao, Yu; Xin, Bo-Tao; Zhang, Yanmin; Wu, Jianbing; Lu, Xiaolin; Zheng, Ying; Tang, Weifang; Zhou, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-(1H-imidazol-2-yl)pyridine derivs. have been designed and synthesized, and they were screened for BRAF kinase inhibitory activity.  Besides, their biol. activities were evaluated in vitro and in vivo.  All the compds. were reported for the first time, and compds. I and II displayed the most potent antiproliferative activity against cell line A375 in vitro, with IC50 values of 4.26 and 2.93 μM, resp., which were comparable with the pos. control Sorafenib.  Those two compds. were further evaluated for the in vivo efficacy using an A375 xenograft nude mice model.  The results showed that the growth of A375 cancer cells xenografts was suppressed by factors of 35.68% and 42.50% (percent tumor growth inhibition values) after intragastric (ig) administration of compd. I and II at concn. of 50 mg/kg.  Thus they may be promising lead compds. to be developed as an alternative for current Sorafenib therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEdpxPrhB6MrVg90H21EOLACvtfcHk0lh0QTW22CylJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvJ&md5=b270c12f2711cbf8e81d1ced544f091e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%25202-%25281H-imidazol-2-yl%2529%2520pyridine%2520sorafenib%2520derivatives%2520as%2520potential%2520BRAF%2520inhibitors%2520and%2520anti-tumor%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D170%26epage%3D183%26doi%3D10.1016%2Fj.ejmech.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Meca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Císařová, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drahoňovský, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvořák, D.</span><span> </span><span class="NLM_article-title">Enantiomerically pure axially chiral aminocarbene complexes of chromium</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1858</span><span class="refDoi"> DOI: 10.1021/om701188p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om701188p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=1850-1858&issue=8&author=L.+Mecaauthor=I.+C%C3%ADsa%C5%99ov%C3%A1author=D.+Draho%C5%88ovsk%C3%BDauthor=D.+Dvo%C5%99%C3%A1k&title=Enantiomerically+pure+axially+chiral+aminocarbene+complexes+of+chromium&doi=10.1021%2Fom701188p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fom701188p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom701188p%26sid%3Dliteratum%253Aachs%26aulast%3DMeca%26aufirst%3DL.%26aulast%3DC%25C3%25ADsa%25C5%2599ov%25C3%25A1%26aufirst%3DI.%26aulast%3DDraho%25C5%2588ovsk%25C3%25BD%26aufirst%3DD.%26aulast%3DDvo%25C5%2599%25C3%25A1k%26aufirst%3DD.%26atitle%3DEnantiomerically%2520pure%2520axially%2520chiral%2520aminocarbene%2520complexes%2520of%2520chromium%26jtitle%3DOrganometallics%26date%3D2008%26volume%3D27%26issue%3D8%26spage%3D1850%26epage%3D1858%26doi%3D10.1021%2Fom701188p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>Molecular Operating Environment (MOE), version <span class="NLM_edition">2014.09</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span> (<span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite No. 910, Montreal, QC H3A 2R7, Canada</span>),<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2014.09%3B+Chemical+Computing+Group+Inc.+%281010+Sherbooke+St.+West%2C+Suite+No.+910%2C+Montreal%2C+QC+H3A+2R7%2C+Canada%29%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span>Schrödinger Release 2014-2: LigPrep, <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2014-2%3A+LigPrep%2C+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lh0QTW22CylJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span>Schrödinger Release 2014-2: Schrödinger Suite 2014-2 Protein Preparation Wizard; Epik, version <span class="NLM_edition">2.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Impact, version <span class="NLM_edition">6.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Prime, version <span class="NLM_edition">3.6</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2014-2%3A+Schr%C3%B6dinger+Suite+2014-2+Protein+Preparation+Wizard%3B+Epik%2C+version+2.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014%3B+Impact%2C+version+6.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014%3B+Prime%2C+version+3.6%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202014-2%2520Protein%2520Preparation%2520Wizard%253B%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>Small-Molecule Drug Discovery Suite 2014-2: Glide, version <span class="NLM_edition">9.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2014-2%3A+Glide%2C+version+9.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgFdAiBZrzZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>Schrödinger Release 2017-2: Canvas; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2017-2%3A+Canvas%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCanvas%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebbioso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1002/cmdc.201200193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201200193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1256-1266&author=D.+A.+Stolfaauthor=A.+Stefanachiauthor=J.+M.+Gajerauthor=A.+Nebbiosoauthor=L.+Altucciauthor=S.+Cellamareauthor=M.+Jungauthor=A.+Carotti&title=Design%2C+synthesis%2C+and+biological+evaluation+of+2-aminobenzanilide+derivatives+as+potent+and+selective+HDAC+inhibitors&doi=10.1002%2Fcmdc.201200193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200193%26sid%3Dliteratum%253Aachs%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGajer%26aufirst%3DJ.%2BM.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25202-aminobenzanilide%2520derivatives%2520as%2520potent%2520and%2520selective%2520HDAC%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1256%26epage%3D1266%26doi%3D10.1002%2Fcmdc.201200193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Marek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes Mourao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003645</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.ppat.1003645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=24086136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOnurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003645&author=M.+Marekauthor=S.+Kannanauthor=A.+T.+Hauserauthor=M.+Moraes+Mouraoauthor=S.+Cabyauthor=V.+Curaauthor=D.+A.+Stolfaauthor=K.+Schmidtkunzauthor=J.+Lancelotauthor=L.+Andradeauthor=J.+P.+Renaudauthor=G.+Oliveiraauthor=W.+Sipplauthor=M.+Jungauthor=J.+Cavarelliauthor=R.+J.+Pierceauthor=C.+Romier&title=Structural+basis+for+the+inhibition+of+histone+deacetylase+8+%28HDAC8%29%2C+a+key+epigenetic+player+in+the+blood+fluke+Schistosoma+mansoni&doi=10.1371%2Fjournal.ppat.1003645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni</span></div><div class="casAuthors">Marek, Martin; Kannan, Srinivasaraghavan; Hauser, Alexander-Thomas; Mourao, Marina Moraes; Caby, Stephanie; Cura, Vincent; Stolfa, Diana A.; Schmidtkunz, Karin; Lancelot, Julien; Andrade, Luiza; Renaud, Jean-Paul; Oliveira, Guilherme; Sippl, Wolfgang; Jung, Manfred; Cavarelli, Jean; Pierce, Raymond J.; Romier, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1003645</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The treatment of schistosomiasis, a disease caused by blood flukes parasites of the Schistosoma genus, depends on the intensive use of a single drug, praziquantel, which increases the likelihood of the development of drug-resistant parasite strains and renders the search for new drugs a strategic priority.  Currently, inhibitors of human epigenetic enzymes are actively investigated as novel anti-cancer drugs and have the potential to be used as new anti-parasitic agents.  Here, we report that Schistosoma mansoni histone deacetylase 8 (smHDAC8), the most expressed class I HDAC isotype in this organism, is a functional acetyl--lysine deacetylase that plays an important role in parasite infectivity.  The crystal structure of smHDAC8 shows that this enzyme adopts a canonical α/β HDAC fold, with specific solvent exposed loops corresponding to insertions in the schistosome HDAC8 sequence.  Importantly, structures of smHDAC8 in complex with generic HDAC inhibitors revealed specific structural changes in the smHDAC8 active site that cannot be accommodated by human HDACs.  Using a structure-based approach, we identified several small-mol. inhibitors that build on these specificities.  These mols. exhibit an inhibitory effect on smHDAC8 but show reduced affinity for human HDACs.  Crucially, we show that a newly identified smHDAC8 inhibitor has the capacity to induce apoptosis and mortality in schistosomes.  Taken together, our biol. and structural findings define the framework for the rational design of small-mol. inhibitors specifically interfering with schistosome epigenetic mechanisms, and further support an anti-parasitic epigenome targeting strategy to treat neglected diseases caused by eukaryotic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIGu8lR_TxrVg90H21EOLACvtfcHk0lgFdAiBZrzZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOnurzI&md5=9fef2938ff73df80fc60b739c878f9a6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003645%26sid%3Dliteratum%253Aachs%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DHauser%26aufirst%3DA.%2BT.%26aulast%3DMoraes%2BMourao%26aufirst%3DM.%26aulast%3DCaby%26aufirst%3DS.%26aulast%3DCura%26aufirst%3DV.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DRenaud%26aufirst%3DJ.%2BP.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCavarelli%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DRomier%26aufirst%3DC.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520histone%2520deacetylase%25208%2520%2528HDAC8%2529%252C%2520a%2520key%2520epigenetic%2520player%2520in%2520the%2520blood%2520fluke%2520Schistosoma%2520mansoni%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003645%26doi%3D10.1371%2Fjournal.ppat.1003645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skowron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthold, F.</span><span> </span><span class="NLM_article-title">Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA</span> <span class="citation_source-journal">J. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/S1525-1578(10)60013-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS1525-1578%2810%2960013-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15681479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFKrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=89-96&author=M.+Fischerauthor=M.+Skowronauthor=F.+Berthold&title=Reliable+transcript+quantification+by+real-time+reverse+transcriptase-polymerase+chain+reaction+in+primary+neuroblastoma+using+normalization+to+averaged+expression+levels+of+the+control+genes+HPRT1+and+SDHA&doi=10.1016%2FS1525-1578%2810%2960013-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA</span></div><div class="casAuthors">Fischer, Matthias; Skowron, Matthias; Berthold, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">JMDIFP</span>;
        ISSN:<span class="NLM_cas:issn">1525-1578</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology and the Association for Molecular Pathology</span>)
        </div><div class="casAbstract">Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) represents a sensitive and efficient technique to det. expression levels of target genes in multiple samples and is increasingly used in clin. oncol. to evaluate the patient's outcome or to detect minimal residual disease.  Normalization of raw data are required to obtain comparable results between different specimens and is usually achieved by correlating transcript abundances of target genes with those of a single control gene with putatively stable expression levels.  In this study, expression stability of six supposed control genes was evaluated in 64 samples of primary neuroblastoma and HPRT1 and SDHA mRNA levels were shown to exhibit the least expression variability among the samples.  Because application of more than one control gene may enhance reliability of real-time RT-PCR results, various normalization factors consisting of the geometrical mean of multiple control gene expression values were calcd. and evaluated by mRNA quantification of 14 target genes.  Comparison with transcript levels detd. by oligonucleotide-array expression anal. revealed that target gene mRNA quantification became most consistent after normalization to averaged expression levels of HPRT1 and SDHA.  This normalization factor was in addn. demonstrated to be not assocd. with stage of disease or MYCN amplification status of the tumor.  Thus, these data indicate that the geometrical mean of HPRT1 and SDHA transcript levels represents a suitable internal control for biol. and clin. studies investigating differential gene expression in primary neuroblastoma by real-time RT-PCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAEeAQts387bVg90H21EOLACvtfcHk0lgayla8yJPn0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFKrt74%253D&md5=ce40921135d77a6fdcd7bb1ac0c947dc</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1525-1578%2810%2960013-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1525-1578%252810%252960013-X%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DSkowron%26aufirst%3DM.%26aulast%3DBerthold%26aufirst%3DF.%26atitle%3DReliable%2520transcript%2520quantification%2520by%2520real-time%2520reverse%2520transcriptase-polymerase%2520chain%2520reaction%2520in%2520primary%2520neuroblastoma%2520using%2520normalization%2520to%2520averaged%2520expression%2520levels%2520of%2520the%2520control%2520genes%2520HPRT1%2520and%2520SDHA%26jtitle%3DJ.%2520Mol.%2520Diagn.%26date%3D2005%26volume%3D7%26spage%3D89%26epage%3D96%26doi%3D10.1016%2FS1525-1578%2810%2960013-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matthes Zessin, Zsófia Kutil, Marat Meleshin, Zora Nováková, Ehab Ghazy, Diana Kalbas, Martin Marek, Christophe Romier, Wolfgang Sippl, Cyril Bařinka, <span class="NLM_string-name hlFld-ContribAuthor">Mike Schutkowski</span>. </span><span class="cited-content_cbyCitation_article-title">One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (48)
                                     , 4777-4789. <a href="https://doi.org/10.1021/acs.biochem.9b00786" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00786%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DOne-Atom%252BSubstitution%252BEnables%252BDirect%252Band%252BContinuous%252BMonitoring%252Bof%252BHistone%252BDeacylase%252BActivity%26aulast%3DZessin%26aufirst%3DMatthes%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10092019%26date%3D04112019%26date%3D14112019%26date%3D04112019%26volume%3D58%26issue%3D48%26spage%3D4777%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martin Marek, Tajith B. Shaik, Tino Heimburg, Alokta Chakrabarti, Julien Lancelot, Elizabeth Ramos-Morales, Cyrielle Da Veiga, Dmitrii Kalinin, Jelena Melesina, Dina Robaa, Karin Schmidtkunz, Takayoshi Suzuki, Ralph Holl, Eric Ennifar, Raymond J. Pierce, Manfred Jung, Wolfgang Sippl, <span class="NLM_string-name hlFld-ContribAuthor">Christophe Romier</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10000-10016. <a href="https://doi.org/10.1021/acs.jmedchem.8b01087" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01087%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCharacterization%252Bof%252BHistone%252BDeacetylase%252B8%252B%252528HDAC8%252529%252BSelective%252BInhibition%252BReveals%252BSpecific%252BActive%252BSite%252BStructural%252Band%252BFunctional%252BDeterminants%26aulast%3DMarek%26aufirst%3DMartin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D08112018%26date%3D22102018%26volume%3D61%26issue%3D22%26spage%3D10000%26epage%3D10016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diana Lamaa, Hsin-Ping Lin, Lena Zig, Cyril Bauvais, Guillaume Bollot, Jérôme Bignon, Helene Levaique, Olivier Pamlard, Joelle Dubois, Mehdi Ouaissi, Martin Souce, Athena Kasselouri, François Saller, Delphine Borgel, Chantal Jayat-Vignoles, Hazar Al-Mouhammad, Jean Feuillard, Karim Benihoud, Mouad Alami, <span class="NLM_string-name hlFld-ContribAuthor">Abdallah Hamze</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6574-6591. <a href="https://doi.org/10.1021/acs.jmedchem.8b00050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BTubulin%252Band%252BHistone%252BDeacetylase%252BInhibitor%252BBased%252Bon%252Biso-Combretastatin%252BA-4%26aulast%3DLamaa%26aufirst%3DDiana%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12012018%26date%3D26072018%26date%3D13072018%26volume%3D61%26issue%3D15%26spage%3D6574%26epage%3D6591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Shao-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Lin-Feng  Jin</span>, <span class="hlFld-ContribAuthor ">Tong  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113588. <a href="https://doi.org/10.1016/j.ejmech.2021.113588" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113588%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bdual%252Binhibitors%252Btargeting%252Bcrosstalk%252Bbetween%252Bhistone%252Bepigenetic%252Bmodulators%252Bfor%252Bcancer%252Btherapy%26aulast%3DDuan%26aufirst%3DYing-Chao%26date%3D2021%26volume%3D222%26spage%3D113588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Yao</span>, <span class="hlFld-ContribAuthor ">Qiushuang  Gao</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Ji  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Exploration of Methionine 274 Acting as a “Switch” of the Selective Pocket Involved in HDAC8 Inhibition: An
              in Silico
              Study. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (12)
                                     , 1933-1944. <a href="https://doi.org/10.1002/cmdc.202001004" title="DOI URL">https://doi.org/10.1002/cmdc.202001004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202001004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202001004%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMechanistic%252BExploration%252Bof%252BMethionine%252B274%252BActing%252Bas%252Ba%252B%2525E2%252580%25259CSwitch%2525E2%252580%25259D%252Bof%252Bthe%252BSelective%252BPocket%252BInvolved%252Bin%252BHDAC8%252BInhibition%25253A%252BAn%252Bin%252BSilico%252BStudy%26aulast%3DYao%26aufirst%3DPeng%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D12%26spage%3D1933%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jelena  Melesina</span>, <span class="hlFld-ContribAuthor ">Conrad V.  Simoben</span>, <span class="hlFld-ContribAuthor ">Lucas  Praetorius</span>, <span class="hlFld-ContribAuthor ">Emre F.  Bülbül</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies To Design Selective Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (9)
                                     , 1336-1359. <a href="https://doi.org/10.1002/cmdc.202000934" title="DOI URL">https://doi.org/10.1002/cmdc.202000934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000934%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStrategies%252BTo%252BDesign%252BSelective%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DMelesina%26aufirst%3DJelena%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D9%26spage%3D1336%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugo Rolando  Vaca</span>, <span class="hlFld-ContribAuthor ">Ana María  Celentano</span>, <span class="hlFld-ContribAuthor ">María Agustina  Toscanini</span>, <span class="hlFld-ContribAuthor ">Tino  Heimburg</span>, <span class="hlFld-ContribAuthor ">Ehab  Ghazy</span>, <span class="hlFld-ContribAuthor ">Patrik  Zeyen</span>, <span class="hlFld-ContribAuthor ">Alexander-Thomas  Hauser</span>, <span class="hlFld-ContribAuthor ">Guilherme  Oliveira</span>, <span class="hlFld-ContribAuthor ">María Celina  Elissondo</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Federico  Camicia</span>, <span class="hlFld-ContribAuthor ">Mara Cecilia  Rosenzvit</span>, . </span><span class="cited-content_cbyCitation_article-title">The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2021,</strong> <em>15 </em>
                                    (3)
                                     , e0009226. <a href="https://doi.org/10.1371/journal.pntd.0009226" title="DOI URL">https://doi.org/10.1371/journal.pntd.0009226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0009226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0009226%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DThe%252Bpotential%252Bfor%252Bhistone%252Bdeacetylase%252B%252528HDAC%252529%252Binhibitors%252Bas%252Bcestocidal%252Bdrugs%26aulast%3DVaca%26aufirst%3DHugo%2BRolando%26date%3D2021%26date%3D2021%26volume%3D15%26issue%3D3%26spage%3De0009226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (1)
                                     , 1-8. <a href="https://doi.org/10.1080/07391102.2019.1661876" title="DOI URL">https://doi.org/10.1080/07391102.2019.1661876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1661876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1661876%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDevelopment%252Bof%252Bdecision%252Btrees%252Bto%252Bdiscriminate%252BHDAC8%252Binhibitors%252Band%252Bnon-inhibitors%252Busing%252Brecursive%252Bpartitioning%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2021%26date%3D2019%26volume%3D39%26issue%3D1%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dušan  Ružić</span>, <span class="hlFld-ContribAuthor ">Nemanja  Đoković</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolić</span>, <span class="hlFld-ContribAuthor ">Zorica  Vujić</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Arhiv za farmaciju</span><span> <strong>2021,</strong> <em>71 </em>
                                    (2)
                                     , 73-100. <a href="https://doi.org/10.5937/arhfarm71-30618" title="DOI URL">https://doi.org/10.5937/arhfarm71-30618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5937/arhfarm71-30618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5937%2Farhfarm71-30618%26sid%3Dliteratum%253Aachs%26jtitle%3DArhiv%2520za%2520farmaciju%26atitle%3DMedicinal%252Bchemistry%252Bof%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DRu%25C5%25BEi%25C4%2587%26aufirst%3DDu%25C5%25A1an%26date%3D2021%26volume%3D71%26issue%3D2%26spage%3D73%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luciana  Ângelo de Souza</span>, <span class="hlFld-ContribAuthor ">Matheus  Silva e Bastos</span>, <span class="hlFld-ContribAuthor ">Joice  de Melo Agripino</span>, <span class="hlFld-ContribAuthor ">Thiago  Souza Onofre</span>, <span class="hlFld-ContribAuthor ">Lourdes Fanny  Apaza Calla</span>, <span class="hlFld-ContribAuthor ">Tino  Heimburg</span>, <span class="hlFld-ContribAuthor ">Ehab  Ghazy</span>, <span class="hlFld-ContribAuthor ">Theresa  Bayer</span>, <span class="hlFld-ContribAuthor ">Victor Hugo  Ferraz da Silva</span>, <span class="hlFld-ContribAuthor ">Paula  Dutra Ribeiro</span>, <span class="hlFld-ContribAuthor ">Leandro  Licursi de Oliveira</span>, <span class="hlFld-ContribAuthor ">Gustavo  Costa Bressan</span>, <span class="hlFld-ContribAuthor ">Márcia Rogéria  de Almeida Lamêgo</span>, <span class="hlFld-ContribAuthor ">Abelardo  Silva-Júnior</span>, <span class="hlFld-ContribAuthor ">Raphael  de Souza Vasconcellos</span>, <span class="hlFld-ContribAuthor ">Ana Márcia  Suarez-Fontes</span>, <span class="hlFld-ContribAuthor ">Juliana  Almeida-Silva</span>, <span class="hlFld-ContribAuthor ">Marcos André  Vannier-Santos</span>, <span class="hlFld-ContribAuthor ">Raymond  Pierce</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Juliana  Lopes Rangel Fietto</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>180 </em>, 114191. <a href="https://doi.org/10.1016/j.bcp.2020.114191" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114191%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DHistone%252Bdeacetylases%252Binhibitors%252Bas%252Bnew%252Bpotential%252Bdrugs%252Bagainst%252BLeishmania%252Bbraziliensis%25252C%252Bthe%252Bmain%252Bcausative%252Bagent%252Bof%252Bnew%252Bworld%252Btegumentary%252Bleishmaniasis%26aulast%3D%25C3%2582ngelo%2Bde%2BSouza%26aufirst%3DLuciana%26date%3D2020%26volume%3D180%26spage%3D114191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad-Nazir  Menbari</span>, , <span class="hlFld-ContribAuthor ">Karim  Rahimi</span>, , <span class="hlFld-ContribAuthor ">Abbas  Ahmadi</span>, , <span class="hlFld-ContribAuthor ">Samira  Mohammadi-Yeganeh</span>, , <span class="hlFld-ContribAuthor ">Anvar  Elyasi</span>, , <span class="hlFld-ContribAuthor ">Nikoo  Darvishi</span>, , <span class="hlFld-ContribAuthor ">Vahedeh  Hosseini</span>, , <span class="hlFld-ContribAuthor ">Mohammad  Abdi</span>, . </span><span class="cited-content_cbyCitation_article-title">Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis. </span><span class="cited-content_cbyCitation_journal-name">Iranian Biomedical Journal</span><span> <strong>2020,</strong> <em>24 </em>
                                    (5)
                                     , 283-289. <a href="https://doi.org/10.29252/ibj.24.5.283" title="DOI URL">https://doi.org/10.29252/ibj.24.5.283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.29252/ibj.24.5.283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.29252%2Fibj.24.5.283%26sid%3Dliteratum%253Aachs%26jtitle%3DIranian%2520Biomedical%2520Journal%26atitle%3DAssociation%252Bof%252BHDAC8%252BExpression%252Bwith%252BPathological%252BFindings%252Bin%252BTriple%252BNegative%252Band%252BNon-Triple%252BNegative%252BBreast%252BCancer%25253A%252BImplications%252Bfor%252BDiagnosis%26aulast%3DMenbari%26aufirst%3DMohammad-Nazir%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D5%26spage%3D283%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kriti  Kashyap</span>, <span class="hlFld-ContribAuthor ">Rita  Kakkar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2020,</strong> <em>123 </em>, 103850. <a href="https://doi.org/10.1016/j.compbiomed.2020.103850" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2020.103850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2020.103850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2020.103850%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DPharmacophore-enabled%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bstudies%252Bfor%252Bidentification%252Bof%252Bpotent%252Band%252Bselective%252Bhistone%252Bdeacetylase%252B8%252Binhibitors%26aulast%3DKashyap%26aufirst%3DKriti%26date%3D2020%26volume%3D123%26spage%3D103850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehab  Ghazy</span>, <span class="hlFld-ContribAuthor ">Patrik  Zeyen</span>, <span class="hlFld-ContribAuthor ">Daniel  Herp</span>, <span class="hlFld-ContribAuthor ">Martin  Hügle</span>, <span class="hlFld-ContribAuthor ">Karin  Schmidtkunz</span>, <span class="hlFld-ContribAuthor ">Frank  Erdmann</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Matthias  Schmidt</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Morales</span>, <span class="hlFld-ContribAuthor ">Christophe  Romier</span>, <span class="hlFld-ContribAuthor ">Stefan  Günther</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112338. <a href="https://doi.org/10.1016/j.ejmech.2020.112338" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112338%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bdual%252Btargeting%252Binhibitors%252Bof%252Bhistone%252Bdeacetylase%252B6%25252F8%252Band%252Bbromodomain%252BBRPF1%26aulast%3DGhazy%26aufirst%3DEhab%26date%3D2020%26volume%3D200%26spage%3D112338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun Biao  Ying</span>, <span class="hlFld-ContribAuthor ">Song Song  Wang</span>, <span class="hlFld-ContribAuthor ">Dian  He</span>, <span class="hlFld-ContribAuthor ">Hongtian  Zhu</span>, <span class="hlFld-ContribAuthor ">Chenghong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Ruili  Lin</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the binding mechanism of HDAC8 selective inhibitors: Lessons from the modification of Cap group. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2020,</strong> <em>121 </em>
                                    (5-6)
                                     , 3162-3172. <a href="https://doi.org/10.1002/jcb.29583" title="DOI URL">https://doi.org/10.1002/jcb.29583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29583%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DExploring%252Bthe%252Bbinding%252Bmechanism%252Bof%252BHDAC8%252Bselective%252Binhibitors%25253A%252BLessons%252Bfrom%252Bthe%252Bmodification%252Bof%252BCap%252Bgroup%26aulast%3DZhang%26aufirst%3DMin%26date%3D2020%26volume%3D121%26issue%3D5-6%26spage%3D3162%26epage%3D3172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunlong  Zhao</span>, <span class="hlFld-ContribAuthor ">Hang  Dong</span>, <span class="hlFld-ContribAuthor ">Qifu  Xu</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 263-274. <a href="https://doi.org/10.1080/13543776.2020.1725470" title="DOI URL">https://doi.org/10.1080/13543776.2020.1725470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1725470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1725470%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DHistone%252Bdeacetylase%252B%252528HDAC%252529%252Binhibitors%252Bin%252Bcancer%25253A%252Ba%252Bpatent%252Breview%252B%2525282017-present%252529%26aulast%3DZhao%26aufirst%3DChunlong%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D263%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Su</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yepeng  Luan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel histone deacetylase inhibitors bearing a 4‐piperidin‐4‐yl‐triazole scaffold as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2020,</strong> <em>81 </em>
                                    (1)
                                     , 52-61. <a href="https://doi.org/10.1002/ddr.21603" title="DOI URL">https://doi.org/10.1002/ddr.21603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21603%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DNovel%252Bhistone%252Bdeacetylase%252Binhibitors%252Bbearing%252Ba%252B4%2525E2%252580%252590piperidin%2525E2%252580%2525904%2525E2%252580%252590yl%2525E2%252580%252590triazole%252Bscaffold%252Bas%252Bantitumor%252Bagents%26aulast%3DWang%26aufirst%3DYan%26date%3D2020%26date%3D2019%26volume%3D81%26issue%3D1%26spage%3D52%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kriti  Kashyap</span>, <span class="hlFld-ContribAuthor ">Rita  Kakkar</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (1)
                                     , 48-65. <a href="https://doi.org/10.1080/07391102.2019.1567388" title="DOI URL">https://doi.org/10.1080/07391102.2019.1567388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1567388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1567388%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DAn%252Binsight%252Binto%252Bselective%252Band%252Bpotent%252Binhibition%252Bof%252Bhistone%252Bdeacetylase%252B8%252Bthrough%252Binduced-fit%252Bdocking%25252C%252Bpharmacophore%252Bmodeling%252Band%252BQSAR%252Bstudies%26aulast%3DKashyap%26aufirst%3DKriti%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D1%26spage%3D48%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Bai</span>, <span class="hlFld-ContribAuthor ">Daid  Ahmad</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Guihua  Cui</span>, <span class="hlFld-ContribAuthor ">Wenliang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (12)
                                     , 995-1004. <a href="https://doi.org/10.2174/1568026619666190125145110" title="DOI URL">https://doi.org/10.2174/1568026619666190125145110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190125145110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190125145110%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DResearch%252BAdvances%252Bin%252Bthe%252BUse%252Bof%252BHistone%252BDeacetylase%252BInhibitors%252Bfor%252BEpigenetic%252BTargeting%252Bof%252BCancer%26aulast%3DBai%26aufirst%3DYu%26date%3D2019%26volume%3D19%26issue%3D12%26spage%3D995%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina  Reßing</span>, <span class="hlFld-ContribAuthor ">Viktoria  Marquardt</span>, <span class="hlFld-ContribAuthor ">Christoph G. W.  Gertzen</span>, <span class="hlFld-ContribAuthor ">Andrea  Schöler</span>, <span class="hlFld-ContribAuthor ">Alexander  Schramm</span>, <span class="hlFld-ContribAuthor ">Thomas  Kurz</span>, <span class="hlFld-ContribAuthor ">Holger  Gohlke</span>, <span class="hlFld-ContribAuthor ">Achim  Aigner</span>, <span class="hlFld-ContribAuthor ">Marc  Remke</span>, <span class="hlFld-ContribAuthor ">Finn K.  Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (7)
                                     , 1109-1115. <a href="https://doi.org/10.1039/C8MD00454D" title="DOI URL">https://doi.org/10.1039/C8MD00454D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00454D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00454D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%2525CE%2525B2-peptoid-capped%252BHDAC%252Binhibitors%252Bwith%252Banti-neuroblastoma%252Band%252Banti-glioblastoma%252Bactivity%26aulast%3DRe%25C3%259Fing%26aufirst%3DNina%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D7%26spage%3D1109%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Jelena  Melesina</span>, <span class="hlFld-ContribAuthor ">Chiara  Luise</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Epigenetic Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 455-486. <a href="https://doi.org/10.1007/7355_2019_80" title="DOI URL">https://doi.org/10.1007/7355_2019_80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_80%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-Based%252BDesign%252Bof%252BEpigenetic%252BInhibitors%26aulast%3DRobaa%26aufirst%3DDina%26date%3D2019%26date%3D2019%26spage%3D455%26epage%3D486%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Shen</span>, <span class="hlFld-ContribAuthor ">Sara  Najafi</span>, <span class="hlFld-ContribAuthor ">Sina  Stäble</span>, <span class="hlFld-ContribAuthor ">Johannes  Fabian</span>, <span class="hlFld-ContribAuthor ">Emily  Koeneke</span>, <span class="hlFld-ContribAuthor ">Fiona R.  Kolbinger</span>, <span class="hlFld-ContribAuthor ">Jagoda K.  Wrobel</span>, <span class="hlFld-ContribAuthor ">Benjamin  Meder</span>, <span class="hlFld-ContribAuthor ">Martin  Distel</span>, <span class="hlFld-ContribAuthor ">Tino  Heimburg</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Heike  Peterziel</span>, <span class="hlFld-ContribAuthor ">Dominique  Kranz</span>, <span class="hlFld-ContribAuthor ">Michael  Boutros</span>, <span class="hlFld-ContribAuthor ">Frank  Westermann</span>, <span class="hlFld-ContribAuthor ">Olaf  Witt</span>, <span class="hlFld-ContribAuthor ">Ina  Oehme</span>. </span><span class="cited-content_cbyCitation_article-title">A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Differentiation</span><span> <strong>2018,</strong> <em>25 </em>
                                    (12)
                                     , 2053-2070. <a href="https://doi.org/10.1038/s41418-018-0080-0" title="DOI URL">https://doi.org/10.1038/s41418-018-0080-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41418-018-0080-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41418-018-0080-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Differentiation%26atitle%3DA%252Bkinome-wide%252BRNAi%252Bscreen%252Bidentifies%252BALK%252Bas%252Ba%252Btarget%252Bto%252Bsensitize%252Bneuroblastoma%252Bcells%252Bfor%252BHDAC8-inhibitor%252Btreatment%26aulast%3DShen%26aufirst%3DJing%26date%3D2018%26date%3D2018%26volume%3D25%26issue%3D12%26spage%3D2053%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sk Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and nonselective HDAC8 inhibitors: a therapeutic patent review. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2018,</strong> <em>7 </em>
                                    (6)
                                     , 259-276. <a href="https://doi.org/10.4155/ppa-2018-0019" title="DOI URL">https://doi.org/10.4155/ppa-2018-0019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2018-0019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2018-0019%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DSelective%252Band%252Bnonselective%252BHDAC8%252Binhibitors%25253A%252Ba%252Btherapeutic%252Bpatent%252Breview%26aulast%3DAdhikari%26aufirst%3DNilanjan%26date%3D2018%26volume%3D7%26issue%3D6%26spage%3D259%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona R.  Kolbinger</span>, <span class="hlFld-ContribAuthor ">Emily  Koeneke</span>, <span class="hlFld-ContribAuthor ">Johannes  Ridinger</span>, <span class="hlFld-ContribAuthor ">Tino  Heimburg</span>, <span class="hlFld-ContribAuthor ">Michael  Müller</span>, <span class="hlFld-ContribAuthor ">Theresa  Bayer</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Nikolas  Gunkel</span>, <span class="hlFld-ContribAuthor ">Aubry K.  Miller</span>, <span class="hlFld-ContribAuthor ">Frank  Westermann</span>, <span class="hlFld-ContribAuthor ">Olaf  Witt</span>, <span class="hlFld-ContribAuthor ">Ina  Oehme</span>. </span><span class="cited-content_cbyCitation_article-title">The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines. </span><span class="cited-content_cbyCitation_journal-name">Archives of Toxicology</span><span> <strong>2018,</strong> <em>92 </em>
                                    (8)
                                     , 2649-2664. <a href="https://doi.org/10.1007/s00204-018-2234-8" title="DOI URL">https://doi.org/10.1007/s00204-018-2234-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00204-018-2234-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00204-018-2234-8%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Toxicology%26atitle%3DThe%252BHDAC6%25252F8%25252F10%252Binhibitor%252BTH34%252Binduces%252BDNA%252Bdamage-mediated%252Bcell%252Bdeath%252Bin%252Bhuman%252Bhigh-grade%252Bneuroblastoma%252Bcell%252Blines%26aulast%3DKolbinger%26aufirst%3DFiona%2BR.%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D8%26spage%3D2649%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">Stuart J  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules as tools to study the chemical epigenetics of lysine acetylation. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2018,</strong> <em>45 </em>, 166-178. <a href="https://doi.org/10.1016/j.cbpa.2018.06.015" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DSmall%252Bmolecules%252Bas%252Btools%252Bto%252Bstudy%252Bthe%252Bchemical%252Bepigenetics%252Bof%252Blysine%252Bacetylation%26aulast%3DSchiedel%26aufirst%3DMatthias%26date%3D2018%26volume%3D45%26spage%3D166%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunlong  Zhao</span>, <span class="hlFld-ContribAuthor ">Jie  Zang</span>, <span class="hlFld-ContribAuthor ">Qin'ge  Ding</span>, <span class="hlFld-ContribAuthor ">Elizabeth S.  Inks</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, <span class="hlFld-ContribAuthor ">C. James  Chou</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 282-291. <a href="https://doi.org/10.1016/j.ejmech.2018.03.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmeta-sulfamoyl%252BN-hydroxybenzamides%252Bas%252BHDAC8%252Bselective%252Binhibitors%26aulast%3DZhao%26aufirst%3DChunlong%26date%3D2018%26volume%3D150%26spage%3D282%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0016.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously identified benzhydroxamic acid based HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Series of the herein described benzhydroxamic acids as HDAC8 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) aldehyde, toluene; (ii) Na(AcO)<sub>3</sub>BH, AcOH; (b) Boc<sub>2</sub>O, MeOH, <i>t</i>-BuOH; (c) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF; (<b>7a</b>,<b>b</b>) (iii) TFA, CHCl<sub>3</sub>.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, aniline; (b) (COCl)<sub>2</sub>, 4-chloroaniline, cat. DMF, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>; (c) aq NaOH, MeOH; (d) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) SOCl<sub>2</sub>, MeOH; (b) K<sub>2</sub>CO<sub>3</sub>, DMF; (c) aq NaOH, MeOH; (d) (i) PyBOP, DIPEA, H<sub>2</sub>NOTHP, THF; (ii) cat. HCl, THF.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding modes in HDAC8: (a) reference inhibitor <b>1</b>, (b) benzamidohydroxamic acid <b>2</b>, (c) corresponding quinoline derivative <b>3</b>, and (d) 3-aminobenzhydroxamic acid derivative <b>4</b>. Side chains of active site residues are shown as white sticks and the ligands as yellow sticks. The zinc ion is depicted as cyan ball, while cocrystallized water molecules are shown as red spheres. Hydrogen bonds are shown as yellow dashed lines, and coordination of the zinc ion is shown as pale-cyan dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding mode of the most potent HDAC8 inhibitors: (a) 4-methoxy-3-benzylaminobenzhydroxamic acid <b>8b</b>, (b) 2,4-dichlorobenzylaminobenzhydroxamic acid derivative <b>8f</b>, (c) inverted amide derivative <b>12b</b>, and (d) 3-benzyloxybenzhydroxamic acid derivative <b>20a</b> in human HDAC8. Ligands are colored in yellow, side chains of active site residues are shown as white sticks, the zinc ion is depicted as cyan ball, while the cocrystallized water molecule is shown as red balls. Hydrogen bonds are shown as yellow dashed lines, and coordination of the zinc ion is shown as pale-cyan dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular target engagement and selectivity. (A) Acetylation of SMC3, α-tubulin, and histone H3 is shown in Western blots of whole-cell lysates 6 h after treatment of BE(2)-C cells with 10 μM <b>3</b>, <b>8a</b>, <b>8b</b>, <b>8f</b>, or <b>20a</b>. HSC70, tubulin, histone H3, β-actin, and Ponceau staining were used as a loading control. (B) The normalized ratios from three independent experiments are shown in the bar graphs on the right.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/medium/jm-2017-01447a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. The developed HDAC inhibitors decrease clonogenic growth capacity as well as metabolic activity and induce signs of neuronal differentiation in BE(2)-C neuroblastoma cells. (A) Colonies were stained (pictures) and quantified (bar diagram). Where treatment is indicated, cells were treated with 10 μM compound for 96 h and colonies were stained after another 6 d of growth time. Solvent (DMSO) treatment is marked with a minus sign. (B) Displayed are the IC<sub>50</sub> curves and the calculated metabolic IC<sub>50</sub> values. After 24 h of culture, BE(2)-C cells were treated with the compounds for 72 h. After incubation with WST-8, fluorescence intensity was measured to determine the metabolic activity of the treated cells. (C) Real-time PCR was used to analyze the expression of differentiation markers (<i>CDKN1A</i>, <i>TH</i>, <i>NTRK1</i>). After 24 h of culture, BE(2)-C cells were treated with compounds (6 μM <b>1</b>; 10 μM <b>8b</b>; 10 μM <b>20a</b>) for 72 h. Expression was normalized to solvent (DMSO; marked with a minus sign) treated cells. (D) Immunofluorescent pictures show neurofilament (red) and DAPI (blue) staining of BE(2)-C cells 6 days after treatment with 6 μM <b>1</b>, 10 μM <b>8b</b>, 10 μM <b>20a</b> (scale bar = 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01447/20171221/images/large/jm-2017-01447a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01447&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 65 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Matthay, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiermacher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackall, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">Neuroblastoma</span> <span class="citation_source-journal">Nat. Rev. Dis. Primers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">16078</span><span class="refDoi"> DOI: 10.1038/nrdp.2016.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnrdp.2016.78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27830764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC2snkslKjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=16078&author=K.+K.+Matthayauthor=J.+M.+Marisauthor=G.+Schleiermacherauthor=A.+Nakagawaraauthor=C.+L.+Mackallauthor=L.+Dillerauthor=W.+A.+Weiss&title=Neuroblastoma&doi=10.1038%2Fnrdp.2016.78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroblastoma</span></div><div class="casAuthors">Matthay Katherine K; Weiss William A; Matthay Katherine K; Weiss William A; Maris John M; Maris John M; Schleiermacher Gudrun; Nakagawara Akira; Mackall Crystal L; Diller Lisa; Diller Lisa; Weiss William A</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16078</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuroblastoma is the most common extracranial solid tumour occurring in childhood and has a diverse clinical presentation and course depending on the tumour biology.  Unique features of these neuroendocrine tumours are the early age of onset, the high frequency of metastatic disease at diagnosis and the tendency for spontaneous regression of tumours in infancy.  The most malignant tumours have amplification of the MYCN oncogene (encoding a transcription factor), which is usually associated with poor survival, even in localized disease.  Although transgenic mouse models have shown that MYCN overexpression can be a tumour-initiating factor, many other cooperating genes and tumour suppressor genes are still under investigation and might also have a role in tumour development.  Segmental chromosome alterations are frequent in neuroblastoma and are associated with worse outcome.  The rare familial neuroblastomas are usually associated with germline mutations in ALK, which is mutated in 10-15% of primary tumours, and provides a potential therapeutic target.  Risk-stratified therapy has facilitated the reduction of therapy for children with low-risk and intermediate-risk disease.  Advances in therapy for patients with high-risk disease include intensive induction chemotherapy and myeloablative chemotherapy, followed by the treatment of minimal residual disease using differentiation therapy and immunotherapy; these have improved 5-year overall survival to 50%.  Currently, new approaches targeting the noradrenaline transporter, genetic pathways and the tumour microenvironment hold promise for further improvements in survival and long-term quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQdT7LUUfcj9K0qsdY6Nc1fW6udTcc2ea-wbCglg8Uvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snkslKjug%253D%253D&md5=532f7d7b32c15182fa6b366c5470f3b5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2016.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2016.78%26sid%3Dliteratum%253Aachs%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DSchleiermacher%26aufirst%3DG.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DMackall%26aufirst%3DC.%2BL.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DNeuroblastoma%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2016%26volume%3D2%26spage%3D16078%26doi%3D10.1038%2Fnrdp.2016.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Applebaum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volchenboum, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, S. L.</span><span> </span><span class="NLM_article-title">Second malignancies in patients with neuroblastoma: the effects of risk-based therapy</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1002/pbc.25249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fpbc.25249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ktVyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=128-133&author=M.+A.+Applebaumauthor=T.+O.+Hendersonauthor=S.+M.+Leeauthor=N.+Pintoauthor=S.+L.+Volchenboumauthor=S.+L.+Cohn&title=Second+malignancies+in+patients+with+neuroblastoma%3A+the+effects+of+risk-based+therapy&doi=10.1002%2Fpbc.25249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Second malignancies in patients with neuroblastoma: the effects of risk-based therapy</span></div><div class="casAuthors">Applebaum Mark A; Henderson Tara O; Lee Sang Mee; Pinto Navin; Volchenboum Samuel L; Cohn Susan L</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  To investigate the incidence of second malignant neoplasms (SMN) for patients with neuroblastoma, we analyzed patients from the SEER database according to three treatment eras (Era 1: 1973-1989, Era 2: 1990-1996, and Era 3: 1997-2006) corresponding to the introduction of multi-agent chemotherapy, risk-based treatment, and stem cell transplant.  PROCEDURES:  The SEER database was mined for all patients with neuroblastoma or ganglioneuroblastoma.  Cumulative incidence of SMN was calculated with death as a competing risk.  A poisson regression model was used to estimate incidence rate ratios and 95% confidence intervals to compare the rates of SMN between patients in different Eras.  RESULTS:  The analytic cohort included 2,801 patients.  Thirty-four patients developed a SMN, accounting for 1.2% of all patients.  Of the patients who developed a SMN, 47.1% received radiation for their primary neuroblastoma.  Fourteen of the SMN were carcinomas, and 10 were hematologic malignancies, with six cases of acute myelogenous leukemia.  There was no difference in the incidence of SMN in Era 1 compared to Era 3 (P = 0.48).  The cumulative incidence of SMN at 30 years for high-risk patients was 10.44% (95% CI 3.98-20.52%) compared to 3.57% (95% CI 1.87-6.12%) for non-high-risk patients (P < 0.001).  CONCLUSIONS:  This study showed no increase in the incidence of SMNs for children treated in the most recent treatment era as compared to earlier Eras.  However, as the risk for developing SMN does not plateau, the number of SMNs will likely continue to rise in the cohort of patients treated after 1996.  Comprehensive follow-up care for these survivors will be important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDA1hbcBHxjv3jf77P2BG3fW6udTcc2eZ1xan2gUEyALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ktVyrug%253D%253D&md5=b4417f0399494267ca6aaff83bf7aa55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fpbc.25249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.25249%26sid%3Dliteratum%253Aachs%26aulast%3DApplebaum%26aufirst%3DM.%2BA.%26aulast%3DHenderson%26aufirst%3DT.%2BO.%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DPinto%26aufirst%3DN.%26aulast%3DVolchenboum%26aufirst%3DS.%2BL.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26atitle%3DSecond%2520malignancies%2520in%2520patients%2520with%2520neuroblastoma%253A%2520the%2520effects%2520of%2520risk-based%2520therapy%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2015%26volume%3D62%26spage%3D128%26epage%3D133%26doi%3D10.1002%2Fpbc.25249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croucher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolla, V.</span><span> </span><span class="NLM_article-title">Therapeutic targets for neuroblastomas</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1517/14728222.2014.867946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1517%2F14728222.2014.867946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=24387342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=277-292&author=G.+M.+Brodeurauthor=R.+Iyerauthor=J.+L.+Croucherauthor=T.+G.+Zhuangauthor=M.+Higashiauthor=V.+Kolla&title=Therapeutic+targets+for+neuroblastomas&doi=10.1517%2F14728222.2014.867946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for neuroblastomas</span></div><div class="casAuthors">Brodeur, Garrett M.; Iyer, Radhika; Croucher, Jamie L.; Zhuang, Tiangang; Higashi, Mayumi; Kolla, Venkatadri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Neuroblastoma (NB) is the most common and deadly solid tumor in children.  Despite recent improvements, the long-term outlook for high-risk NB is still < 50%.  Further, there is considerable short- and long-term toxicity.  More effective, less toxic therapy is needed, and the development of targeted therapies offers great promise.  Areas covered: Relevant literature was reviewed to identify current and future therapeutic targets that are crit. to malignant transformation and progression of NB.  The potential or actual NB therapeutic targets are classified into four categories: i) genes activated by amplification, mutation, translocation or autocrine overexpression; ii) genes inactivated by deletion, mutation or epigenetic silencing; iii) membrane-assocd. genes expressed on most NBs but few other tissues; or iv) common target genes relevant to NB as well as other tumors.  Expert opinion: Therapeutic approaches have been developed to some of these targets, but many remain untargeted at the present time.  It is unlikely that single targeted agents will be sufficient for long-term cure, at least for high-risk NBs.  The challenge will be how to integrate targeted agents with each other and with conventional therapy to enhance their efficacy, while simultaneously reducing systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ArJGyg75X7Vg90H21EOLACvtfcHk0lgX6YCkJW-qfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1CjtLk%253D&md5=2b4a761c3dfa0eb78f6ff14429a06672</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.867946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.867946%26sid%3Dliteratum%253Aachs%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DIyer%26aufirst%3DR.%26aulast%3DCroucher%26aufirst%3DJ.%2BL.%26aulast%3DZhuang%26aufirst%3DT.%2BG.%26aulast%3DHigashi%26aufirst%3DM.%26aulast%3DKolla%26aufirst%3DV.%26atitle%3DTherapeutic%2520targets%2520for%2520neuroblastomas%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D277%26epage%3D292%26doi%3D10.1517%2F14728222.2014.867946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klempnauer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span> </span><span class="NLM_article-title">Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1038/305245a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F305245a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1983&pages=245-248&author=M.+Schwabauthor=K.+Alitaloauthor=K.+H.+Klempnauerauthor=H.+E.+Varmusauthor=J.+M.+Bishopauthor=F.+Gilbertauthor=G.+Brodeurauthor=M.+Goldsteinauthor=J.+Trent&title=Amplified+DNA+with+limited+homology+to+myc+cellular+oncogene+is+shared+by+human+neuroblastoma+cell+lines+and+a+neuroblastoma+tumour&doi=10.1038%2F305245a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F305245a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F305245a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DAlitalo%26aufirst%3DK.%26aulast%3DKlempnauer%26aufirst%3DK.%2BH.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26aulast%3DGilbert%26aufirst%3DF.%26aulast%3DBrodeur%26aufirst%3DG.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DTrent%26aufirst%3DJ.%26atitle%3DAmplified%2520DNA%2520with%2520limited%2520homology%2520to%2520myc%2520cellular%2520oncogene%2520is%2520shared%2520by%2520human%2520neuroblastoma%2520cell%2520lines%2520and%2520a%2520neuroblastoma%2520tumour%26jtitle%3DNature%26date%3D1983%26volume%3D305%26spage%3D245%26epage%3D248%26doi%3D10.1038%2F305245a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span> </span><span class="NLM_article-title">Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1038/316160a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F316160a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1985&pages=160-162&author=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishop&title=Human+N-myc+gene+contributes+to+neoplastic+transformation+of+mammalian+cells+in+culture&doi=10.1038%2F316160a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F316160a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F316160a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26atitle%3DHuman%2520N-myc%2520gene%2520contributes%2520to%2520neoplastic%2520transformation%2520of%2520mammalian%2520cells%2520in%2520culture%26jtitle%3DNature%26date%3D1985%26volume%3D316%26spage%3D160%26epage%3D162%26doi%3D10.1038%2F316160a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzeschik, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J.</span><span> </span><span class="NLM_article-title">Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1038/308288a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2F308288a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1984&pages=288-291&author=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishopauthor=K.+H.+Grzeschikauthor=S.+L.+Naylorauthor=A.+Y.+Sakaguchiauthor=G.+Brodeurauthor=J.+Trent&title=Chromosome+localization+in+normal+human+cells+and+neuroblastomas+of+a+gene+related+to+c-myc&doi=10.1038%2F308288a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F308288a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F308288a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26aulast%3DGrzeschik%26aufirst%3DK.%2BH.%26aulast%3DNaylor%26aufirst%3DS.%2BL.%26aulast%3DSakaguchi%26aufirst%3DA.%2BY.%26aulast%3DBrodeur%26aufirst%3DG.%26aulast%3DTrent%26aufirst%3DJ.%26atitle%3DChromosome%2520localization%2520in%2520normal%2520human%2520cells%2520and%2520neuroblastomas%2520of%2520a%2520gene%2520related%2520to%2520c-myc%26jtitle%3DNature%26date%3D1984%26volume%3D308%26spage%3D288%26epage%3D291%26doi%3D10.1038%2F308288a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, J. M.</span><span> </span><span class="NLM_article-title">Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span><span class="refDoi"> DOI: 10.1126/science.6719137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1126%2Fscience.6719137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=6719137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADyaL2c7ps1Chtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=1984&pages=1121-1124&author=G.+M.+Brodeurauthor=R.+C.+Seegerauthor=M.+Schwabauthor=H.+E.+Varmusauthor=J.+M.+Bishop&title=Amplification+of+N-myc+in+untreated+human+neuroblastomas+correlates+with+advanced+disease+stage&doi=10.1126%2Fscience.6719137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage</span></div><div class="casAuthors">Brodeur G M; Seeger R C; Schwab M; Varmus H E; Bishop J M</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">4653</span>),
    <span class="NLM_cas:pages">1121-4</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A domain of DNA designated N-myc is amplified 20- to 140-fold in human neuroblastoma cell lines but not in cell lines from other tumor types.  N-myc has now been found to be amplified in neuroblastoma tissue from 24 of 63 untreated patients (38 percent).  The extent of amplification appears to be bimodal, with amplification of 100- to 300-fold in 12 cases and 3- to 10-fold in 10 others.  Amplification was found in 0 of 15 patients with stage 1 or 2 disease, whereas 24 of 48 cases (50 percent) with stage 3 or 4 had evidence of N-myc amplification.  These data indicate that N-myc amplification is a common event in untreated human neuroblastomas.  Furthermore, N-myc amplification is highly correlated with advanced stages of disease (P less than 0.001) and with the ability to grow in vitro as an established cell line, both of which are associated with a poor prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ87Kw6s8IBfftos8R3JUhXfW6udTcc2ebq9GDU_SubV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7ps1Chtw%253D%253D&md5=8920f3fcf76f0f8ae977a839a36c04b0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.6719137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6719137%26sid%3Dliteratum%253Aachs%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DSeeger%26aufirst%3DR.%2BC.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26aulast%3DBishop%26aufirst%3DJ.%2BM.%26atitle%3DAmplification%2520of%2520N-myc%2520in%2520untreated%2520human%2520neuroblastomas%2520correlates%2520with%2520advanced%2520disease%2520stage%26jtitle%3DScience%26date%3D1984%26volume%3D224%26spage%3D1121%26epage%3D1124%26doi%3D10.1126%2Fscience.6719137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1038/nature07261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnature07261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=18724359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene&doi=10.1038%2Fnature07261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ALK as a major familial neuroblastoma predisposition gene</span></div><div class="casAuthors">Mosse, Yael P.; Laudenslager, Marci; Longo, Luca; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Perri, Patrizia; Laureys, Genevieve; Speleman, Frank; Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon; Torkamani, Ali; Schork, Nicholas J.; Brodeur, Garrett M.; Tonini, Gian P.; Rappaport, Eric; Devoto, Marcella; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">930-935</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma is a childhood cancer that can be inherited, but the genetic etiol. is largely unknown.  Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired.  We first identified a significant linkage signal at chromosome bands 2p23-24 using a whole-genome scan in neuroblastoma pedigrees.  Re-sequencing of regional candidate genes identified three sep. germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight sep. families.  Re-sequencing in 194 high-risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples.  Nine of the ten mutations map to crit. regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers.  Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK mRNA resulted in profound inhibition of growth in all cell lines harboring mutant or amplified ALK, as well as in two out of six wild-type cell lines for ALK.  Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell-surface kinase is a tractable therapeutic target for this lethal pediatric malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNOcIFf5xjbVg90H21EOLACvtfcHk0ljeNWHmlSgwSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP&md5=bb998ef8f6bfbd85f928263e13954ce4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature07261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07261%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935%26doi%3D10.1038%2Fnature07261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1016/j.canlet.2010.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.canlet.2010.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=20934803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=81-94&author=E.+Ardiniauthor=P.+Magnaghiauthor=P.+Orsiniauthor=A.+Galvaniauthor=M.+Menichincheri&title=Anaplastic+Lymphoma+Kinase%3A+role+in+specific+tumours%2C+and+development+of+small+molecule+inhibitors+for+cancer+therapy&doi=10.1016%2Fj.canlet.2010.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic Lymphoma Kinase: Role in specific tumours, and development of small molecule inhibitors for cancer therapy</span></div><div class="casAuthors">Ardini, E.; Magnaghi, P.; Orsini, P.; Galvani, A.; Menichincheri, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-94</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase first identified as the product of a gene rearrangement in Anaplastic Large Cell Lymphoma.  ALK has subsequently been found to be rearranged, mutated, or amplified in a further series of tumors including neuroblastoma, and Non-Small Cell Lung Cancer.  There is strong preclin. evidence that ALK is a driving force for oncogenesis in these cases, and that inhibition of ALK kinase activity results in anti-tumoral efficacy.  These observations have sparked the development of small mol. kinase inhibitors, the most advanced of which is currently in clin. testing and which has shown promising preliminary activity in the subset of lung cancer patients whose tumors harbor activated ALK.  In this review, we describe the various oncogenic forms of ALK, relevant clin. settings, and give a detailed overview of current drug discovery efforts in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw80IgX8jf7rVg90H21EOLACvtfcHk0ljeNWHmlSgwSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7vF&md5=9b72a030b1c4e3c90c0e570ce0c48f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DMenichincheri%26aufirst%3DM.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520role%2520in%2520specific%2520tumours%252C%2520and%2520development%2520of%2520small%2520molecule%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2010%26volume%3D299%26spage%3D81%26epage%3D94%26doi%3D10.1016%2Fj.canlet.2010.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogarty, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, S. L.</span><span> </span><span class="NLM_article-title">Neuroblastoma</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">2106</span><span class="NLM_x">–</span> <span class="NLM_lpage">2120</span><span class="refDoi"> DOI: 10.1016/S0140-6736(07)60983-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS0140-6736%2807%2960983-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=17586306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVKqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=2106-2120&author=J.+M.+Marisauthor=M.+D.+Hogartyauthor=R.+Bagatellauthor=S.+L.+Cohn&title=Neuroblastoma&doi=10.1016%2FS0140-6736%2807%2960983-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroblastoma</span></div><div class="casAuthors">Maris, John M.; Hogarty, Michael D.; Bagatell, Rochelle; Cohn, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">9579</span>),
    <span class="NLM_cas:pages">2106-2120</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. hallmark of neuroblastoma is heterogeneity, with the likelihood of cure varying widely according to age at diagnosis, extent of disease, and tumor biol.  A subset of tumors will undergo spontaneous regression while others show relentless progression.  Around half of all cases are currently classified as high-risk for disease relapse, with overall survival rates less than 40% despite intensive multimodal therapy.  This Seminar focuses on recent advances in our understanding of the biol. of this complex pediatric solid tumor.  We outline plans for the development of a uniform International Neuroblastoma Risk Group (INRG) classification system, and summarize strategies for risk-based therapies.  We also update readers on new discoveries related to the underlying mol. pathogenesis of this tumor, with special emphasis on advances that are translatable to the clinic.  Finally, we discuss new approaches to treatment, including recently discovered mol. targets that might provide more effective treatment strategies with the potential for less toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5PXEdfjVYN7Vg90H21EOLACvtfcHk0lgU4udbf9dIJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVKqtb0%253D&md5=bb569d774aae58d605b4eee46ef2229a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2960983-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252960983-0%26sid%3Dliteratum%253Aachs%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DHogarty%26aufirst%3DM.%2BD.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26atitle%3DNeuroblastoma%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D2106%26epage%3D2120%26doi%3D10.1016%2FS0140-6736%2807%2960983-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">The clinical development of histone deacetylase inhibitors as targeted anticancer drugs</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span><span class="refDoi"> DOI: 10.1517/13543784.2010.510514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1517%2F13543784.2010.510514" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1049-1066&author=P.+A.+Marks&title=The+clinical+development+of+histone+deacetylase+inhibitors+as+targeted+anticancer+drugs&doi=10.1517%2F13543784.2010.510514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543784.2010.510514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2010.510514%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DThe%2520clinical%2520development%2520of%2520histone%2520deacetylase%2520inhibitors%2520as%2520targeted%2520anticancer%2520drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D1049%26epage%3D1066%26doi%3D10.1517%2F13543784.2010.510514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span><span class="refDoi"> DOI: 10.1038/nrd2133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnrd2133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=16955068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors&doi=10.1038%2Fnrd2133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of histone deacetylase inhibitors</span></div><div class="casAuthors">Bolden, Jessica E.; Peart, Melissa J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">769-784</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and have a key role in the epigenetic regulation of gene expression.  In addn., the activity of non-histone proteins can be regulated through HDAC-mediated hypo-acetylation.  In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes assocd. with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclin. studies.  However, such studies have also indicated that the effects of HDAC inhibitors could be considerably broader and more complicated than originally understood.  Here we summarize recent advances in the understanding of the mol. events that underlie the anticancer effects of HDAC inhibitors, and discuss how such information could be used in optimizing the development and application of these agents in the clinic, either as monotherapies or in combination with other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhfqS1awkOHbVg90H21EOLACvtfcHk0lgU4udbf9dIJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D&md5=91e55ee942fda3e4e2055ddf299fc866</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2133%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D769%26epage%3D784%26doi%3D10.1038%2Fnrd2133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wagner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackanson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubbert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1007/s13148-010-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1007%2Fs13148-010-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21258646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeqsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=117-136&author=J.+M.+Wagnerauthor=B.+Hackansonauthor=M.+Lubbertauthor=M.+Jung&title=Histone+deacetylase+%28HDAC%29+inhibitors+in+recent+clinical+trials+for+cancer+therapy&doi=10.1007%2Fs13148-010-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy</span></div><div class="casAuthors">Wagner, Julia M.; Hackanson, Bjoern; Luebbert, Michael; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">117-136</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7075</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Heritable changes in gene expression that are not based upon alterations in the DNA sequence are defined as epigenetics.  The most common mechanisms of epigenetic regulation are the methylation of CpG islands within the DNA and the modification of amino acids in the N-terminal histone tails.  In the last years, it became evident that the onset of cancer and its progression may not occur only due to genetic mutations but also because of changes in the patterns of epigenetic modifications.  In contrast to genetic mutations, which are almost impossible to reverse, epigenetic changes are potentially reversible.  This implies that they are amenable to pharmacol. interventions.  Therefore, a lot of work in recent years has focussed on the development of small mol. enzyme inhibitors like DNA-methyltransferase inhibitors or inhibitors of histone-modifying enzymes.  These may reverse misregulated epigenetic states and be implemented in the treatment of cancer or other diseases, e.g., neurol. disorders.  Today, several epigenetic drugs are already approved by the FDA and the EMEA for cancer treatment and around ten histone deacetylase (HDAC) inhibitors are in clin. development.  This review will give an update on recent clin. trials of the HDAC inhibitors used systemically that were reported in 2009 and 2010 and will present an overview of different biomarkers to monitor the biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62EyFQbmSEbVg90H21EOLACvtfcHk0lgU4udbf9dIJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeqsrrF&md5=c2b02cc37f94c85c4496822b9bf13af9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs13148-010-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13148-010-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%2BM.%26aulast%3DHackanson%26aufirst%3DB.%26aulast%3DLubbert%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520in%2520recent%2520clinical%2520trials%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Epigenet.%26date%3D2010%26volume%3D1%26spage%3D117%26epage%3D136%26doi%3D10.1007%2Fs13148-010-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deubzer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hero, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp-Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span> </span><span class="NLM_article-title">Histone deacetylase 8 in neuroblastoma tumorigenesis</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1158%2F1078-0432.CCR-08-0684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=19118036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Cjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=91-99&author=I.+Oehmeauthor=H.+E.+Deubzerauthor=D.+Wegenerauthor=D.+Pickertauthor=J.+P.+Linkeauthor=B.+Heroauthor=A.+Kopp-Schneiderauthor=F.+Westermannauthor=S.+M.+Ulrichauthor=A.+von+Deimlingauthor=M.+Fischerauthor=O.+Witt&title=Histone+deacetylase+8+in+neuroblastoma+tumorigenesis&doi=10.1158%2F1078-0432.CCR-08-0684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase 8 in Neuroblastoma Tumorigenesis</span></div><div class="casAuthors">Oehme, Ina; Deubzer, Hedwig E.; Wegener, Dennis; Pickert, Diana; Linke, Jan-Peter; Hero, Barbara; Kopp-Schneider, Annette; Westermann, Frank; Ulrich, Scott M.; von Deimling, Andreas; Fischer, Matthias; Witt, Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The effects of pan-histone deacetylase (HDAC) inhibitors on cancer cells have shown that HDACs are involved in fundamental tumor biol. processes such as cell cycle control, differentiation, and apoptosis.  However, because of the unselective nature of these compds., little is known about the contribution of individual HDAC family members to tumorigenesis and progression.  The purpose of this study was to evaluate the role of individual HDACs in neuroblastoma tumorigenesis.  Exptl. Design: We have investigated the mRNA expression of all HDAC1-11 family members in a large cohort of primary neuroblastoma samples covering the full spectrum of the disease.  HDACs assocd. with disease stage and survival were subsequently functionally evaluated in cell culture models.  RESULTS: Only HDAC8 expression was significantly correlated with advanced disease and metastasis and down-regulated in stage 4S neuroblastoma assocd. with spontaneous regression.  High HDAC8 expression was assocd. with poor prognostic markers and poor overall and event-free survival.  The knockdown of HDAC8 resulted in the inhibition of proliferation, reduced clonogenic growth, cell cycle arrest, and differentiation in cultured neuroblastoma cells.  The treatment of neuroblastoma cell lines as well as short-term-culture neuroblastoma cells with an HDAC8-selective small-mol. inhibitor inhibited cell proliferation and clone formation, induced differentiation, and thus reproduced the HDAC8 knockdown phenotype.  Global histone 4 acetylation was not affected by HDAC8 knockdown or by selective inhibitor treatment.  CONCLUSIONS: Our data point toward an important role of HDAC8 in neuroblastoma pathogenesis and identify this HDAC family member as a specific drug target for the differentiation therapy of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsN9HmNgpdA7Vg90H21EOLACvtfcHk0lgUAyUG90Y8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Cjuw%253D%253D&md5=8c8e0b989c0036b233332a74a355dece</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0684%26sid%3Dliteratum%253Aachs%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DPickert%26aufirst%3DD.%26aulast%3DLinke%26aufirst%3DJ.%2BP.%26aulast%3DHero%26aufirst%3DB.%26aulast%3DKopp-Schneider%26aufirst%3DA.%26aulast%3DWestermann%26aufirst%3DF.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DWitt%26aufirst%3DO.%26atitle%3DHistone%2520deacetylase%25208%2520in%2520neuroblastoma%2520tumorigenesis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D91%26epage%3D99%26doi%3D10.1158%2F1078-0432.CCR-08-0684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Waltregny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leval, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenisson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly Tran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellahcene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidle, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castronovo, V.</span><span> </span><span class="NLM_article-title">Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)63320-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS0002-9440%2810%2963320-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15277229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFWjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=553-564&author=D.+Waltregnyauthor=L.+De+Levalauthor=W.+Glenissonauthor=S.+Ly+Tranauthor=B.+J.+Northauthor=A.+Bellahceneauthor=U.+Weidleauthor=E.+Verdinauthor=V.+Castronovo&title=Expression+of+histone+deacetylase+8%2C+a+class+I+histone+deacetylase%2C+is+restricted+to+cells+showing+smooth+muscle+differentiation+in+normal+human+tissues&doi=10.1016%2FS0002-9440%2810%2963320-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues</span></div><div class="casAuthors">Waltregny, David; de Leval, Laurence; Glenisson, Wendy; Tran, Siv Ly; North, Brian J.; Bellahcene, Akeila; Weidle, Ulrich; Verdin, Eric; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) were originally identified as nuclear enzymes involved in gene transcription regulation.  Until recently, it was thought that their activity was restricted within the nucleus, with histones as unique substrates.  The demonstration that specific HDACs deacetylate nonhistone proteins, such as p53 and α-tubulin, broadened the field of activity of these enzymes.  HDAC8, a class I HDAC, is considered to be ubiquitously expressed, as suggested by results of Northern blots performed on tissue RNA exts., and transfection expts. using various cell lines have indicated that this enzyme may display a prominent nuclear localization.  Using immunohistochem., we unexpectedly found that, in normal human tissues, HDAC8 is exclusively expressed by cells showing smooth muscle differentiation, including visceral and vascular smooth muscle cells, myoepithelial cells, and myofibroblasts, and is mainly detected in their cytosol.  These findings were confirmed in vitro by nucleo-cytoplasmic fractionation and immunoblot expts. performed on human primary smooth muscle cells and by the cytosolic detection of epitope-tagged HDAC8 overexpressed in fibroblasts.  Immunocytochem. strongly suggested a cytoskeleton-like distribution of the enzyme.  Further double-immunofluorescence staining expts. coupled with confocal microscopy anal. showed that epitope-tagged HDAC8 overexpressed in murine fibroblasts formed cytoplasmic stress fiber-like structures that co-localized with the smooth muscle cytoskeleton protein smooth muscle α-actin.  Our works represent the first demonstration of the restricted expression of a class I HDAC to a specific cell type and indicate that HDAC8, besides being a novel marker of smooth muscle differentiation, may play a role in the biol. of these contractile cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpOq75rK-D27Vg90H21EOLACvtfcHk0lgUAyUG90Y8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFWjsrg%253D&md5=732e18585b7a3917e81a7b9f9560f94e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963320-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963320-2%26sid%3Dliteratum%253Aachs%26aulast%3DWaltregny%26aufirst%3DD.%26aulast%3DDe%2BLeval%26aufirst%3DL.%26aulast%3DGlenisson%26aufirst%3DW.%26aulast%3DLy%2BTran%26aufirst%3DS.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DBellahcene%26aufirst%3DA.%26aulast%3DWeidle%26aufirst%3DU.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DExpression%2520of%2520histone%2520deacetylase%25208%252C%2520a%2520class%2520I%2520histone%2520deacetylase%252C%2520is%2520restricted%2520to%2520cells%2520showing%2520smooth%2520muscle%2520differentiation%2520in%2520normal%2520human%2520tissues%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D553%26epage%3D564%26doi%3D10.1016%2FS0002-9440%2810%2963320-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Waltregny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenisson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colige, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castronovo, V.</span><span> </span><span class="NLM_article-title">Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1096/fj.04-2303fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1096%2Ffj.04-2303fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15772115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=966-968&author=D.+Waltregnyauthor=W.+Glenissonauthor=S.+L.+Tranauthor=B.+J.+Northauthor=E.+Verdinauthor=A.+Coligeauthor=V.+Castronovo&title=Histone+deacetylase+HDAC8+associates+with+smooth+muscle+alpha-actin+and+is+essential+for+smooth+muscle+cell+contractility&doi=10.1096%2Ffj.04-2303fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle cell contractility</span></div><div class="casAuthors">Waltregny, David; Glenisson, Wendy; Tran, Siv Ly; North, Brian J.; Verdin, Eric; Colige, Alain; Castronovo, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">966-968, 10.1096/fj.04-2303fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Although originally characterized as nuclear enzymes controlling the stability of nucleosomes, histone deacetylases (HDACs) may also exert their activity within the cytosol.  Recently, we have demonstrated that HDAC8, a class I HDAC, is a novel, prominently cytosolic marker of smooth muscle differentiation.  As HDAC8 displays a striking stress fiber-like pattern of distribution and is coexpressed in vivo with smooth muscle α-actin (α-SMA) and smooth muscle myosin heavy chain, we have explored the possible participation of this HDAC in smooth muscle cytoskeleton regulation.  Cell fractionation assays performed with primary human smooth muscle cells (HSMCs) showed that HDAC8, in contrast to HDAC1 and HDAC3, was enriched in cytoskeleton-bound protein fractions and insol. cell pellets, suggesting an assocn. of HDAC8 with the cytoskeleton.  Coimmunopptn. expts. using HSMCs, NIH-3T3 cells, and human prostate tissue lysates further demonstrated that HDAC8 assocs. with α-SMA but not with β-actin.  HDAC8 silencing through RNA interference strongly reduced the capacity of HSMCs to contract collagen lattices.  Mock transfections had no effect on HSMC contractility, and transfections with small interfering RNAs (siRNAs) specific for HDAC6, a cytosolic HDAC that functions as an α-tubulin deacetylase, resulted in a weak contraction inhibition.  Although mock- and HDAC6 siRNA-transfected HSMCs showed no noticeable morphol. changes, HDAC8 siRNA-transfected HSMCs displayed a size redn. with diminished cell spreading after replating.  Altogether, our findings indicate that HDAC8 assocs. with the smooth muscle actin cytoskeleton and may regulate the contractile capacity of smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgU-_XQBcSZLVg90H21EOLACvtfcHk0lgUAyUG90Y8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVaguro%253D&md5=a279fcbb0866cf8b90d9a6d288719c45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-2303fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-2303fje%26sid%3Dliteratum%253Aachs%26aulast%3DWaltregny%26aufirst%3DD.%26aulast%3DGlenisson%26aufirst%3DW.%26aulast%3DTran%26aufirst%3DS.%2BL.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DColige%26aufirst%3DA.%26aulast%3DCastronovo%26aufirst%3DV.%26atitle%3DHistone%2520deacetylase%2520HDAC8%2520associates%2520with%2520smooth%2520muscle%2520alpha-actin%2520and%2520is%2520essential%2520for%2520smooth%2520muscle%2520cell%2520contractility%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D966%26epage%3D968%26doi%3D10.1096%2Ffj.04-2303fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">HDAC8: a multifaceted target for therapeutic interventions</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.tips.2015.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=26013035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=481-492&author=A.+Chakrabartiauthor=I.+Oehmeauthor=O.+Wittauthor=G.+Oliveiraauthor=W.+Sipplauthor=C.+Romierauthor=R.+J.+Pierceauthor=M.+Jung&title=HDAC8%3A+a+multifaceted+target+for+therapeutic+interventions&doi=10.1016%2Fj.tips.2015.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC8: a multifaceted target for therapeutic interventions</span></div><div class="casAuthors">Chakrabarti, Alokta; Oehme, Ina; Witt, Olaf; Oliveira, Guilherme; Sippl, Wolfgang; Romier, Christophe; Pierce, Raymond J.; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">481-492</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 8 (HDAC8) is a class I histone deacetylase implicated as a therapeutic target in various diseases, including cancer, X-linked intellectual disability, and parasitic infections.  It is a structurally well-characterized enzyme that also deacetylates nonhistone proteins.  In cancer, HDAC8 is a major 'epigenetic player' that is linked to deregulated expression or interaction with transcription factors crit. to tumorigenesis.  In the parasite Schistosoma mansoni and in viral infections, HDAC8 is a novel target to subdue infection.  The current challenge remains in the development of potent selective inhibitors that would specifically target HDAC8 with fewer adverse effects compared with pan-HDAC inhibitors.  Here, we review HDAC8 as a drug target and discuss inhibitors with respect to their structural features and therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPwG01nKtWHLVg90H21EOLACvtfcHk0ljt7Xmh3YGH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGqsL4%253D&md5=c99b5c390930dc17398d15f20127758b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DHDAC8%253A%2520a%2520multifaceted%2520target%2520for%2520therapeutic%2520interventions%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D481%26epage%3D492%26doi%3D10.1016%2Fj.tips.2015.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">HDAC8 functions in spindle assembly during mouse oocyte meiosis</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">20092</span><span class="NLM_x">–</span> <span class="NLM_lpage">20102</span><span class="refDoi"> DOI: 10.18632/oncotarget.15383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.18632%2Foncotarget.15383" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=20092-20102&author=K.+Zhangauthor=Y.+Luauthor=C.+Jiangauthor=W.+Liuauthor=J.+Shuauthor=X.+Chenauthor=Y.+Shiauthor=E.+Wangauthor=L.+Wangauthor=Q.+Huauthor=Y.+Daiauthor=B.+Xiong&title=HDAC8+functions+in+spindle+assembly+during+mouse+oocyte+meiosis&doi=10.18632%2Foncotarget.15383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15383%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DHDAC8%2520functions%2520in%2520spindle%2520assembly%2520during%2520mouse%2520oocyte%2520meiosis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D20092%26epage%3D20102%26doi%3D10.18632%2Foncotarget.15383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ahn, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span> </span><span class="NLM_article-title">Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.3892/or.2016.5280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.3892%2For.2016.5280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28004115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FnsVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=540-546&author=M.+Y.+Ahnauthor=J.+H.+Yoon&title=Histone+deacetylase+8+as+a+novel+therapeutic+target+in+oral+squamous+cell+carcinoma&doi=10.3892%2For.2016.5280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma</span></div><div class="casAuthors">Ahn Mee-Young; Yoon Jung-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">540-546</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The overexpression of histone deacetylases (HDACs) has been observed in many cancers and inhibition of specific HDAC has emerged as a new target for cancer therapy.  The present study examined the expression of HDAC8 and the inhibitory effect of HDAC8 in oral squamous cell carcinoma (OSCC).  The expression of HDAC8 was measured in human OSCC tissues and OSCC cell lines using immunohistochemistry and immunoblotting.  HDAC8 was knocked down in OSCC cells by transfection with HDAC8 siRNAs and cell proliferation was quantified.  Apoptosis and autophagy were measured using flow cytometry and immunoblotting.  HDAC8 were overexpressed in OSCC tissues and OSCC cells, mainly localized in the cytoplasm.  HDAC8 siRNAs effectively reduced the level of HDAC8 expression and HDAC8 silencing significantly inhibited the proliferation of OSCC cells.  HDAC8 knockdown induced apoptotic cell death through caspases activation and pro-survival autophagy in OSCC cells.  Combination with HDAC silencing and autophagy inhibition enhanced cell death by increasing apoptosis in OSCC cells.  This study suggests that inhibition of HDAC8 might become a novel therapeutic strategy for OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8yUczl3YjjK__Jf7-eMvJfW6udTcc2eZcu1RG3HmRJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FnsVWlsA%253D%253D&md5=a27ce3d78ba9e6f16b0ef97f6540f579</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3892%2For.2016.5280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2016.5280%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DM.%2BY.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26atitle%3DHistone%2520deacetylase%25208%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D540%26epage%3D546%26doi%3D10.3892%2For.2016.5280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watrin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minamino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saitoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Baere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decroos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Donato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francey, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyftodimou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hullings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaulin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi-Jaulin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seimiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillessen-Kaesbach, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krantz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span> </span><span class="NLM_article-title">HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nature11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnature11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=22885700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOgsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2012&pages=313-317&author=M.+A.+Deardorffauthor=M.+Bandoauthor=R.+Nakatoauthor=E.+Watrinauthor=T.+Itohauthor=M.+Minaminoauthor=K.+Saitohauthor=M.+Komataauthor=Y.+Katouauthor=D.+Clarkauthor=K.+E.+Coleauthor=E.+De+Baereauthor=C.+Decroosauthor=N.+Di+Donatoauthor=S.+Ernstauthor=L.+J.+Franceyauthor=Y.+Gyftodimouauthor=K.+Hirashimaauthor=M.+Hullingsauthor=Y.+Ishikawaauthor=C.+Jaulinauthor=M.+Kaurauthor=T.+Kiyonoauthor=P.+M.+Lombardiauthor=L.+Magnaghi-Jaulinauthor=G.+R.+Mortierauthor=N.+Nozakiauthor=M.+B.+Petersenauthor=H.+Seimiyaauthor=V.+M.+Siuauthor=Y.+Suzukiauthor=K.+Takagakiauthor=J.+J.+Wildeauthor=P.+J.+Willemsauthor=C.+Prigentauthor=G.+Gillessen-Kaesbachauthor=D.+W.+Christiansonauthor=F.+J.+Kaiserauthor=L.+G.+Jacksonauthor=T.+Hirotaauthor=I.+D.+Krantzauthor=K.+Shirahige&title=HDAC8+mutations+in+Cornelia+de+Lange+syndrome+affect+the+cohesin+acetylation+cycle&doi=10.1038%2Fnature11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle</span></div><div class="casAuthors">Deardorff, Matthew A.; Bando, Masashige; Nakato, Ryuichiro; Watrin, Erwan; Itoh, Takehiko; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Clark, Dinah; Cole, Kathryn E.; De Baere, Elfride; Decroos, Christophe; Di Donato, Nataliya; Ernst, Sarah; Francey, Lauren J.; Gyftodimou, Yolanda; Hirashima, Kyotaro; Hullings, Melanie; Ishikawa, Yuuichi; Jaulin, Christian; Kaur, Maninder; Kiyono, Tohru; Lombardi, Patrick M.; Magnaghi-Jaulin, Laura; Mortier, Geert R.; Nozaki, Naohito; Petersen, Michael B.; Seimiya, Hiroyuki; Siu, Victoria M.; Suzuki, Yutaka; Takagaki, Kentaro; Wilde, Jonathan J.; Willems, Patrick J.; Prigent, Claude; Gillessen-Kaesbach, Gabriele; Christianson, David W.; Kaiser, Frank J.; Jackson, Laird G.; Hirota, Toru; Krantz, Ian D.; Shirahige, Katsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">489</span>
        (<span class="NLM_cas:issue">7415</span>),
    <span class="NLM_cas:pages">313-317</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL for nearly 60% of individuals with classical CdLS, and by mutations in the core cohesin components SMC1A (∼5%) and SMC3 (<1%) for a smaller fraction of probands.  In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein.  These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion and also has key roles in gene regulation.  SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin, and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase.  Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands.  Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissoln. of the used' cohesin complex released from chromatin in both prophase and anaphase.  SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunopptn. sequencing anal. demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjfmQ9HBsaFrVg90H21EOLACvtfcHk0lipM6F0k2vqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOgsLnK&md5=27192552507822ccf105587884fb16f4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11316%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DNakato%26aufirst%3DR.%26aulast%3DWatrin%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMinamino%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DK.%26aulast%3DKomata%26aufirst%3DM.%26aulast%3DKatou%26aufirst%3DY.%26aulast%3DClark%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DK.%2BE.%26aulast%3DDe%2BBaere%26aufirst%3DE.%26aulast%3DDecroos%26aufirst%3DC.%26aulast%3DDi%2BDonato%26aufirst%3DN.%26aulast%3DErnst%26aufirst%3DS.%26aulast%3DFrancey%26aufirst%3DL.%2BJ.%26aulast%3DGyftodimou%26aufirst%3DY.%26aulast%3DHirashima%26aufirst%3DK.%26aulast%3DHullings%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DJaulin%26aufirst%3DC.%26aulast%3DKaur%26aufirst%3DM.%26aulast%3DKiyono%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DP.%2BM.%26aulast%3DMagnaghi-Jaulin%26aufirst%3DL.%26aulast%3DMortier%26aufirst%3DG.%2BR.%26aulast%3DNozaki%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DM.%2BB.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DV.%2BM.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DTakagaki%26aufirst%3DK.%26aulast%3DWilde%26aufirst%3DJ.%2BJ.%26aulast%3DWillems%26aufirst%3DP.%2BJ.%26aulast%3DPrigent%26aufirst%3DC.%26aulast%3DGillessen-Kaesbach%26aufirst%3DG.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26aulast%3DKaiser%26aufirst%3DF.%2BJ.%26aulast%3DJackson%26aufirst%3DL.%2BG.%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DKrantz%26aufirst%3DI.%2BD.%26aulast%3DShirahige%26aufirst%3DK.%26atitle%3DHDAC8%2520mutations%2520in%2520Cornelia%2520de%2520Lange%2520syndrome%2520affect%2520the%2520cohesin%2520acetylation%2520cycle%26jtitle%3DNature%26date%3D2012%26volume%3D489%26spage%3D313%26epage%3D317%26doi%3D10.1038%2Fnature11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Structural aspects of HDAC8 mechanism and dysfunction in Cornelia de Lange syndrome spectrum disorders</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1002/pro.3030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fpro.3030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaku73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=1965-1976&author=M.+A.+Deardorffauthor=N.+J.+Porterauthor=D.+W.+Christianson&title=Structural+aspects+of+HDAC8+mechanism+and+dysfunction+in+Cornelia+de+Lange+syndrome+spectrum+disorders&doi=10.1002%2Fpro.3030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Aspects of HDAC8 Mechanism and Dysfunction in Cornelia de Lange Syndrome Spectrum Disorders</span></div><div class="casAuthors">Deardorff, Matthew A.; Porter, Nicholas A.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cornelia de Lange Syndrome (CdLS) encompasses a broad spectrum of phenotypes characterized by distinctive craniofacial abnormalities, limb malformations, growth retardation, and intellectual disability.  CdLS spectrum disorders are referred to as cohesinopathies, with approx. 70% of patients having a mutation in a gene encoding a core cohesin protein (SMC1A, SMC3, or RAD21) or a cohesin regulatory proteins (NIPBL or HDAC8).  Notably, the regulatory function of HDAC8 in cohesin biol. has only recently been discovered.  This Zn2+-dependent hydrolase catalyzes the deacetylation of SMC3, a necessary step for cohesin recycling during the cell cycle.  To date, 23 different missense mutants in the gene encoding HDAC8 have been identified in children with developmental features that overlap those of CdLS.  Enzymol., biophys., and structural studies of CdLS HDAC8 protein mutants have yielded crit. insight on compromised catalysis in vitro.  Most CdLS HDAC8 mutations trigger structural changes that directly or indirectly impact substrate binding and catalysis.  Addnl., several mutations significantly compromise protein thermostability.  Intriguingly, catalytic activity in many HDAC8 mutants can be partially or fully restored by an N-acylthiourea activator, suggesting a plausible strategy for the chem. rescue of compromised HDAC8 catalysis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMxVdwmHSqrbVg90H21EOLACvtfcHk0lipM6F0k2vqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaku73E&md5=6449ec62657ab407b0206ea1e1c7f173</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpro.3030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3030%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DStructural%2520aspects%2520of%2520HDAC8%2520mechanism%2520and%2520dysfunction%2520in%2520Cornelia%2520de%2520Lange%2520syndrome%2520spectrum%2520disorders%26jtitle%3DProtein%2520Sci.%26date%3D2016%26volume%3D25%26spage%3D1965%26epage%3D1976%26doi%3D10.1002%2Fpro.3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Decroos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deardorff, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2157</span><span class="NLM_x">–</span> <span class="NLM_lpage">2164</span><span class="refDoi"> DOI: 10.1021/cb5003762</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5003762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eksLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2157-2164&author=C.+Decroosauthor=C.+M.+Bowmanauthor=J.+A.+Moserauthor=K.+E.+Christiansonauthor=M.+A.+Deardorffauthor=D.+W.+Christianson&title=Compromised+structure+and+function+of+HDAC8+mutants+identified+in+Cornelia+de+Lange+Syndrome+spectrum+disorders&doi=10.1021%2Fcb5003762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Compromised Structure and Function of HDAC8 Mutants Identified in Cornelia de Lange Syndrome Spectrum Disorders</span></div><div class="casAuthors">Decroos, Christophe; Bowman, Christine M.; Moser, Joe-Ann S.; Christianson, Karen E.; Deardorff, Matthew A.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2157-2164</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cornelia de Lange Syndrome (CdLS) is a multiple congenital anomaly disorder resulting from mutations in genes that encode the core components of the cohesin complex, SMC1A, SMC3, and RAD21, or two of its regulatory proteins, NIPBL and HDAC8.  HDAC8 is the human SMC3 lysine deacetylase required for cohesin recycling in the cell cycle.  To date, 16 different missense mutations in HDAC8 have recently been identified in children diagnosed with CdLS.  To understand the mol. effects of these mutations in causing CdLS and overlapping phenotypes, we have fully characterized the structure and function of five HDAC8 mutants: C153F, A188T, I243N, T311M, and H334R.  X-ray crystal structures reveal that each mutation causes local structural changes that compromise catalysis and/or thermostability.  For example, the C153F mutation triggers conformational changes that block acetate product release channels, resulting in only 2% residual catalytic activity.  In contrast, the H334R mutation causes structural changes in a polypeptide loop distant from the active site and results in 91% residual activity, but the thermostability of this mutant is significantly compromised.  Strikingly, the catalytic activity of these mutants can be partially or fully rescued in vitro by the HDAC8 activator N-(phenylcarbamothioyl)benzamide.  These results suggest that HDAC8 activators might be useful leads in the search for new therapeutic strategies in managing CdLS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8dzIXLt_xjrVg90H21EOLACvtfcHk0lipM6F0k2vqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eksLjF&md5=5872ac8e7a5b59c484d879de209a93a9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb5003762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5003762%26sid%3Dliteratum%253Aachs%26aulast%3DDecroos%26aufirst%3DC.%26aulast%3DBowman%26aufirst%3DC.%2BM.%26aulast%3DMoser%26aufirst%3DJ.%2BA.%26aulast%3DChristianson%26aufirst%3DK.%2BE.%26aulast%3DDeardorff%26aufirst%3DM.%2BA.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DCompromised%2520structure%2520and%2520function%2520of%2520HDAC8%2520mutants%2520identified%2520in%2520Cornelia%2520de%2520Lange%2520Syndrome%2520spectrum%2520disorders%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2157%26epage%3D2164%26doi%3D10.1021%2Fcb5003762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisawad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span> </span><span class="NLM_article-title">A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span><span class="refDoi"> DOI: 10.1038/leu.2008.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fleu.2008.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=18256683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1026-1034&author=S.+Balasubramanianauthor=J.+Ramosauthor=W.+Luoauthor=M.+Sirisawadauthor=E.+Vernerauthor=J.+J.+Buggy&title=A+novel+histone+deacetylase+8+%28HDAC8%29-specific+inhibitor+PCI-34051+induces+apoptosis+in+T-cell+lymphomas&doi=10.1038%2Fleu.2008.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas</span></div><div class="casAuthors">Balasubramanian, S.; Ramos, J.; Luo, W.; Sirisawad, M.; Verner, E.; Buggy, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1026-1034</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We have developed a potent, histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 with >200-fold selectivity over the other HDAC isoforms.  PCI-34051 induces caspase-dependent apoptosis in cell lines derived from T-cell lymphomas or leukemias, but not in other hematopoietic or solid tumor lines.  Unlike broad-spectrum HDAC inhibitors, PCI-34051 does not cause detectable histone or tubulin acetylation.  Cells defective in T-cell receptor signaling were still sensitive to PCI-34051-induced apoptosis, whereas a phospholipase C-γ1 (PLCγ1)-defective line was resistant.  Jurkat cells showed a dose-dependent decrease in PCI-34051-induced apoptosis upon treatment with a PLC inhibitor U73122, but not with an inactive analog.  We found that rapid intracellular calcium mobilization from endoplasmic reticulum (ER) and later cytochrome c release from mitochondria are essential for the apoptotic mechanism.  The rapid Ca2+ flux was dependent on PCI-34051 concn., and was blocked by the PLC inhibitor U73122.  Further, apoptosis was blocked by Ca2+ chelators (BAPTA) and enhanced by Ca2+ effectors (thapsigargin), supporting this model.  These studies show that HDAC8-selective inhibitors have a unique mechanism of action involving PLCγ1 activation and calcium-induced apoptosis, and could offer benefits including a greater therapeutic index for treating T-cell malignancies.  Leukemia (2008) 22, 1026-1034; doi:10.1038/leu.2008.9; published online 7 Feb. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-VB4Wb3h1bVg90H21EOLACvtfcHk0lj2YycyNSqpsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSrtr0%253D&md5=03446a05b396ea9497e4f6f9254cae03</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fleu.2008.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2008.9%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSirisawad%26aufirst%3DM.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520novel%2520histone%2520deacetylase%25208%2520%2528HDAC8%2529-specific%2520inhibitor%2520PCI-34051%2520induces%2520apoptosis%2520in%2520T-cell%2520lymphomas%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D1026%26epage%3D1034%26doi%3D10.1038%2Fleu.2008.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">802</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2017.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejphar.2017.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28223126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=802&publication_year=2017&pages=20-26&author=G.+Zhaoauthor=G.+Wangauthor=H.+Baiauthor=T.+Liauthor=F.+Gongauthor=H.+Yangauthor=J.+Wenauthor=W.+Wang&title=Targeted+inhibition+of+HDAC8+increases+the+doxorubicin+sensitivity+of+neuroblastoma+cells+via+up+regulation+of+miR-137&doi=10.1016%2Fj.ejphar.2017.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137</span></div><div class="casAuthors">Zhao, Gang; Wang, Guoliang; Bai, Hongmin; Li, Tiandong; Gong, Fanghe; Yang, Huan; Wen, Jinchong; Wang, Weimin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">802</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) have been suggested to be potential therapeutic targets for cancer treatment.  Recent studies revealed that HDAC8 expression was assocd. with poor prognostic markers and poor overall survival rate of neuroblastoma (NB).  Our present study revealed that among the four members of class I HDACs, HDAC8 is significantly over expressed in NB cells as compared with the normal fibroblast 3T3 cells or primary normal human astrocytes (NHA) cells.  Targeted inhibition of HDAC8 by its specific siRNA (si-HDAC8) can inhibit the in vitro growth of NB cells.  Furthermore, si-HDAC8 significantly increases the sensitivity of NB cells to doxorubicin (Dox).  Silencing of HDAC8 can increase the expression of miR-137, which has been suggested to mediate the Dox sensitivity of NB cells.  Knockdown of miR-137 can attenuate si-HDAC8 enhanced Dox sensitivity.  Further, si-HDAC8 can also inhibit the expression of multi-drug resistance gene 1 (MDR1).  While knockdown of miR-137 can attenuate si-HDAC8 induced down regulation of MDR1.  Collectively, our data revealed that targeted inhibition of HDAC8 can suppress the growth of NB cells and increase Dox sensitivity via up regulation of miR-137 and suppression of MDR1.  Therefor, combination of HDAC8 inhibitor will be helpful to elevate the treatment outcome of NB patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgKOpVYIWCerVg90H21EOLACvtfcHk0lj2YycyNSqpsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGmu70%253D&md5=ef067dab9ddb0ae88505ea7be4969a7b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DTargeted%2520inhibition%2520of%2520HDAC8%2520increases%2520the%2520doxorubicin%2520sensitivity%2520of%2520neuroblastoma%2520cells%2520via%2520up%2520regulation%2520of%2520miR-137%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D802%26spage%3D20%26epage%3D26%26doi%3D10.1016%2Fj.ejphar.2017.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bid, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewdu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. E.</span><span> </span><span class="NLM_article-title">HDAC8, a potential therapeutic target for the treatment of malignant peripheral nerve sheath tumors (MPNST)</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0133302</span><span class="refDoi"> DOI: 10.1371/journal.pone.0133302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.pone.0133302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0133302&author=G.+Lopezauthor=K.+L.+Billauthor=H.+K.+Bidauthor=D.+Braggioauthor=D.+Constantinoauthor=B.+Prudnerauthor=A.+Zewduauthor=K.+Batteauthor=D.+Levauthor=R.+E.+Pollock&title=HDAC8%2C+a+potential+therapeutic+target+for+the+treatment+of+malignant+peripheral+nerve+sheath+tumors+%28MPNST%29&doi=10.1371%2Fjournal.pone.0133302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0133302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0133302%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DBill%26aufirst%3DK.%2BL.%26aulast%3DBid%26aufirst%3DH.%2BK.%26aulast%3DBraggio%26aufirst%3DD.%26aulast%3DConstantino%26aufirst%3DD.%26aulast%3DPrudner%26aufirst%3DB.%26aulast%3DZewdu%26aufirst%3DA.%26aulast%3DBatte%26aufirst%3DK.%26aulast%3DLev%26aufirst%3DD.%26aulast%3DPollock%26aufirst%3DR.%2BE.%26atitle%3DHDAC8%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520malignant%2520peripheral%2520nerve%2520sheath%2520tumors%2520%2528MPNST%2529%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0133302%26doi%3D10.1371%2Fjournal.pone.0133302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rettig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeneke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trippel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burhenne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp-Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernekorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deubzer, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span> </span><span class="NLM_article-title">Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1657</span><span class="refDoi"> DOI: 10.1038/cddis.2015.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fcddis.2015.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25695609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1657&author=I.+Rettigauthor=E.+Koenekeauthor=F.+Trippelauthor=W.+C.+Muellerauthor=J.+Burhenneauthor=A.+Kopp-Schneiderauthor=J.+Fabianauthor=A.+Schoberauthor=U.+Fernekornauthor=A.+von+Deimlingauthor=H.+E.+Deubzerauthor=T.+Mildeauthor=O.+Wittauthor=I.+Oehme&title=Selective+inhibition+of+HDAC8+decreases+neuroblastoma+growth+in+vitro+and+in+vivo+and+enhances+retinoic+acid-mediated+differentiation&doi=10.1038%2Fcddis.2015.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation</span></div><div class="casAuthors">Rettig, I.; Koeneke, E.; Trippel, F.; Mueller, W. C.; Burhenne, J.; Kopp-Schneider, A.; Fabian, J.; Schober, A.; Fernekorn, U.; von Deimling, A.; Deubzer, H. E.; Milde, T.; Witt, O.; Oehme, I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1657</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For differentiation-defective malignancies, compds. that modulate transcription, such as retinoic acid and histone deacetylase (HDAC) inhibitors, are of particular interest.  HDAC inhibitors are currently under investigation for the treatment of a broad spectrum of cancer diseases.  However, one clin. drawback is class-specific toxicity of unselective inhibitors, limiting their full anticancer potential.  Selective targeting of individual HDAC isoenzymes in defined tumor entities may therefore be an attractive alternative treatment approach.  We have previously identified HDAC family member 8 (HDAC8) as a novel target in childhood neuroblastoma.  Using small-mol. inhibitors, we now demonstrate that selective inhibition of HDAC8 exhibits antineuroblastoma activity without toxicity in two xenograft mouse models of MYCN oncogene-amplified neuroblastoma.  In contrast, the unselective HDAC inhibitor vorinostat was more toxic in the same models.  HDAC8-selective inhibition induced cell cycle arrest and differentiation in vitro and in vivo.  Upon combination with retinoic acid, differentiation was significantly enhanced, as demonstrated by elongated neurofilament-pos. neurites and upregulation of NTRK1.  Addnl., MYCN oncogene expression was downregulated in vitro and tumor cell growth was markedly reduced in vivo.  Mechanistic studies suggest that cAMP-response element-binding protein (CREB) links HDAC8- and retinoic acid-mediated gene transcription.  In conclusion, HDAC-selective targeting can be effective in tumors exhibiting HDAC isoenzyme-dependent tumor growth in vivo and can be combined with differentiation-inducing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ55O9b9Q78LVg90H21EOLACvtfcHk0lj2YycyNSqpsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSis7s%253D&md5=41a5cfe6aaa685304b3bef0eae03a8ff</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.24%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DI.%26aulast%3DKoeneke%26aufirst%3DE.%26aulast%3DTrippel%26aufirst%3DF.%26aulast%3DMueller%26aufirst%3DW.%2BC.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DKopp-Schneider%26aufirst%3DA.%26aulast%3DFabian%26aufirst%3DJ.%26aulast%3DSchober%26aufirst%3DA.%26aulast%3DFernekorn%26aufirst%3DU.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DMilde%26aufirst%3DT.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DOehme%26aufirst%3DI.%26atitle%3DSelective%2520inhibition%2520of%2520HDAC8%2520decreases%2520neuroblastoma%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%2520and%2520enhances%2520retinoic%2520acid-mediated%2520differentiation%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1657%26doi%3D10.1038%2Fcddis.2015.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Krennhrubec, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedglin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, S. M.</span><span> </span><span class="NLM_article-title">Design and evaluation of “Linkerless” hydroxamic acids as selective HDAC8 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2878</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmcl.2007.02.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2874-2878&author=K.+Krennhrubecauthor=B.+L.+Marshallauthor=M.+Hedglinauthor=E.+Verdinauthor=S.+M.+Ulrich&title=Design+and+evaluation+of+%E2%80%9CLinkerless%E2%80%9D+hydroxamic+acids+as+selective+HDAC8+inhibitors&doi=10.1016%2Fj.bmcl.2007.02.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.064%26sid%3Dliteratum%253Aachs%26aulast%3DKrennhrubec%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DHedglin%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DUlrich%26aufirst%3DS.%2BM.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520%25E2%2580%259CLinkerless%25E2%2580%259D%2520hydroxamic%2520acids%2520as%2520selective%2520HDAC8%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2874%26epage%3D2878%26doi%3D10.1016%2Fj.bmcl.2007.02.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macarron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawiec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, M.</span><span> </span><span class="NLM_article-title">Identification of novel isoform-selective inhibitors within class I histone deacetylases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span><span class="refDoi"> DOI: 10.1124/jpet.103.055541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1124%2Fjpet.103.055541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=12975486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Shs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=720-728&author=E.+Huauthor=E.+Dulauthor=C.+M.+Sungauthor=Z.+Chenauthor=R.+Kirkpatrickauthor=G.+F.+Zhangauthor=K.+Johansonauthor=R.+Liuauthor=A.+Lagoauthor=G.+Hofmannauthor=R.+Macarronauthor=M.+de+los+Frailesauthor=P.+Perezauthor=J.+Krawiecauthor=J.+Winklerauthor=M.+Jaye&title=Identification+of+novel+isoform-selective+inhibitors+within+class+I+histone+deacetylases&doi=10.1124%2Fjpet.103.055541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel isoform-selective inhibitors within class I histone deacetylases</span></div><div class="casAuthors">Hu, Erding; Dul, Edward; Sung, Chiu-Mei; Chen, Zunxuan; Kirkpatrick, Robert; Zhang, Gui-Feng; Johanson, Kyung; Liu, Ronggang; Lago, Amparo; Hofmann, Glenn; MacArron, Ricardo; de los Frailes, Maite; Perez, Paloma; Krawiec, John; Winkler, James; Jaye, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">720-728</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) represent an expanding family of protein modifying-enzymes that play important roles in cell proliferation, chromosome remodeling, and gene transcription.  We have previously shown that recombinant human HDAC8 can be expressed in bacteria and retain its catalytic activity.  To further explore the catalytic activity of HDACs, we expressed two addnl. human class I HDACs, HDAC1 and HDAC3, in baculovirus.  Recombinant HDAC1 and HDAC3 fusion proteins remained sol. and catalytically active and were purified to near homogeneity.  Interestingly, trichostatin (TSA) was found to be a potent inhibitor for all three HDACs (IC50 value of ∼0.1 - 0.3 μM), whereas another HDAC inhibitor MS-27-275 (N-(2-aminophenyl)-4-[N-(pyridin-3-methyloxycarbonyl)-aminomethyl]benzamide) preferentially inhibited HDAC1 (IC50 value of ∼0.3 μM) vs. HDAC3 (IC50 value of ∼8 μM) and had no inhibitory activity toward HDAC8 (IC50 value >100 μM).  MS-27-275 as well as TSA increased histone H4 acetylation, induced apoptosis in the human colon cancer cell line SW620, and activated the simian virus 40 early promoter.  HDAC1 protein was more abundantly expressed in SW620 cells compared with that of HDAC3 and HDAC8.  Using purified recombinant HDAC proteins, we identified several novel HDAC inhibitors that preferentially inhibit HDAC1 or HDAC8.  These inhibitors displayed distinct properties in inducing histone acetylation and reporter gene expression.  These results suggest selective HDAC inhibitors could be identified using recombinantly expressed HDACs and that HDAC1 may be a promising therapeutic target for designing HDAC inhibitors for proliferative diseases such as cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNLO26_4qQdLVg90H21EOLACvtfcHk0lhl4Gb6NXb6iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Shs7k%253D&md5=453e111a1f7f9cdf1249e26c254d93e9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055541%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DDul%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DC.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKirkpatrick%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%2BF.%26aulast%3DJohanson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLago%26aufirst%3DA.%26aulast%3DHofmann%26aufirst%3DG.%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3Dde%2Blos%2BFrailes%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3DKrawiec%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DJaye%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520novel%2520isoform-selective%2520inhibitors%2520within%2520class%2520I%2520histone%2520deacetylases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D307%26spage%3D720%26epage%3D728%26doi%3D10.1124%2Fjpet.103.055541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbinger, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.4155%2Ffmc-2016-0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27572818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1609-1634&author=A.+Chakrabartiauthor=J.+Melesinaauthor=F.+R.+Kolbingerauthor=I.+Oehmeauthor=J.+Sengerauthor=O.+Wittauthor=W.+Sipplauthor=M.+Jung&title=Targeting+histone+deacetylase+8+as+a+therapeutic+approach+to+cancer+and+neurodegenerative+diseases&doi=10.4155%2Ffmc-2016-0117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases</span></div><div class="casAuthors">Chakrabarti, Alokta; Melesina, Jelena; Kolbinger, Fiona R.; Oehme, Ina; Senger, Johanna; Witt, Olaf; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1609-1634</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase 8 (HDAC8), a unique class I zinc-dependent HDAC, is an emerging target in cancer and other diseases.  Its substrate repertoire extends beyond histones to many nonhistone proteins.  Besides being a deacetylase, HDAC8 also mediates signaling via scaffolding functions.  Aberrant expression or deregulated interactions with transcription factors are crit. in HDAC8-dependent cancers.  Many potent HDAC8-selective inhibitors with cellular activity and anticancer effects have been reported.  We present HDAC8 as a druggable target and discuss inhibitors of different chem. scaffolds with cellular effects.  Furthermore, we review HDAC8 activators that revert activity of mutant enzymes.  Isotype-selective HDAC8 targeting in patients with HDAC8-relevant cancers is challenging, however, is promising to avoid adverse side effects as obsd. with pan-HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAgIFjNGH66LVg90H21EOLACvtfcHk0lhl4Gb6NXb6iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKhsrzF&md5=942984331e8f3c589b9257c17d2a9ec2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0117%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DKolbinger%26aufirst%3DF.%2BR.%26aulast%3DOehme%26aufirst%3DI.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DTargeting%2520histone%2520deacetylase%25208%2520as%2520a%2520therapeutic%2520approach%2520to%2520cancer%2520and%2520neurodegenerative%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1609%26epage%3D1634%26doi%3D10.4155%2Ffmc-2016-0117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9562</span><span class="NLM_x">–</span> <span class="NLM_lpage">9575</span><span class="refDoi"> DOI: 10.1021/jm300837y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300837y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9562-9575&author=T.+Suzukiauthor=Y.+Otaauthor=M.+Riauthor=M.+Bandoauthor=A.+Gotohauthor=Y.+Itohauthor=H.+Tsumotoauthor=P.+R.+Tatumauthor=T.+Mizukamiauthor=H.+Nakagawaauthor=S.+Iidaauthor=R.+Uedaauthor=K.+Shirahigeauthor=N.+Miyata&title=Rapid+discovery+of+highly+potent+and+selective+inhibitors+of+histone+deacetylase+8+using+click+chemistry+to+generate+candidate+libraries&doi=10.1021%2Fjm300837y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Ri, Masaki; Bando, Masashige; Gotoh, Aogu; Itoh, Yukihiro; Tsumoto, Hiroki; Tatum, Prima R.; Mizukami, Tamio; Nakagawa, Hidehiko; Iida, Shinsuke; Ueda, Ryuzo; Shirahige, Katsuhiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9562-9575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each contg. a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site.  These compds. were synthesized by using click chem.  Screening identified HDAC8-selective inhibitors including (I) (IC50 = 0.070 μM), which was more potent than PCI-34058 (IC50 = 0.31 μM), a known HDAC8 inhibitor.  Mol. modeling suggested that the phenylthiomethyl group of I binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity.  The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI50 = 3-80 μM).  These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGB7i5Bnw337Vg90H21EOLACvtfcHk0lgDJdx2aIugrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI&md5=9b730c0469b62c3ebd93a5e58c520a12</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300837y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300837y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DGotoh%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRapid%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25208%2520using%2520click%2520chemistry%2520to%2520generate%2520candidate%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9562%26epage%3D9575%26doi%3D10.1021%2Fjm300837y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1002/cmdc.201300414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201300414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=657-664&author=T.+Suzukiauthor=N.+Mutoauthor=M.+Bandoauthor=Y.+Itohauthor=A.+Masakiauthor=M.+Riauthor=Y.+Otaauthor=H.+Nakagawaauthor=S.+Iidaauthor=K.+Shirahigeauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+NCC149+derivatives+as+histone+deacetylase+8-selective+inhibitors&doi=10.1002%2Fcmdc.201300414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300414%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMuto%26aufirst%3DN.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMasaki%26aufirst%3DA.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520NCC149%2520derivatives%2520as%2520histone%2520deacetylase%25208-selective%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D657%26epage%3D664%26doi%3D10.1002%2Fcmdc.201300414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Huang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. I.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of ortho-aryl <i>N</i>-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1824</span><span class="refDoi"> DOI: 10.1002/cmdc.201200300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201200300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=22907916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1WrtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1815-1824&author=W.+J.+Huangauthor=Y.+C.+Wangauthor=S.+W.+Chaoauthor=C.+Y.+Yangauthor=L.+C.+Chenauthor=M.+H.+Linauthor=W.+C.+Houauthor=M.+Y.+Chenauthor=T.+L.+Leeauthor=P.+Yangauthor=C.+I.+Chang&title=Synthesis+and+biological+evaluation+of+ortho-aryl+N-hydroxycinnamides+as+potent+histone+deacetylase+%28HDAC%29+8+isoform-selective+inhibitors&doi=10.1002%2Fcmdc.201200300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors</span></div><div class="casAuthors">Huang, Wei-Jan; Wang, Yi-Ching; Chao, Shi-Wei; Yang, Chen-Yui; Chen, Liang-Chieh; Lin, Mei-Hsiang; Hou, Wen-Chi; Chen, Mei-Yu; Lee, Tai-Lin; Yang, Ping; Chang, Chung-I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1815-1824, S1815/1-S1815/41</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biol. process and diseases.  In contrast to other isoenzymes, HDAC8 is uniquely incapable of histone acetylation.  To delineate its physiol. function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques.  Enzyme inhibitory anal. demonstrated that some of the resulting compds. exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50 nM.  Among them, compd. (I) showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells.  Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compd. I.  These results suggest the effectiveness of our design concept, which may lead to a tool compd. for studying the specific role of HDAC8 in cellular biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop4xm7qu7wc7Vg90H21EOLACvtfcHk0lgDJdx2aIugrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1WrtLzL&md5=05279fdc5e9bc353f12fa3b1b0f3e365</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200300%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DChao%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DL.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DHou%26aufirst%3DW.%2BC.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%2BI.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520ortho-aryl%2520N-hydroxycinnamides%2520as%2520potent%2520histone%2520deacetylase%2520%2528HDAC%2529%25208%2520isoform-selective%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1815%26epage%3D1824%26doi%3D10.1002%2Fcmdc.201200300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Discovery of histone deacetylase 8 selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2605</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmcl.2011.01.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21334896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2601-2605&author=W.+Tangauthor=T.+Luoauthor=E.+F.+Greenbergauthor=J.+E.+Bradnerauthor=S.+L.+Schreiber&title=Discovery+of+histone+deacetylase+8+selective+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of histone deacetylase 8 selective inhibitors</span></div><div class="casAuthors">Tang, Weiping; Luo, Tuoping; Greenberg, Edward F.; Bradner, James E.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2601-2605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An efficient method for synthesizing candidate histone deacetylase (HDAC) inhibitors in 96-well plates, which are used directly in high-throughput screening, is reported.  Building blocks having hydrazide, aldehyde and hydroxamic acid functionalities were used.  The hydrazides were coupled with different aldehydes in DMSO.  The resulting products have the previously identified cap/linker/biasing element structure known to favor inhibition of HDACs.  These compds. were assayed without further purifn.  HDAC8-selective inhibitors were discovered from this novel collection of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTgHmuzYhy_LVg90H21EOLACvtfcHk0lgDJdx2aIugrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKisbw%253D&md5=5faa470ee503cbf4d3fb652295fc5075</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.134%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DGreenberg%26aufirst%3DE.%2BF.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520histone%2520deacetylase%25208%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2601%26epage%3D2605%26doi%3D10.1016%2Fj.bmcl.2011.01.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ingham, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yueh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porco, J. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeler, A. B.</span><span> </span><span class="NLM_article-title">Development of a potent and selective HDAC8 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeksbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=929-932&author=O.+J.+Inghamauthor=R.+M.+Paranalauthor=W.+B.+Smithauthor=R.+A.+Escobarauthor=H.+Yuehauthor=T.+Snyderauthor=J.+A.+Porcoauthor=J.+E.+Bradnerauthor=A.+B.+Beeler&title=Development+of+a+potent+and+selective+HDAC8+inhibitor&doi=10.1021%2Facsmedchemlett.6b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Potent and Selective HDAC8 Inhibitor</span></div><div class="casAuthors">Ingham, Oscar J.; Paranal, Ronald M.; Smith, William B.; Escobar, Randolph A.; Yueh, Han; Snyder, Tracy; Porco, John A.; Bradner, James E.; Beeler, Aaron B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel, isoform-selective inhibitor of histone deacetylase 8 (HDAC8) has been discovered by the repurposing of a diverse compd. collection.  Medicinal chem. optimization led to the identification of a highly potent (0.8 nM) and selective inhibitor I of HDAC8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKF0r_7S2dWLVg90H21EOLACvtfcHk0li6NT_FGKsZOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeksbbP&md5=69ab76f942dfc6a6b7801b90f48aa619</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00239%26sid%3Dliteratum%253Aachs%26aulast%3DIngham%26aufirst%3DO.%2BJ.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DEscobar%26aufirst%3DR.%2BA.%26aulast%3DYueh%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DT.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBeeler%26aufirst%3DA.%2BB.%26atitle%3DDevelopment%2520of%2520a%2520potent%2520and%2520selective%2520HDAC8%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D929%26epage%3D932%26doi%3D10.1021%2Facsmedchemlett.6b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobler, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radetich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancost, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span> </span><span class="NLM_article-title">Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4626</span><span class="NLM_x">–</span> <span class="NLM_lpage">4634</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2011.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=21723733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovF2ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=4626-4634&author=L.+Whiteheadauthor=M.+R.+Doblerauthor=B.+Radetichauthor=Y.+Zhuauthor=P.+W.+Atadjaauthor=T.+Claiborneauthor=J.+E.+Grobauthor=A.+McRinerauthor=M.+R.+Pancostauthor=A.+Patnaikauthor=W.+Shaoauthor=M.+Shultzauthor=R.+Tichkuleauthor=R.+A.+Tommasiauthor=B.+Vashauthor=P.+Wangauthor=T.+Stams&title=Human+HDAC+isoform+selectivity+achieved+via+exploitation+of+the+acetate+release+channel+with+structurally+unique+small+molecule+inhibitors&doi=10.1016%2Fj.bmc.2011.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors</span></div><div class="casAuthors">Whitehead, Lewis; Dobler, Markus R.; Radetich, Branko; Zhu, Yanyi; Atadja, Peter W.; Claiborne, Tavina; Grob, Jonathan E.; McRiner, Andrew; Pancost, Margaret R.; Patnaik, Anup; Shao, Wenlin; Shultz, Michael; Tichkule, Ritesh; Tommasi, Ruben A.; Vash, Brian; Wang, Ping; Stams, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4626-4634</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we report the discovery of a family of novel yet simple, amino-acid derived class I HDAC inhibitors that demonstrate isoform selectivity via access to the internal acetate release channel.  Isoform selectivity criteria is discussed on the basis of X-ray crystallog. and mol. modeling of these novel inhibitors bound to HDAC8, potentially revealing insights into the mechanism of enzymic function through novel structural features revealed at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgV7MIGevIxrVg90H21EOLACvtfcHk0li6NT_FGKsZOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovF2ju7w%253D&md5=c252ec223e909e92ec165f60a1a33b16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DDobler%26aufirst%3DM.%2BR.%26aulast%3DRadetich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DAtadja%26aufirst%3DP.%2BW.%26aulast%3DClaiborne%26aufirst%3DT.%26aulast%3DGrob%26aufirst%3DJ.%2BE.%26aulast%3DMcRiner%26aufirst%3DA.%26aulast%3DPancost%26aufirst%3DM.%2BR.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DTichkule%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%2BA.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStams%26aufirst%3DT.%26atitle%3DHuman%2520HDAC%2520isoform%2520selectivity%2520achieved%2520via%2520exploitation%2520of%2520the%2520acetate%2520release%2520channel%2520with%2520structurally%2520unique%2520small%2520molecule%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D4626%26epage%3D4634%26doi%3D10.1016%2Fj.bmc.2011.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Galletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintavalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, D.</span><span> </span><span class="NLM_article-title">Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span><span class="refDoi"> DOI: 10.1002/cmdc.200900309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.200900309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=19821480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWrs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1991-2001&author=P.+Gallettiauthor=A.+Quintavallaauthor=C.+Ventriciauthor=G.+Gianniniauthor=W.+Cabriauthor=S.+Pencoauthor=G.+Galloauthor=S.+Vincentiauthor=D.+Giacomini&title=Azetidinones+as+zinc-binding+groups+to+design+selective+HDAC8+inhibitors&doi=10.1002%2Fcmdc.200900309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors</span></div><div class="casAuthors">Galletti, Paola; Quintavalla, Arianna; Ventrici, Caterina; Giannini, Giuseppe; Cabri, Walter; Penco, Sergio; Gallo, Grazia; Vincenti, Silvia; Giacomini, Daria</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1991-2001</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Azetidinones, commonly known as β-lactams, are well-known heterocyclic compds.  Herein we described the synthesis and biol. evaluation of a series of novel β-lactams.  In vitro inhibition assays against HDAC isoforms showed an interesting isoform-selectivity of these compds. towards HDAC6 and HDAC8.  The isoform selectivity changed in response to modification of the azetidinone-ring nitrogen atom substituent.  The presence of an N-thiomethyl group is a prerequisite for the activity of these compds. in the micromolar range towards HDAC8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cOvRDsk9pLVg90H21EOLACvtfcHk0li6NT_FGKsZOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWrs7%252FE&md5=8d65eae30d5583a1273f52179a0d2602</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900309%26sid%3Dliteratum%253Aachs%26aulast%3DGalletti%26aufirst%3DP.%26aulast%3DQuintavalla%26aufirst%3DA.%26aulast%3DVentrici%26aufirst%3DC.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DVincenti%26aufirst%3DS.%26aulast%3DGiacomini%26aufirst%3DD.%26atitle%3DAzetidinones%2520as%2520zinc-binding%2520groups%2520to%2520design%2520selective%2520HDAC8%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1991%26epage%3D2001%26doi%3D10.1002%2Fcmdc.200900309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ononye, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanHeyst, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblak, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. L.</span><span> </span><span class="NLM_article-title">Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1021/ml400158k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400158k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=757-761&author=S.+N.+Ononyeauthor=M.+D.+VanHeystauthor=E.+Z.+Oblakauthor=W.+Zhouauthor=M.+Ammarauthor=A.+C.+Andersonauthor=D.+L.+Wright&title=Tropolones+as+lead-like+natural+products%3A+the+development+of+potent+and+selective+histone+deacetylase+inhibitors&doi=10.1021%2Fml400158k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors</span></div><div class="casAuthors">Ononye, Sophia N.; VanHeyst, Michael D.; Oblak, E. Zachary; Zhou, Wangda; Ammar, Mohamed; Anderson, Amy C.; Wright, Dennis L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">757-761</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products have long been recognized as a rich source of potent therapeutics, but further development is often limited by high structural complexity and high mol. wt.  In contrast, at the core of the thujaplicins is a lead-like tropolone scaffold characterized by relatively low mol. wt., ample sites for diversification, and metal-binding functionality poised for targeting a range of metalloenzyme drug targets.  Here, we describe the development of this underutilized scaffold for the discovery of tropolone derivs., e.g., I [R = Ph, 2-naphthyl, 4-MeOC6H4, 2,5-(MeOO)2C6H3, 2,3,4-(MeO)3C6H2], that function as isoenzyme-selective inhibitors of the validated anticancer drug target, histone deacetylase (HDAC).  Several monosubstituted tropolones display remarkable levels of selectivity for HDAC2 and potently inhibit the growth of T-cell lymphocyte cell lines.  The tropolones represent a new chemotype of isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWSNRk2L481rVg90H21EOLACvtfcHk0ljGUpKAHNvyiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCjsLc%253D&md5=7268eddf4ca6e61601488f423d52aafb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml400158k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400158k%26sid%3Dliteratum%253Aachs%26aulast%3DOnonye%26aufirst%3DS.%2BN.%26aulast%3DVanHeyst%26aufirst%3DM.%2BD.%26aulast%3DOblak%26aufirst%3DE.%2BZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAmmar%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BL.%26atitle%3DTropolones%2520as%2520lead-like%2520natural%2520products%253A%2520the%2520development%2520of%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D757%26epage%3D761%26doi%3D10.1021%2Fml400158k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">De Vreese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’hooghe, M.</span><span> </span><span class="NLM_article-title">Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejmech.2017.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=28453994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=174-195&author=R.+De+Vreeseauthor=M.+D%E2%80%99hooghe&title=Synthesis+and+applications+of+benzohydroxamic+acid-based+histone+deacetylase+inhibitors&doi=10.1016%2Fj.ejmech.2017.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors</span></div><div class="casAuthors">De Vreese, Rob; D'hooghe, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-195</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This paper provides an overview of the synthesis and biol. activity of the most representative benzohydroxamic acid-based histone deacetylase inhibitors published to date.  Benzohydroxamic acids comprise an important class of HDAC inhibitors, and recently several of these structures have been evaluated in clin. trials for the treatment of a variety of cancers.  In this overview, benzohydroxamic acids were divided in four different classes based on their reported selectivity towards zinc-dependent HDACs: a first and major class consists of HDAC6 selective inhibitors, a second class deals with pan-HDAC inhibitors, a third class comprises HDAC8 selective inhibitors and a fourth, minor class includes dual HDAC6/8 selective inhibitors.  Through this approach, structure-activity relationships were identified for each class, which could help future researchers in the design and development of novel benzohydroxamic acid-based HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyKAa1s9hoSbVg90H21EOLACvtfcHk0ljGUpKAHNvyiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslOhur0%253D&md5=769c343bdbb3fe610eff001afa79e0bb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVreese%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599hooghe%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520benzohydroxamic%2520acid-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D174%26epage%3D195%26doi%3D10.1016%2Fj.ejmech.2017.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Di Micco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span> </span><span class="NLM_article-title">Structural basis for the design and synthesis of selective HDAC inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3807</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2013.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3795-3807&author=S.+Di+Miccoauthor=M.+G.+Chiniauthor=S.+Terraccianoauthor=I.+Brunoauthor=R.+Riccioauthor=G.+Bifulco&title=Structural+basis+for+the+design+and+synthesis+of+selective+HDAC+inhibitors&doi=10.1016%2Fj.bmc.2013.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMicco%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DM.%2BG.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DBruno%26aufirst%3DI.%26aulast%3DRiccio%26aufirst%3DR.%26aulast%3DBifulco%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520the%2520design%2520and%2520synthesis%2520of%2520selective%2520HDAC%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3795%26epage%3D3807%26doi%3D10.1016%2Fj.bmc.2013.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Heimburg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robaa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of novel inhibitors targeting HDAC8 from Schistosoma mansoni for the treatment of schistosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2435</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Smtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2423-2435&author=T.+Heimburgauthor=A.+Chakrabartiauthor=J.+Lancelotauthor=M.+Marekauthor=J.+Melesinaauthor=A.+T.+Hauserauthor=T.+B.+Shaikauthor=S.+Duclaudauthor=D.+Robaaauthor=F.+Erdmannauthor=M.+Schmidtauthor=C.+Romierauthor=R.+J.+Pierceauthor=M.+Jungauthor=W.+Sippl&title=Structure-based+design+and+synthesis+of+novel+inhibitors+targeting+HDAC8+from+Schistosoma+mansoni+for+the+treatment+of+schistosomiasis&doi=10.1021%2Facs.jmedchem.5b01478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis</span></div><div class="casAuthors">Heimburg, Tino; Chakrabarti, Alokta; Lancelot, Julien; Marek, Martin; Melesina, Jelena; Hauser, Alexander-Thomas; Shaik, Tajith B.; Duclaud, Sylvie; Robaa, Dina; Erdmann, Frank; Schmidt, Matthias; Romier, Christophe; Pierce, Raymond J.; Jung, Manfred; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2423-2435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel.  In this study, a series of new benzohydroxamates were prepd. as potent inhibitors of Schistosoma mansoni histone deacetylase 8 (smHDAC8).  Crystallog. anal. provided insights into the inhibition mode of smHDAC8 activity by these 3-amidobenzohydroxamates.  The newly designed inhibitors were evaluated in screens for enzyme inhibitory activity against schistosome and human HDACs.  Twenty-seven compds. were found to be active in the nanomolar range, and some of them showed selectivity toward smHDAC8 over the major human HDACs (1 and 6).  The active benzohydroxamates were addnl. screened for lethality against the schistosome larval stage using a fluorescence-based assay.  Four of these showed significant dose-dependent killing of the schistosome larvae and markedly impaired egg laying of adult worm pairs maintained in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSRG-zzL4EB7Vg90H21EOLACvtfcHk0ljGUpKAHNvyiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Smtr8%253D&md5=ca2c4d9cb317d33484f22d350d41d55c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01478%26sid%3Dliteratum%253Aachs%26aulast%3DHeimburg%26aufirst%3DT.%26aulast%3DChakrabarti%26aufirst%3DA.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DA.%2BT.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26aulast%3DDuclaud%26aufirst%3DS.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520inhibitors%2520targeting%2520HDAC8%2520from%2520Schistosoma%2520mansoni%2520for%2520the%2520treatment%2520of%2520schistosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2423%26epage%3D2435%26doi%3D10.1021%2Facs.jmedchem.5b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyano, H.</span><span> </span><span class="NLM_article-title">Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.12.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2011.12.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1442-1460&author=K.+Hadaauthor=A.+Sudaauthor=K.+Asohauthor=T.+Tsukudaauthor=M.+Hasegawaauthor=Y.+Satoauthor=K.+Ogawaauthor=S.+Kuramotoauthor=Y.+Aokiauthor=N.+Shimmaauthor=T.+Ishikawaauthor=H.+Koyano&title=Angiogenesis+inhibitors+identified+by+cell-based+high-throughput+screening%3A+synthesis%2C+structure-activity+relationships+and+biological+evaluation+of+3-%5B%28E%29-styryl%5Dbenzamides+that+specifically+inhibit+endothelial+cell+proliferation&doi=10.1016%2Fj.bmc.2011.12.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.12.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.12.058%26sid%3Dliteratum%253Aachs%26aulast%3DHada%26aufirst%3DK.%26aulast%3DSuda%26aufirst%3DA.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKuramoto%26aufirst%3DS.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKoyano%26aufirst%3DH.%26atitle%3DAngiogenesis%2520inhibitors%2520identified%2520by%2520cell-based%2520high-throughput%2520screening%253A%2520synthesis%252C%2520structure-activity%2520relationships%2520and%2520biological%2520evaluation%2520of%25203-%255B%2528E%2529-styryl%255Dbenzamides%2520that%2520specifically%2520inhibit%2520endothelial%2520cell%2520proliferation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D1442%26epage%3D1460%26doi%3D10.1016%2Fj.bmc.2011.12.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Tasler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegoraro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirrgiebel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlert, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubbutat, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachtele, C.</span><span> </span><span class="NLM_article-title">Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6728</span><span class="NLM_x">–</span> <span class="NLM_lpage">6737</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.bmc.2009.07.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6728-6737&author=S.+Taslerauthor=O.+Mullerauthor=T.+Wieberauthor=T.+Herzauthor=S.+Pegoraroauthor=W.+Saebauthor=M.+Langauthor=R.+Kraussauthor=F.+Totzkeauthor=U.+Zirrgiebelauthor=J.+E.+Ehlertauthor=M.+H.+Kubbutatauthor=C.+Schachtele&title=Substituted+2-arylbenzothiazoles+as+kinase+inhibitors%3A+hit-to-lead+optimization&doi=10.1016%2Fj.bmc.2009.07.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DTasler%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DO.%26aulast%3DWieber%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DT.%26aulast%3DPegoraro%26aufirst%3DS.%26aulast%3DSaeb%26aufirst%3DW.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DKrauss%26aufirst%3DR.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DZirrgiebel%26aufirst%3DU.%26aulast%3DEhlert%26aufirst%3DJ.%2BE.%26aulast%3DKubbutat%26aufirst%3DM.%2BH.%26aulast%3DSchachtele%26aufirst%3DC.%26atitle%3DSubstituted%25202-arylbenzothiazoles%2520as%2520kinase%2520inhibitors%253A%2520hit-to-lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6728%26epage%3D6737%26doi%3D10.1016%2Fj.bmc.2009.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Vannini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span> </span><span class="NLM_article-title">Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span><span class="refDoi"> DOI: 10.1038/sj.embor.7401047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fsj.embor.7401047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=17721440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFWks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=879-884&author=A.+Vanniniauthor=C.+Volpariauthor=P.+Gallinariauthor=P.+Jonesauthor=M.+Mattuauthor=A.+Carfiauthor=R.+De+Francescoauthor=C.+Steinkuhlerauthor=S.+Di+Marco&title=Substrate+binding+to+histone+deacetylases+as+shown+by+the+crystal+structure+of+the+HDAC8-substrate+complex&doi=10.1038%2Fsj.embor.7401047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex</span></div><div class="casAuthors">Vannini, Alessandro; Volpari, Cinzia; Gallinari, Paola; Jones, Philip; Mattu, Marco; Carfi, Andrea; De Francesco, Raffaele; Steinkuehler, Christian; Di Marco, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">879-884</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) - an enzyme family that deacetylates histones and non-histone proteins - are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clin. trials.  Here, we report the 2.0 Å resoln. crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate.  The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition.  Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation.  A similar interaction is obsd. in a new hydroxamate inhibitor-HDAC8 structure that we also solved.  The crucial role of Asp101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnS-LTrNkPbVg90H21EOLACvtfcHk0ljErFuKbD6dcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFWks7Y%253D&md5=1362cac7c0820d5b250b05597fafa7dc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7401047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7401047%26sid%3Dliteratum%253Aachs%26aulast%3DVannini%26aufirst%3DA.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DGallinari%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DMattu%26aufirst%3DM.%26aulast%3DCarfi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26atitle%3DSubstrate%2520binding%2520to%2520histone%2520deacetylases%2520as%2520shown%2520by%2520the%2520crystal%2520structure%2520of%2520the%2520HDAC8-substrate%2520complex%26jtitle%3DEMBO%2520Rep.%26date%3D2007%26volume%3D8%26spage%3D879%26epage%3D884%26doi%3D10.1038%2Fsj.embor.7401047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Millard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celardo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordiyenko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairall, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwabe, J. W.</span><span> </span><span class="NLM_article-title">Class I HDACs share a common mechanism of regulation by inositol phosphates</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.molcel.2013.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.molcel.2013.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=23791785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=57-67&author=C.+J.+Millardauthor=P.+J.+Watsonauthor=I.+Celardoauthor=Y.+Gordiyenkoauthor=S.+M.+Cowleyauthor=C.+V.+Robinsonauthor=L.+Fairallauthor=J.+W.+Schwabe&title=Class+I+HDACs+share+a+common+mechanism+of+regulation+by+inositol+phosphates&doi=10.1016%2Fj.molcel.2013.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates</span></div><div class="casAuthors">Millard, Christopher J.; Watson, Peter J.; Celardo, Ivana; Gordiyenko, Yuliya; Cowley, Shaun M.; Robinson, Carol V.; Fairall, Louise; Schwabe, John W. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Class I histone deacetylases (HDAC1, HDAC2, and HDAC3) are recruited by cognate corepressor proteins into specific transcriptional repression complexes that target HDAC activity to chromatin resulting in chromatin condensation and transcriptional silencing.  The authors previously reported the structure of HDAC3 in complex with the SMRT corepressor.  This structure revealed inositol-tetraphosphate [Ins(1,4,5,6)P4] at the interface of the two proteins.  It was previously unclear whether the role of Ins(1,4,5,6)P4 is to act as a structural cofactor or a regulator of HDAC3 activity.  Here the authors report the structure of HDAC1 in complex with MTA1 from the NuRD complex.  The ELM2-SANT domains from MTA1 wrap completely around HDAC1 occupying both sides of the active site such that the adjacent BAH domain is ideally positioned to recruit nucleosomes to the active site of the enzyme.  Functional assays of both the HDAC1 and HDAC3 complexes reveal that Ins(1,4,5,6)P4 is a bona fide conserved regulator of class I HDAC complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYPhL0103LkLVg90H21EOLACvtfcHk0ljErFuKbD6dcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVygu74%253D&md5=05a4267bf965b5a6217873217044ef2a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DMillard%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DP.%2BJ.%26aulast%3DCelardo%26aufirst%3DI.%26aulast%3DGordiyenko%26aufirst%3DY.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DRobinson%26aufirst%3DC.%2BV.%26aulast%3DFairall%26aufirst%3DL.%26aulast%3DSchwabe%26aufirst%3DJ.%2BW.%26atitle%3DClass%2520I%2520HDACs%2520share%2520a%2520common%2520mechanism%2520of%2520regulation%2520by%2520inositol%2520phosphates%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D51%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fj.molcel.2013.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, D. W.</span><span> </span><span class="NLM_article-title">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span><span class="refDoi"> DOI: 10.1038/nchembio.2134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnchembio.2134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27454933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=741-747&author=Y.+Haiauthor=D.+W.+Christianson&title=Histone+deacetylase+6+structure+and+molecular+basis+of+catalysis+and+inhibition&doi=10.1038%2Fnchembio.2134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 structure and molecular basis of catalysis and inhibition</span></div><div class="casAuthors">Hai, Yang; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">741-747</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a crit. target for drug design because of its role in oncogenic transformation and cancer metastasis, and is unique among all histone deacetylases in that it contains tandem catalytic domains designated CD1 and CD2.  We now report the crystal structures of CD2 from Homo sapiens HDAC6 and of CD1 and CD2 from Danio rerio HDAC6.  We correlated these structures with activity measurements using 13 different substrates.  The catalytic activity of CD2 from both species exhibited broad substrate specificity, whereas that of CD1 was highly specific for substrates bearing C-terminal acetyllysine residues.  Crystal structures of substrate complexes yielded unprecedented snapshots of the catalytic mechanism.  Addnl., crystal structures of complexes with eight different inhibitors, including belinostat and panobinostat (currently used in cancer chemotherapy), the macrocyclic tetrapeptide HC toxin, and the HDAC6-specific inhibitor N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide, revealed surprising new insight regarding changes in Zn2+ coordination and isoenzyme-specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqCfziGBHBRLVg90H21EOLACvtfcHk0litUDtOJUG4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rJ&md5=e167bc6f66e00923da4f2bced2b306b9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2134%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DY.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520structure%2520and%2520molecular%2520basis%2520of%2520catalysis%2520and%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D741%26epage%3D747%26doi%3D10.1038%2Fnchembio.2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Miyake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keusch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, P.</span><span> </span><span class="NLM_article-title">Structural insights into HDAC6 tubulin deacetylation and its selective inhibition</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1038/nchembio.2140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fnchembio.2140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=27454931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=748-754&author=Y.+Miyakeauthor=J.+J.+Keuschauthor=L.+Wangauthor=M.+Saitoauthor=D.+Hessauthor=X.+Wangauthor=B.+J.+Melanconauthor=P.+Helquistauthor=H.+Gutauthor=P.+Matthias&title=Structural+insights+into+HDAC6+tubulin+deacetylation+and+its+selective+inhibition&doi=10.1038%2Fnchembio.2140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into HDAC6 tubulin deacetylation and its selective inhibition</span></div><div class="casAuthors">Miyake, Yasuyuki; Keusch, Jeremy J.; Wang, Longlong; Saito, Makoto; Hess, Daniel; Wang, Xiaoning; Melancon, Bruce J.; Helquist, Paul; Gut, Heinz; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report crystal structures of zebrafish histone deacetylase 6 (HDAC6) catalytic domains in tandem or as single domains in complex with the (R) and (S) enantiomers of trichostatin A (TSA) or with the HDAC6-specific inhibitor, nexturastat A.  The tandem domains formed, together with the inter-domain linker, an ellipsoid-shaped complex with pseudo-twofold symmetry.  The authors identified important active site differences between both catalytic domains and revealed the binding mode of HDAC6 selective inhibitors.  HDAC inhibition assays with (R)- and (S)-TSA showed that (R)-TSA was a broad-range inhibitor, whereas (S)-TSA had moderate selectivity for HDAC6.  The authors identified a uniquely positioned α-helix and a flexible Trp residue in the loop joining α-helixes H20 to H21 as crit. for deacetylation of the physiol. substrate, tubulin.  Using single-mol. measurements and biochem. assays, the authors demonstrated that HDAC6 catalytic domain 2 deacetylated α-tubulin Lys-40 in the lumen of microtubules, but that its preferred substrate was unpolymd. tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERJRurS1cC7Vg90H21EOLACvtfcHk0litUDtOJUG4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rM&md5=4abe529ab89615df33f54350a1a8c69a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2140%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DY.%26aulast%3DKeusch%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DGut%26aufirst%3DH.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DStructural%2520insights%2520into%2520HDAC6%2520tubulin%2520deacetylation%2520and%2520its%2520selective%2520inhibition%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D748%26epage%3D754%26doi%3D10.1038%2Fnchembio.2140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rodrigues, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira-Silva, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sant’Anna, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ionta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of novel <i>N</i>-acylhydrazone derivatives as potent histone deacetylase 6/8 dual inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=655-670&author=D.+A.+Rodriguesauthor=G.+A.+Ferreira-Silvaauthor=A.+C.+Ferreiraauthor=R.+A.+Fernandesauthor=J.+K.+Kweeauthor=C.+M.+Sant%E2%80%99Annaauthor=M.+Iontaauthor=C.+A.+Fraga&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+novel+N-acylhydrazone+derivatives+as+potent+histone+deacetylase+6%2F8+dual+inhibitors&doi=10.1021%2Facs.jmedchem.5b01525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01525%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DFerreira-Silva%26aufirst%3DG.%2BA.%26aulast%3DFerreira%26aufirst%3DA.%2BC.%26aulast%3DFernandes%26aufirst%3DR.%2BA.%26aulast%3DKwee%26aufirst%3DJ.%2BK.%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DC.%2BM.%26aulast%3DIonta%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520novel%2520N-acylhydrazone%2520derivatives%2520as%2520potent%2520histone%2520deacetylase%25206%252F8%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D655%26epage%3D670%26doi%3D10.1021%2Facs.jmedchem.5b01525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melesina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easmon, J.</span><span> </span><span class="NLM_article-title">2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic acids as novel selective histone deacetylase-6 inhibitors with antiproliferative activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0134556</span><span class="refDoi"> DOI: 10.1371/journal.pone.0134556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.pone.0134556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0134556&author=L.+Wangauthor=M.+Koflerauthor=G.+Broschauthor=J.+Melesinaauthor=W.+Sipplauthor=E.+D.+Martinezauthor=J.+Easmon&title=2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic+acids+as+novel+selective+histone+deacetylase-6+inhibitors+with+antiproliferative+activity&doi=10.1371%2Fjournal.pone.0134556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0134556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0134556%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKofler%26aufirst%3DM.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DMelesina%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DEasmon%26aufirst%3DJ.%26atitle%3D2-Benzazolyl-4-piperazin-1-ylsulfonylbenzenecarbohydroxamic%2520acids%2520as%2520novel%2520selective%2520histone%2520deacetylase-6%2520inhibitors%2520with%2520antiproliferative%2520activity%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0134556%26doi%3D10.1371%2Fjournal.pone.0134556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Olson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidoud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davoine, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holson, E. B.</span><span> </span><span class="NLM_article-title">Discovery of the first histone deacetylase 6/8 dual inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4816</span><span class="NLM_x">–</span> <span class="NLM_lpage">4820</span><span class="refDoi"> DOI: 10.1021/jm400390r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400390r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4816-4820&author=D.+E.+Olsonauthor=F.+F.+Wagnerauthor=T.+Kayaauthor=J.+P.+Galeauthor=N.+Aidoudauthor=E.+L.+Davoineauthor=F.+Lazzaroauthor=M.+Weiwerauthor=Y.+L.+Zhangauthor=E.+B.+Holson&title=Discovery+of+the+first+histone+deacetylase+6%2F8+dual+inhibitors&doi=10.1021%2Fjm400390r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm400390r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400390r%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DKaya%26aufirst%3DT.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DAidoud%26aufirst%3DN.%26aulast%3DDavoine%26aufirst%3DE.%2BL.%26aulast%3DLazzaro%26aufirst%3DF.%26aulast%3DWeiwer%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DDiscovery%2520of%2520the%2520first%2520histone%2520deacetylase%25206%252F8%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4816%26epage%3D4820%26doi%3D10.1021%2Fjm400390r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Summerhill, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, M. C.</span><span> </span><span class="NLM_article-title">Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2F0169-328X%2887%2990002-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=2887236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A280%3ADyaL2szgtVKltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1987&pages=99-103&author=E.+M.+Summerhillauthor=K.+Woodauthor=M.+C.+Fishman&title=Regulation+of+tyrosine+hydroxylase+gene+expression+during+differentiation+of+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tyrosine hydroxylase gene expression during differentiation of neuroblastoma cells</span></div><div class="casAuthors">Summerhill E M; Wood K; Fishman M C</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-103</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Differentiation of N1E-115 neuroblastoma cells into neuron-like cells, with extension of neurites and acquisition of excitable membranes, can be induced by dimethyl sulfoxide (DMSO).  We have found this differentiation to be accompanied by an increase in tyrosine hydroxylase (TH) mRNA, an increase disproportionate to changes in mRNAs for other measured, non-neuron-specific genes.  The mRNA increases slowly over several days and falls gradually after removal of DMSO.  Nuclear run-on studies suggest that a change in the rate of transcription cannot explain the increase in steady-state mRNA levels.  TH mRNA half-life does, however, increase.  This suggests that regulation is exerted in this case not at the level of transcription but rather at that of mRNA stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnvM5iSt7HV5otVjB3IRIyfW6udTcc2ea4iEOINXLkILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szgtVKltQ%253D%253D&md5=12c44bf5b4b352f2861c01a8222f5b90</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2887%2990002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252887%252990002-7%26sid%3Dliteratum%253Aachs%26aulast%3DSummerhill%26aufirst%3DE.%2BM.%26aulast%3DWood%26aufirst%3DK.%26aulast%3DFishman%26aufirst%3DM.%2BC.%26atitle%3DRegulation%2520of%2520tyrosine%2520hydroxylase%2520gene%2520expression%2520during%2520differentiation%2520of%2520neuroblastoma%2520cells%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D388%26spage%3D99%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Eggert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span> </span><span class="NLM_article-title">Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1038%2Fsj.onc.1203518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10803465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtF2jsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2043-2051&author=A.+Eggertauthor=N.+Ikegakiauthor=X.+Liuauthor=T.+T.+Chouauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=G.+M.+Brodeur&title=Molecular+dissection+of+TrkA+signal+transduction+pathways+mediating+differentiation+in+human+neuroblastoma+cells&doi=10.1038%2Fsj.onc.1203518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells</span></div><div class="casAuthors">Eggert, Angelika; Ikegaki, Naohiko; Liu, Xing-Ge; Chou, Thomas T.; Lee, Virginia M.; Trojanowski, John Q.; Brodeur, Garrett M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2043-2051</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the neurotrophin receptor TrkA by its ligand nerve growth factor (NGF) initiates a cascade of signaling events leading to neuronal differentiation in vitro and might play an important role in the differentiation of favorable neuroblastomas (NB) in vivo.  To study TrkA signal transduction pathways and their effects on differentiation in NB, we stably expressed wild-type TrkA and five different TrkA mutants in the NGF unresponsive human NB cell line SH-SY5Y.  Resulting clones were characterized by TrkA mRNA and protein expression, and by autophosphorylation of the receptor.  Introduction of wild-type TrkA restored NGF responsiveness of SH-SY5Y cells, as demonstrated by morphol. differentiation, activation of mitogen-activated protein kinases (MAPK) and induction of immediate-early genes.  Expression of TrkA in the absence of NGF resulted in growth inhibition of transfectants compared to parental cells, whereas NGF-treatment increased their proliferation rate.  Anal. of downstream signal transduction pathways indicated that NGF-induced differentiation was dependent on TrkA kinase activity.  Our data suggest that several redundant pathways are present further downstream, but activation of the RAS/MAPK signaling pathway seems to be of major importance for NGF mediated differentiation of NB cells.  Our results also show that the signaling effector SH2-B is a substrate of NGF-mediated Trk signaling in NB, whereas it is not activated by NGF in rat pheochromocytoma PC12 cells.  This might explain the differences we obsd. in TrkA signaling between neuroblastoma and PC12 cells.  Further insight into TrkA signaling may suggest new options for the treatment of NB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMcffQwGzqfrVg90H21EOLACvtfcHk0lhktr-G03O1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtF2jsbk%253D&md5=11c2bc9243954f97c9a8dab11d9103fd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203518%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DA.%26aulast%3DIkegaki%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChou%26aufirst%3DT.%2BT.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26atitle%3DMolecular%2520dissection%2520of%2520TrkA%2520signal%2520transduction%2520pathways%2520mediating%2520differentiation%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2043%26epage%3D2051%26doi%3D10.1038%2Fsj.onc.1203518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrman, S. J.</span><span> </span><span class="NLM_article-title">A review on the use of sodium triacetoxyborohydride in the reductive amination of ketones and aldehydes</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1021/op0601013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op0601013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=971-1031&issue=5&author=A.+F.+Abdel-Magidauthor=S.+J.+Mehrman&title=A+review+on+the+use+of+sodium+triacetoxyborohydride+in+the+reductive+amination+of+ketones+and+aldehydes&doi=10.1021%2Fop0601013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A Review on the Use of Sodium Triacetoxyborohydride in the Reductive Amination of Ketones and Aldehydes</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Mehrman, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-1031</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Sodium triacetoxyborohydride is a mild, very effective, and synthetically useful reducing agent for the reductive amination of aldehydes and ketones.  The examples presented illustrate the reagent's wide scope, the diverse and numerous applications, and the high tolerance for many functional groups.  It also shows fewer limitations than other reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo82o7gXZ4dc7Vg90H21EOLACvtfcHk0lhktr-G03O1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVymurk%253D&md5=23826b51c561015e8aa887606804ec2a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fop0601013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0601013%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DMehrman%26aufirst%3DS.%2BJ.%26atitle%3DA%2520review%2520on%2520the%2520use%2520of%2520sodium%2520triacetoxyborohydride%2520in%2520the%2520reductive%2520amination%2520of%2520ketones%2520and%2520aldehydes%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26issue%3D5%26spage%3D971%26epage%3D1031%26doi%3D10.1021%2Fop0601013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kocienski, P. J.</span> <span class="citation_source-book">Protecting Groups</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Georg Thieme Verlag</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">206</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1055%2Fb-003-108603" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=206&author=P.+J.+Kocienski&title=Protecting+Groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fb-003-108603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1055%252Fb-003-108603%26sid%3Dliteratum%253Aachs%26aulast%3DKocienski%26aufirst%3DP.%2BJ.%26btitle%3DProtecting%2520Groups%26pub%3DGeorg%2520Thieme%2520Verlag%26date%3D2005%26spage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Jiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel 2-(1<i>H</i>-imidazol-2-yl) pyridine sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2Fj.ejmech.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=25461318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=170-183&author=Y.+Jiaoauthor=B.+T.+Xinauthor=Y.+Zhangauthor=J.+Wuauthor=X.+Luauthor=Y.+Zhengauthor=W.+Tangauthor=X.+Zhou&title=Design%2C+synthesis+and+evaluation+of+novel+2-%281H-imidazol-2-yl%29+pyridine+sorafenib+derivatives+as+potential+BRAF+inhibitors+and+anti-tumor+agents&doi=10.1016%2Fj.ejmech.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents</span></div><div class="casAuthors">Jiao, Yu; Xin, Bo-Tao; Zhang, Yanmin; Wu, Jianbing; Lu, Xiaolin; Zheng, Ying; Tang, Weifang; Zhou, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">170-183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-(1H-imidazol-2-yl)pyridine derivs. have been designed and synthesized, and they were screened for BRAF kinase inhibitory activity.  Besides, their biol. activities were evaluated in vitro and in vivo.  All the compds. were reported for the first time, and compds. I and II displayed the most potent antiproliferative activity against cell line A375 in vitro, with IC50 values of 4.26 and 2.93 μM, resp., which were comparable with the pos. control Sorafenib.  Those two compds. were further evaluated for the in vivo efficacy using an A375 xenograft nude mice model.  The results showed that the growth of A375 cancer cells xenografts was suppressed by factors of 35.68% and 42.50% (percent tumor growth inhibition values) after intragastric (ig) administration of compd. I and II at concn. of 50 mg/kg.  Thus they may be promising lead compds. to be developed as an alternative for current Sorafenib therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEdpxPrhB6MrVg90H21EOLACvtfcHk0lg_I6xPg_-C9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksbvJ&md5=b270c12f2711cbf8e81d1ced544f091e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%25202-%25281H-imidazol-2-yl%2529%2520pyridine%2520sorafenib%2520derivatives%2520as%2520potential%2520BRAF%2520inhibitors%2520and%2520anti-tumor%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D170%26epage%3D183%26doi%3D10.1016%2Fj.ejmech.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Meca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Císařová, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drahoňovský, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvořák, D.</span><span> </span><span class="NLM_article-title">Enantiomerically pure axially chiral aminocarbene complexes of chromium</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1858</span><span class="refDoi"> DOI: 10.1021/om701188p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om701188p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=1850-1858&issue=8&author=L.+Mecaauthor=I.+C%C3%ADsa%C5%99ov%C3%A1author=D.+Draho%C5%88ovsk%C3%BDauthor=D.+Dvo%C5%99%C3%A1k&title=Enantiomerically+pure+axially+chiral+aminocarbene+complexes+of+chromium&doi=10.1021%2Fom701188p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fom701188p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom701188p%26sid%3Dliteratum%253Aachs%26aulast%3DMeca%26aufirst%3DL.%26aulast%3DC%25C3%25ADsa%25C5%2599ov%25C3%25A1%26aufirst%3DI.%26aulast%3DDraho%25C5%2588ovsk%25C3%25BD%26aufirst%3DD.%26aulast%3DDvo%25C5%2599%25C3%25A1k%26aufirst%3DD.%26atitle%3DEnantiomerically%2520pure%2520axially%2520chiral%2520aminocarbene%2520complexes%2520of%2520chromium%26jtitle%3DOrganometallics%26date%3D2008%26volume%3D27%26issue%3D8%26spage%3D1850%26epage%3D1858%26doi%3D10.1021%2Fom701188p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>Molecular Operating Environment (MOE), version <span class="NLM_edition">2014.09</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span> (<span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite No. 910, Montreal, QC H3A 2R7, Canada</span>),<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2014.09%3B+Chemical+Computing+Group+Inc.+%281010+Sherbooke+St.+West%2C+Suite+No.+910%2C+Montreal%2C+QC+H3A+2R7%2C+Canada%29%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span>Schrödinger Release 2014-2: LigPrep, <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2014-2%3A+LigPrep%2C+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lg_I6xPg_-C9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span>Schrödinger Release 2014-2: Schrödinger Suite 2014-2 Protein Preparation Wizard; Epik, version <span class="NLM_edition">2.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Impact, version <span class="NLM_edition">6.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Prime, version <span class="NLM_edition">3.6</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2014-2%3A+Schr%C3%B6dinger+Suite+2014-2+Protein+Preparation+Wizard%3B+Epik%2C+version+2.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014%3B+Impact%2C+version+6.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014%3B+Prime%2C+version+3.6%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202014-2%2520Protein%2520Preparation%2520Wizard%253B%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>Small-Molecule Drug Discovery Suite 2014-2: Glide, version <span class="NLM_edition">9.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Small-Molecule+Drug+Discovery+Suite+2014-2%3A+Glide%2C+version+9.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0limTzrBb_WqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>Schrödinger Release 2017-2: Canvas; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Release+2017-2%3A+Canvas%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCanvas%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebbioso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1002/cmdc.201200193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1002%2Fcmdc.201200193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1256-1266&author=D.+A.+Stolfaauthor=A.+Stefanachiauthor=J.+M.+Gajerauthor=A.+Nebbiosoauthor=L.+Altucciauthor=S.+Cellamareauthor=M.+Jungauthor=A.+Carotti&title=Design%2C+synthesis%2C+and+biological+evaluation+of+2-aminobenzanilide+derivatives+as+potent+and+selective+HDAC+inhibitors&doi=10.1002%2Fcmdc.201200193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200193%26sid%3Dliteratum%253Aachs%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGajer%26aufirst%3DJ.%2BM.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25202-aminobenzanilide%2520derivatives%2520as%2520potent%2520and%2520selective%2520HDAC%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1256%26epage%3D1266%26doi%3D10.1002%2Fcmdc.201200193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Marek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes Mourao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolfa, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romier, C.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003645</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1371%2Fjournal.ppat.1003645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=24086136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOnurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003645&author=M.+Marekauthor=S.+Kannanauthor=A.+T.+Hauserauthor=M.+Moraes+Mouraoauthor=S.+Cabyauthor=V.+Curaauthor=D.+A.+Stolfaauthor=K.+Schmidtkunzauthor=J.+Lancelotauthor=L.+Andradeauthor=J.+P.+Renaudauthor=G.+Oliveiraauthor=W.+Sipplauthor=M.+Jungauthor=J.+Cavarelliauthor=R.+J.+Pierceauthor=C.+Romier&title=Structural+basis+for+the+inhibition+of+histone+deacetylase+8+%28HDAC8%29%2C+a+key+epigenetic+player+in+the+blood+fluke+Schistosoma+mansoni&doi=10.1371%2Fjournal.ppat.1003645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni</span></div><div class="casAuthors">Marek, Martin; Kannan, Srinivasaraghavan; Hauser, Alexander-Thomas; Mourao, Marina Moraes; Caby, Stephanie; Cura, Vincent; Stolfa, Diana A.; Schmidtkunz, Karin; Lancelot, Julien; Andrade, Luiza; Renaud, Jean-Paul; Oliveira, Guilherme; Sippl, Wolfgang; Jung, Manfred; Cavarelli, Jean; Pierce, Raymond J.; Romier, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1003645</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The treatment of schistosomiasis, a disease caused by blood flukes parasites of the Schistosoma genus, depends on the intensive use of a single drug, praziquantel, which increases the likelihood of the development of drug-resistant parasite strains and renders the search for new drugs a strategic priority.  Currently, inhibitors of human epigenetic enzymes are actively investigated as novel anti-cancer drugs and have the potential to be used as new anti-parasitic agents.  Here, we report that Schistosoma mansoni histone deacetylase 8 (smHDAC8), the most expressed class I HDAC isotype in this organism, is a functional acetyl--lysine deacetylase that plays an important role in parasite infectivity.  The crystal structure of smHDAC8 shows that this enzyme adopts a canonical α/β HDAC fold, with specific solvent exposed loops corresponding to insertions in the schistosome HDAC8 sequence.  Importantly, structures of smHDAC8 in complex with generic HDAC inhibitors revealed specific structural changes in the smHDAC8 active site that cannot be accommodated by human HDACs.  Using a structure-based approach, we identified several small-mol. inhibitors that build on these specificities.  These mols. exhibit an inhibitory effect on smHDAC8 but show reduced affinity for human HDACs.  Crucially, we show that a newly identified smHDAC8 inhibitor has the capacity to induce apoptosis and mortality in schistosomes.  Taken together, our biol. and structural findings define the framework for the rational design of small-mol. inhibitors specifically interfering with schistosome epigenetic mechanisms, and further support an anti-parasitic epigenome targeting strategy to treat neglected diseases caused by eukaryotic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIGu8lR_TxrVg90H21EOLACvtfcHk0limTzrBb_WqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOnurzI&md5=9fef2938ff73df80fc60b739c878f9a6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003645%26sid%3Dliteratum%253Aachs%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DHauser%26aufirst%3DA.%2BT.%26aulast%3DMoraes%2BMourao%26aufirst%3DM.%26aulast%3DCaby%26aufirst%3DS.%26aulast%3DCura%26aufirst%3DV.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DLancelot%26aufirst%3DJ.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DRenaud%26aufirst%3DJ.%2BP.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DCavarelli%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DR.%2BJ.%26aulast%3DRomier%26aufirst%3DC.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520histone%2520deacetylase%25208%2520%2528HDAC8%2529%252C%2520a%2520key%2520epigenetic%2520player%2520in%2520the%2520blood%2520fluke%2520Schistosoma%2520mansoni%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003645%26doi%3D10.1371%2Fjournal.ppat.1003645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skowron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthold, F.</span><span> </span><span class="NLM_article-title">Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA</span> <span class="citation_source-journal">J. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/S1525-1578(10)60013-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=10.1016%2FS1525-1578%2810%2960013-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=15681479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFKrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=89-96&author=M.+Fischerauthor=M.+Skowronauthor=F.+Berthold&title=Reliable+transcript+quantification+by+real-time+reverse+transcriptase-polymerase+chain+reaction+in+primary+neuroblastoma+using+normalization+to+averaged+expression+levels+of+the+control+genes+HPRT1+and+SDHA&doi=10.1016%2FS1525-1578%2810%2960013-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA</span></div><div class="casAuthors">Fischer, Matthias; Skowron, Matthias; Berthold, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">JMDIFP</span>;
        ISSN:<span class="NLM_cas:issn">1525-1578</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology and the Association for Molecular Pathology</span>)
        </div><div class="casAbstract">Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) represents a sensitive and efficient technique to det. expression levels of target genes in multiple samples and is increasingly used in clin. oncol. to evaluate the patient's outcome or to detect minimal residual disease.  Normalization of raw data are required to obtain comparable results between different specimens and is usually achieved by correlating transcript abundances of target genes with those of a single control gene with putatively stable expression levels.  In this study, expression stability of six supposed control genes was evaluated in 64 samples of primary neuroblastoma and HPRT1 and SDHA mRNA levels were shown to exhibit the least expression variability among the samples.  Because application of more than one control gene may enhance reliability of real-time RT-PCR results, various normalization factors consisting of the geometrical mean of multiple control gene expression values were calcd. and evaluated by mRNA quantification of 14 target genes.  Comparison with transcript levels detd. by oligonucleotide-array expression anal. revealed that target gene mRNA quantification became most consistent after normalization to averaged expression levels of HPRT1 and SDHA.  This normalization factor was in addn. demonstrated to be not assocd. with stage of disease or MYCN amplification status of the tumor.  Thus, these data indicate that the geometrical mean of HPRT1 and SDHA transcript levels represents a suitable internal control for biol. and clin. studies investigating differential gene expression in primary neuroblastoma by real-time RT-PCR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAEeAQts387bVg90H21EOLACvtfcHk0limTzrBb_WqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFKrt74%253D&md5=ce40921135d77a6fdcd7bb1ac0c947dc</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1525-1578%2810%2960013-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1525-1578%252810%252960013-X%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DSkowron%26aufirst%3DM.%26aulast%3DBerthold%26aufirst%3DF.%26atitle%3DReliable%2520transcript%2520quantification%2520by%2520real-time%2520reverse%2520transcriptase-polymerase%2520chain%2520reaction%2520in%2520primary%2520neuroblastoma%2520using%2520normalization%2520to%2520averaged%2520expression%2520levels%2520of%2520the%2520control%2520genes%2520HPRT1%2520and%2520SDHA%26jtitle%3DJ.%2520Mol.%2520Diagn.%26date%3D2005%26volume%3D7%26spage%3D89%26epage%3D96%26doi%3D10.1016%2FS1525-1578%2810%2960013-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5X','PDB','2V5X'); return false;">PDB: 2V5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BKX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BKX','PDB','4BKX'); return false;">PDB: 4BKX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EDU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EDU','PDB','5EDU'); return false;">PDB: 5EDU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G0I','PDB','5G0I'); return false;">PDB: 5G0I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01447">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20026"></div></div></div></div></div><hr /></hr><p class="last">This material is available free of charge. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01447">10.1021/acs.jmedchem.7b01447</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Spectral data for the compounds and docking figures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_001.pdf">jm7b01447_si_001.pdf (791.32 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01447/suppl_file/jm7b01447_si_002.csv">jm7b01447_si_002.csv (2.3 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01447&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01447%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01447" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992d2f5ef03da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
